Coronin 1B Coordinates Actin Dynamics in Lamellipodia by Cai, Liang
CORONIN 1B COORDINATES ACTIN DYNAMICS
IN LAMELLIPODIA
by
Liang Cai
A dissertation submitted to the faculty of the University of North Carolina at Chapel
Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy
in the Department of Cell and Developmental Biology.
Chapel Hill
2007
Approved by
Advisor: James Bear
Committee Member: Vytas Bankaitis
Committee Member: Keith Burridge
Committee Member: Klaus Hahn
Committee Member: Steve Rogers
Committee Member: Michael Schaller
Reader: Dorothy Schafer
c© 2007
Liang Cai
ALL RIGHTS RESERVED
ii
Abstract
LIANG CAI: CORONIN 1B COORDINATES ACTIN DYNAMICS IN
LAMELLIPODIA.
(Under the direction of James Bear.)
Cell migration is critical for a variety of physiological processes. Coronins are a
conserved family of actin binding proteins that affect cell migration. My research
focuses on the molecular mechanism through which Coronin 1B coordinates actin
dynamics in lamellipodia.
We report that Coronin 1B co-localizes with the Arp2/3 complex in lamellipodia,
and co-immunoprecipitates with this complex. This interaction is regulated by PKC
phosphorylation on Ser2. Further, we show that Coronin 1B interacts with not only
the Arp2/3 complex but also the Slingshot 1L (SSH1L) phosphatase, two regulators
of actin filament formation and turnover. Coronin 1B inhibits filament nucleation
by Arp2/3 complex and this inhibition is attenuated by the Ser2 phosphorylation, a
site targeted by SSH1L. Coronin 1B also directs SSH1L to lamellipodia where SSH1L
likely regulates Cofilin activity via dephosphorylation. Accordingly, depleting Coro-
nin 1B increases phospho-Cofilin levels, and alters lamellipodial dynamics and actin
architecture. Thus, Coronin 1B coordinates actin assembly by Arp2/3 complex and
actin disassembly by Cofilin for effective lamellipodial protrusion.
Analysis of Coronin function has been hampered by the lack of a clear under-
standing of how Coronin interacts with F-actin. We identify a surface-exposed con-
served residue, Arg30, which is critical for Coronin 1B binding to F-actin. We demon-
strate that Coronin 1B binds with high affinity to ATP/ADP-Pi F-actin, and the R30D
iii
mutant lacking F-actin binding loses the ability to exert Coronin 1B function.
Using various biochemical assays, we show that Coronin 1B disassembles Arp2/3-
containing actin branches by inducing Arp2/3 dissociation from the side of fila-
ments, which is potently antagonized by Cortactin. Coronin 1B localizes to actin
branches in a mutually exclusive manner with the Arp2/3 complex, and live-cell
imaging reveals a sequential accumulation of these proteins during actin network as-
sembly. Interestingly, depletion of Coronin 1B synchronizes the dynamics of Arp2/3
complex with the actin network. Together, we conclude that Coronin 1B replaces the
Arp2/3 complex at actin branches, promotes branched actin network remodeling,
and coordinates actin dynamics in lamellipodia.
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Chapter 1
Introduction
“Directed cell migration accompanies us from conception to death.” 1
Cell motility is critical for a variety of physiological processes such as wound
healing, cellular immune response, establishing neuronal connections, embryogene-
sis andmorphogenesis. Inappropriate cell movement is responsible for many severe
human diseases, including cancer metastasis, birth defects, cardiovascular diseases
and compromised immune function. Cytoskeletal remodeling is an essential step
during cell migration. Generating and reorganizing a variety of cytoskeleton struc-
tures, especially the actin network, play critical roles in cell migration, but the pre-
cise mechanism by which the actin cytoskeleton and actin-binding proteins affect
motility is still not clearly understood.
1.1 Actin, an important element of the cytoskeleton
Actin, one of the most important cytoskeleton proteins, was found “conagulated”
with myosin in 1887 by Halliburton, where he described it as “myosin-ferment”
1 http://www.cellmigration.org/science/
(Halliburton, 1887). not until 1942, relative pure actin was isolated by Straub using
a novel technique (Zallar and Szabo, 1989). The method used at that time involved
multiple rounds of polymerization and depolymerization reactions, which are es-
sentially the same basic actin purification procedures used today.
Actin is highly conserved throughout evolution. Under appropriate salt condi-
tion, monomer actin has the tendency to self-assembly and forms filaments. The
crystal structure of the actin monomer demonstrated the globular shape of this 42
kDa protein (Kabsch et al., 1985, 1990). Low resolution structure of actin filament
reflected its helix nature (Holmes et al., 1990). Both monomer (G-actin) and polymer
(F-actin) forms of actin exist in vivo and their dynamics are regulated by a variety of
actin-binding proteins, including actin nucleators, G-actin binding proteins, F-actin
binding proteins, actin depolymerizing/severing proteins, actin bundling proteins,
actin crosslinking proteins, pointed end capping proteins, and barbed end capping
proteins (Siripala and Welch, 2007).
1.1.1 The biochemical activity of actin is regulated by its nucleotide
composition
Two actin monomers bind relatively weakly to each other. The addition of the third
molecule stabilizes the actin trimer – “nucleus”, and boosts the polymerization reac-
tion. Assembly the actin nucleus is the rate-limiting step in the formation of an actin
filament. Each actinmonomer carries a tightly boundATPmolecule. After its assem-
bly into the actin filament, ATP is hydrolyzed quickly into the ADP-Pi form with a
half life about 2 seconds 2, followed by the slow release of inorganic phosphate (Pi)
at a rate of 0.002 sec−1 to form ADP F-actin (Pollard et al., 2000). The addition of ATP
2 Every known property of ADP-Pi actin is identical to ATP actin.
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G-actin to a growing filament can be faster than 0.3 sec−1, which creates a filament
end containing all ATP bound actin subunits, called the ATP cap. This fast grow-
ing end of F-actin is called the barbed end, which was named based on the shape
of the myosin head decorated actin filaments observed under electron microscope.
The other end of the actin filament composed of ADP-Pi or ADP actin subunits, is
the slowing growing end, called the pointed end. Under steady state conditions, the
actin polymer maintains a constant length, with the barbed end having a net assem-
bly and the pointed end having a net disassembly. This unique property of actin
filaments dynamics is called treadmilling.
Understanding the nucleotide composition of actin is the key to understanding
its biochemical activity and the regulatory mechanisms of various actin-binding pro-
teins. ATP G-actin is the active form, and can be polymerized above the concentra-
tion of 0.1 µM, while ADP G-actin only starts the polymerization reaction when
the monomer concentration is above 5 µM (Pollard, 1986). These concentrations
are called critical concentrations. In vivo, ADP bound G-actin is quickly exchanged
into the ATP bound form by Profilin. Under ATP depletion condition, significantly
reduced intracellular ATP levels cause stochastic actin depolymerization and de-
construction of the actin cytoskeleton due to the “aging” of actin filaments. Actin
depolymerization factors, such as Cofilin, promote Pi release from ADP-Pi actin
subunits and enhance filaments depolymerization. Within one actin filament, from
barbed end to pointed end, the nucleotide composition changes, from the ATP cap,
to amixture of ATP andADP-Pi actin subunits, to ADP-Pi actin subunits, and ending
with ADP bound subunits. This heterogeneous nature creates unique binding sites
for various actin-binding proteins, and may also be the primary targeting mecha-
nisms for these proteins.
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1.1.2 Actin requires nucleators to promote its polymerization
To generate the complex actin cytoskeleton, efficient actin nucleation is the first and
central step. Spontaneous nucleation of G-actin to form filaments is very slow, and
specific nucleators are required in vivo to promote actin filament formation. Over the
past decade, multiple factors have been identified to promote actin nucleation, in-
cluding Formins, Spire, Cordon-bleu and the Arp2/3 complex. Upon the activation
byWiskottAldrich syndrome protein (WASP), suppressor of cAMP receptor (SCAR)
or WASP family verprolin homologous (WAVE) protein complex, the Arp2/3 com-
plex promotes branched actin network assembly and forms characteristic 70◦ angles
betweenmother and daughter filaments (Mullins et al., 1998). Details related to actin
nucleation by the Arp2/3 complex are covered in the following section.
Formins are a large family of proteins which promote filamentary actin nucle-
ation, with a slower assembly rate than the activated Arp2/3 complex (Pruyne et al.,
2002; Sagot et al., 2002). The conserved core of Formins are formin homology do-
mains 1 and 2, which were found to be directly responsible for actin nucleation in
vitro. Formins promote nucleation by stabilizing the actin dimer and recruiting a
Profilin-bound actin monomer to form the nucleus (Pring et al., 2003). Interestingly,
Formins weakly cap the barbed ends of actin filaments and walk processively with
the barbed ends as the filaments elongate (Zigmond et al., 2003). Spire nucleates
actin filaments at a rate that is similar to that of Formins and stays associated at
pointed ends (Quinlan et al., 2005). This protein has a cluster of four WASP homol-
ogy 2 (WH2) domains, each of which binds an actin monomer, and assembles a
single-stranded, linear actin tetramer. Additional actin monomers are recruited to
this tetramer and complete the two-stranded helix actin nucleus. Cordon-bleu is a
new member of known actin nucleators (Ahuja et al., 2007). This protein has three
WH2 domains with two close linked (20 amino acids between) and the other with 70
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amino acids away. The current model of the activity of Cordon-bleu is that the three
WH2 domains directly help the assembly of the trimeric actin nucleus to initiate
actin nucleation. Different actin nucleators each nucleate actin filaments via distinct
mechanisms and create different actin networks in the cell.
1.1.3 Research approaches to study actin dynamics
The biochemical activities and cellular functions of actin and different actin-binding
proteins have been a intense research area in cell biology for years. A variety of tech-
niques and approaches have been invented to address the dynamics and regulation
of these proteins.
The most wildly used approach is the actin cosedimentation assay. Based on
distinct sedimentation differences between actin monomers and polymers, actin fil-
aments can be pelleted by 100,000×g centrifugation. This assay has be used to exam-
ine the critical concentrations of actin under different conditions. Reactions includ-
ing various actin-binding proteins could be used to verify their F-actin binding activ-
ities (Figure 4.5-A). We have used this assay, combined with quantitive immunoblot-
ting, to measure the F-actin binding affinity of certain proteins (Figure 4.5-E). An al-
teration of the high-speed actin cosedimentation assay is the low-speed actin cosed-
imentation assay, which separates actin bundles from single actin filaments and was
used to examine the bundling activity of actin-binding proteins (Figure 4.12-E).
Actin can be labeled on Cys 374 by pyrene – benzo(d,e,f)phenanthrene. The flu-
orescence of pyrene-labeled actin is much higher after polymerization, which can
be examined relatively easily by a fluorometer. The characterization of properties
of pyrene-labeled actin resulted in the invention of the pyrene actin polymerization
assay (Cooper et al., 1983). This assay has been used to study the actin nucleation ki-
netics of actin nucleators or the effects of actin-binding proteins on actin nucleation
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(Figure 3.8-A). An alteration of this assay is the pyrene actin depolymerization assay,
which is performed by diluting pre-formed pyrene actin filaments under the critical
concentration and monitoring the decay of pyrene fluorescence. The depolymer-
ization assay can be used to study the activity of actin depolymerizing or severing
factors (Figure 4.8-A). Since any alteration on either barbed ends or pointed ends
could significantly affect actin polymerization or depolymerization kinetics, these
pyrene actin assays have been used successfully in examining actin filament end
capping activities of various actin-binding proteins (Figure 3.9).
Pyrene actin assays are solution based assays, which lack the spacial resolution
of individual actin filament elongation. Recently, total internal reflection microscopy
(TIRFM) based actin visual assays have been used to examine the kinetics of actin
polymerization and depolymerization at the single filament level (Amann and Pollard,
2001; Blanchoin et al., 2000a; Kuhn and Pollard, 2005). Actin can be labeled by vari-
ous fluorescent dyes, including Rhodamine, Oregon Green, or different AlexaFluor
dyes (Invitrogen). Reactions can be performed in small volumes (∼10-20 µl) and
monitored by TIRFM in real time. This assay directly visualizes actin filaments
growing under the microscope, and reveals both the spacial and temporal kinetics
of individual actin filaments. TIRFM could be used not only to study the elongation
rate of actin nucleation (Figure 5.4-D), but also to examine actin branching frequency
(Figure 5.4-F). Carefully designed actin visual assays can be used to examine various
biochemical activities of actin-binding proteins, such as VASP capturing filaments
barbed ends 3 or Las17p dissociating from branched actin structures (Martin et al.,
2006a).
Approaches described so far all use purified components and are performed in
vitro. To examine actin dynamics in vivo, genetically encoded fluorescent tagged
3 Personal communication with Dr. Dorothy Schafer.
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actin fusion proteins could be ectopically expressed (Watanabe and Mitchison, 2002).
An alternative is microinjecting trace amounts of dye-labeled actin into cells (Salmon et al.,
2002). The fluorescent actin could be examined using different fluorescentmicroscopy
techniques. To study the kinetics, specifically actin retrograde flow dynamics, either
kymography analysis (Figure 3.3-A) or quantitative fluorescent speckle microscopy
(qFSM) could be utilized (Danuser and Waterman-Storer, 2003; Ponti et al., 2003, 2004).
Using qFSM analysis also produces information about actin polymerization and de-
polymerization kinetics in specific localization in the cell (Ponti et al., 2003). Re-
cently, photoactivatable fluorescent actin has been successfully used in studying
actin turnover in protruding lamellipodia (Kiuchi et al., 2007), which is a reflection
of the expanding variety of techniques available for in vivo analysis of actin dynam-
ics.
A one micron segment of an actin filament has 370 subunits of actin monomer,
whichmakes it impossible to study individual actin subunit dynamics by fluorescent
microscopy. To study the ultra-structure of actin filaments or diverse actin networks
in vivo, different electron microscopy techniques have been used successfully in past
years. To examine purified components, samples could be negative stained and sub-
jected to transmission electron microscopy (TEM) (Figure 5.10-A), or directly visu-
alized by cryo-electron microscopy. This approach has be utilized to precisely mea-
sure actin subunits on and off rates at either end of the filament (Pollard, 1986). TEM
also reveals unique actin structures generated by different actin-binding proteins
(Mullins et al., 1998). To examine actin structures in vivo, phalloidin is recommended
to use in addition to protein extraction solution to preserve actin cytoskeleton dur-
ing the sample preparation. Samples can be visualized by negative staining (Figure
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5.1-B), (Small and Celis, 1978). This approach has been applied successfully in visu-
alizing not only the flat actin network in lamellipodia, but also actin comet tails gen-
erated by Listeria monocytogenes (Sechi et al., 1997). Another common approach used
is platinum replica electron microscopy (Figure 3.3-F), (Svitkina and Borisy, 1999).
This technique uses critical point drying and metal shading and produces very de-
tailed topological structure to actin networks in thin regions in the cell, like lamel-
lipodia. Combination of both fluorescent light microscopy and electron microscopy
on the same sample could employ the advantages of both techniques and establish
functional connections between actin dynamics and ultra-architecture.
1.2 Arp2/3 complex, the generator of branched actin net-
work
TheArp2/3 complex is the only known actin nucleator which can produce the branched
actin structure. Arp2 and Arp3, two subunits of the complex, were initially identi-
fied as unconventional actins, and named actin-related proteins (Machesky et al.,
1994). Later experiments demonstrated that this highly conserved, stably assem-
bled seven-subunit protein complex (Figure 1.1) is the central component for gen-
erating branched actin networks and pushing lamellipodia forward (Svitkina et al.,
1997; Svitkina and Borisy, 1999). The crystal structure of the Arp2/3 complex helped
to reveal the mechanism of its nucleation: by positioning Arp2 and Arp3 in close
proximity to mimic an actin dimer, upon the binding of another actin monomer,
an actin nucleus forms and actin polymerization starts (Robinson et al., 2001). Dic-
tyostelium mutants lacking functional Arp2/3 complex failed to respond to chemo-
tactic stimulation and have greatly reduced cell motility and pseudopod extensions
(Langridge and Kay, 2007). Mice lacking either Arp3 or Arpc3/p21Arc subunit died
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before implantation, due to compromised pre-implantation development (Vauti et al.,
2007; Yae et al., 2006), suggesting that a sufficient amount of functional Arp2/3 com-
plex is crucial for mammals to survive.
1.2.1 Arp2/3 complex requires NPFs for its activation
The Arp2/3 complex is intrinsically inactive and needs to be activated extrinsically
in order to nucleate actin filaments. Nucleation promoting factors (NPFs), which ac-
tivate Arp2/3 complex, are grouped into two categories. Type I NPFs, such asWASP
and SCAR, activate the Arp2/3 complex by inducing its conformational change and
delivering the monomer to form the actin nucleus for polymerization. Type II NPFs,
such as Abp1 and Cortactin, have modest activation activity on their own, but syn-
ergize with Type I NPFs to promote Arp2/3 mediated actin nucleation (Goode et al.,
2001; Uruno et al., 2001; Weaver et al., 2001).
Revealing the signaling transduction cascade that leads to the activation of the
Arp2/3 complexwas an excitingmoment in history (Egile et al., 1999;Machesky et al.,
1999; Rohatgi et al., 1999; Winter et al., 1999; Yarar et al., 1999; Machesky and Insall,
1998). Upon extracellular stimuli, GTPases, most likely Rac1 and Cdc42, are acti-
vated and recruit type I NPFs to plasma membrane. In the case of WASP, binding
between activated GTPase and WASP releases WASP from intrinsic autoinhibition.
Activated WASP transiently binds to the Arp2/3 complex via its acidic domain (A)
and uses its verprolin domain (V, also named WH2 domain) to deliver the actin
monomer to form the nucleus for nucleation. Upon activation, the Arp2/3 complex
is thought to change conformation from an “open” inactive state to a “closed” active
state (Nolen et al., 2004; Rodal et al., 2005), and actin nucleation begins. Growing ev-
idence suggest that NPFs could not only be activated on the plasma membrane, but
9
Figure 1.1: Purified Arp2/3 complex
The Arp2/3 complex was purified from bovine brain. Different subunits were separated by SDS-
PAGE and visualized by silver staining.
also on other cellular organelles. Exploring the Arp2/3 complex activation mech-
anisms under various cellular environments continuously expands knowledge of
actin dynamics in vivo.
1.2.2 The structural role of Arp2/3 complex in branched actin net-
work
Unlike other actin nucleators, the Arp2/3 complex not only nucleates unique branched
actin networks, but also stays associated with actin filaments to maintain the den-
dritic structure of the network. Cryo-electron microscopy revealed the 70◦ char-
acteristic actin branches formed by the Arp2/3 complex, while platinum replica
electron microscopy localized the complex in vivo at the branched actin network
(Mullins et al., 1998; Svitkina and Borisy, 1999). Together with biochemical evidence,
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“the dendritic nucleation treadmilling model” was proposed to explain actin dy-
namics within lamellipodia (Pollard et al., 2001). Activated Arp2/3 complex gener-
ates barbed ends by a side-branchingmechanism in the distal region of lamellipodia.
Rapid elongation of these new actin branches pushes the membrane forward. Dur-
ing the elongation process, actin filaments age by ATP hydrolysis on each actin sub-
unit, followed by phosphate release. At the back of lamellipodia, Cofilin promotes
phosphate dissociation from actin subunits, severs actin filaments and promotes
actin depolymerization. Capping proteins can terminate actin filament growth to
decrease protrusion tendency in a manner antagonistic with Ena/VASP/Mena pro-
teins (Bear et al., 2002). Profilin catalyzes the exchange of ADP for ATP on the actin
monomer, which is essential for continuous actin elongation. It is worth noticing
that in addition to its actin “regeneration” function at the back of lamellipodia,
Cofilin also severes actin filaments in the front of lamellipodia, and synergizes with
the Arp2/3 complex in stimulated lamellipodial extension (DesMarais et al., 2004;
Ghosh et al., 2004)
Regarding its role in maintaining actin filaments within the branched structure,
the Arp2/3 complex is likely to have its Arp2 andArp3 subunits capping the pointed
end of daughter actin filament, while other subunits reside on the mother actin fil-
ament. Several structural models have been proposed to address the exact dock-
ing position of the Arp2/3 complex on mother actin filament (Beltzner and Pollard,
2004; Aguda et al., 2005; Egile et al., 2005). The model based on genetic labeling and
electron microscopy analysis suggests that the Arpc2/p34Arc and Arpc4/p20Arc
subunits (with possible contribution from the Arpc5/p16Arc subunit) align the cen-
tral vertical axis and directly face the groove of the actin filament, with the Arp3 and
Arpc3/p20Arc subunits on one side and the Arpc1/p40Arc subunit on the other
side to prevent horizontal movement (Egile et al., 2005). Interestingly, in these actin
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branches generated by genetically labeled Arp2/3 complex, only Cortactin stays as-
sociated with the actin filaments, while type I NPFs, such as SCAR and WASP, are
not present, supporting the notion that type I NPFs activate the Arp2/3 complex
via the transient interaction. It also indicates that Cortactin not only activates the
Arp2/3 complex but also resides in the branched structure, likely to help the Arp2/3
complex maintaining the actin network.
1.2.3 ATP hydrolysis on the subunits regulates the Arp2/3 complex
activity
Just like actin, Arp2 and Arp3 subunits of the complex have micromolar affinity
to nucleotides. ATP bound Arp2 and Arp3 are required for actin nucleation, since
neither ADP nor non-hydrolyzable ATP analog loaded Arp2/3 complex could ini-
tiate actin polymerization (Dayel et al., 2001). Using Arp2/3 complex purified from
Acanthamoeba castellini, in response to activation by WASP, the Arp2 subunit rapidly
hydrolyzes ATP in parallel with binding of the actin monomer to form a nucleus
for actin polymerization, which happens within seconds (Dayel and Mullins, 2004).
While using Arp2/3 complex purified from Saccharomyces cerevisiae, upon activa-
tion, the Arp2 subunit hydrolyzes ATP much more slowly, which is over minutes
(Martin et al., 2006a). Regardless of the difference in ATP hydrolysis rate, yeast with
an Arp2 mutant that is deficient in ATP hydrolysis fail to internalize actin patches
(Martin et al., 2006a, 2005), indicating that functional ATPase activity of the Arp2/3
complex is essential. Interestingly, the actin branches formed in vitro by the Arp2
mutant have prolonged stability, suggesting that ATP hydrolysis on Arp2 is required
for spontaneous branch dissociation (Martin et al., 2006a).
Together, the Arp2/3 complex not only nucleates actin filaments on the side of
existing ones to form the dendritic actin network, but also plays a structural role in
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maintaining these branched actin structures. The activity of Arp2/3 complex is well
correlated with the ATPase activity of Arp2 and Arp3 subunits. Growing evidence
suggest that, just like actin, ATP hydrolysis plays an important role in defining the
state of the Arp2/3 complex within the cycle. The half life of Arp2/3 containing
actin branches in vitro is over 40 minutes, which is not consistent with the rapid
actin remodeling observed in vivo. Factors that either accelerate Arp2/Arp3 ATP
hydrolysis or directly disassemble branched actin networks are anticipated to exist.
1.3 Cortactin, the stabilizer of branched actin structure
Cortactin, a type II nucleation promoting factor (NPF), has very weak actin nucle-
ation activity alone, but potently synergizes with other NPFs to promote Arp2/3
complexmediated actin polymerization (Uruno et al., 2001;Weaver et al., 2001). Cor-
tactin was identified as a tyrosine phosphorylated protein in Src transformed cells
(Wu et al., 1991). It has F-actin binding activity, and localizes to actin enriched struc-
tures, such asmembrane ruffles, lamellipodia and podosomes in vivo (Wu and Parsons,
1993). The specific localization of Cortactin requires its interaction with both actin
filaments and the Arp2/3 complex (Weed et al., 2000) (Figure 5.1-E). Cortactin binds
to the Arp2/3 complex via its N terminus (Weed et al., 2000), and binds to actin fila-
ments via its tandem repeats in the middle of the molecular (Wu and Parsons, 1993).
The C terminus of Cortactin is the Src homology 3 (SH3) domain, which mediates
Cortactin interacting with other signaling proteins.
Cortactin has many binding partners in vivo and plays important roles in various
actin-dependent processes (Daly, 2004). Cortactin is upregulated in several aggres-
sive forms of cancer, including highly invasive head and neck squamous cell carcino-
mas (Patel et al., 1996). This observation is consistent with enrichment of Cortactin
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in invadopodia (Clark et al., 2007), which are feet-like structures used by cancer cells
to aid migration and invasion.
Cortactin is the only known factor that stabilizes actin branches in vitro (Weaver et al.,
2001). Using purified components to assemble the branched actin network, in the
presence of Cortactin, both the number of branches observed and the stability of
actin branches increase (Weaver et al., 2001) (Figure 5.4-F). However, the biological
significance of this actin branch stabilizing activity has not been addressed.
The activity of Cortactin is precisely regulated, either by phosphorylation, acety-
lation or proteolysis (Zhang et al., 2007; Perrin et al., 2006). Calpain 2, a calcium-
dependent protease, can specifically cleave Cortactin after its actin-binding domain
and limits membrane protrusions to regulate cell migration (Perrin et al., 2006). Hi-
stone deacetylase 6 (HDAC6), a tubulin-specific deacetylase, can interact with Cor-
tactin and decrease its acetylation level. A charge preserving mutant of Cortactin,
which prevents it being regulated by acetylation, has diminished F-actin binding
and impairs cell motility (Zhang et al., 2007), indicating that protein acetylation not
only affects the stability of the microtubule cytoskeleton, but also regulates the bio-
chemical activities of actin-binding proteins. Greater understanding of the regula-
tory mechanisms of Cortactin, a potential biomarker for metastatic carcinomas, is
required.
1.4 Cofilin, the major regulator of actin turnover
ADF/Cofilin proteins (hereafter referred to as Cofilin) control actin filament turnover
in vivo. At the back of lamellipodia, Cofilin is thought to promote filament disas-
sembly via severing and possibly enhanced depolymerization (Svitkina and Borisy,
1999; Iwasa and Mullins, 2007).
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Cofilin is a small protein with its molecular weight below 20 kDa. The first
member of the Cofilin protein family was discovered during the purification of
chicken actin (Bamburg et al., 1980). Cofilin was characterized primarily as an F-
actin binding protein, and was named based on its ability to form cofilamentous
structures with actin (Nishida et al., 1984; Bamburg, 1999). Cofilin is essential for
various biological processes, including cytokinesis, phagocytosis, endocytosis and
other actin dependent cellular events (Bamburg et al., 1980). Mice deficient for actin
depolymerizing factor (ADF) develop irregular thickening of the corneal epithelium,
very similar to that observed in human corneal surface disease (Ikeda et al., 2003).
Lack of the non-muscle-specific cofilin gene (n-cofilin) is embryonic lethal in mice
(Gurniak et al., 2005). Mutant embryos at E9.5 have indistinguishable gross mor-
phology from wild type littermates, indicating that n-cofilin is not essential for the
extensive morphogenetic movements during gastrulation. However, after E9.5, se-
vere developmental defects become evident, and these n-cofilin mutant embryos die
because of a complete lack of neural tube closure. Conditional removal of n-cofilin
in brain revealed that Cofilin is required for radial migration in cerebrum, and lack
of n-cofilin results in not only the lack of intermediate cortical layers, but also the
depletion of the neuronal progenitor pool (Bellenchi et al., 2007).
Mechanistically, Cofilin severs and potentially enhances depolymerization of actin
filaments (Bamburg et al., 1999). The stability of actin filaments is correlated with
the nucleotide state of subunits. After ATP hydrolysis and Pi release from actin,
ADP bound actin subunits have a slightly altered structure compared with ATP or
ADP-Pi bound subunits, and this change results in de-stabilization of actin filaments
(Belmont et al., 1999). Cofilin accelerates Pi release and promotes actin depolymer-
ization at pointed ends of filaments (Carlier et al., 1997; Belmont et al., 1999). In
addition to its enhancing actin filament depolymerization activity, using different
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techniques, Cofilin was demonstrated to have filament severing activity as well
(Cooper et al., 1986; Maciver et al., 1991; Ichetovkin et al., 2000). Are there differ-
ent mechanisms involved for its severing and depolymerizing activities? What does
factor(s) define Cofilin activity? Direct observation of actin filament dynamics un-
der TIRFM resolved this difference (Andrianantoandro and Pollard, 2006). At low
concentrations, Cofilin prefers to sever actin filaments, while high concentrations of
Cofilin accelerate actin depolymerization.
Electron microscopy and helical reconstruction show that Cofilin decorated actin
filaments have changes in the number of subunits per turn (McGough et al., 1997).
4 This twist change results from direct binding of Cofilin to actin filaments. Con-
sistently, molecules that stabilize F-actin by cooperative binding, such as phalloidin
and jasplakinolide, inhibit Cofilin binding to actin filaments (Figure 4.8-C). Based
on site-specific fluorescent probes and cross-liking analysis, an allosteric model was
suggested to explain the severing mechanism of Cofilin (Bobkov et al., 2006). The
binding of one Cofilin molecule alters the adjacent-subunit structure, and stores the
tension. The binding of the second Cofilin on the same actin filament with close
proximity results in the severing. This model is consistent with the observation that
only low concentrations can Cofilin sever actin filaments (Mouneimne et al., 2006;
Pavlov et al., 2007). Despite lacking a complete understanding about its biochemical
activities, Cofilin cooperatively binds along the sides of actin filaments to promote
actin severing and depolymerization, which is essential for actin remodeling in vivo.
The activity of Cofilin is regulated in a variety of ways including phosphoryla-
tion, PIP2 binding, intracellular pH changes and interactions with binding partners
4 From 2.160 subunits per turn to 2.222 subunits per turn
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such as actin interaction protein 1 (AIP1) (Bamburg, 1999). Among these regula-
tions, Serine 3 (Ser3) phosphorylation is the best documented mechanism modu-
lating Cofilin activity. LIM kinase (LIMK) phosphorylates Cofilin and leads to de-
creased F-actin binding (Stanyon and Bernard, 1999). Dephosphorylation of Ser3 on
Cofilin enhances its F-binding and activates Cofilin’s biochemical activity (Agnew et al.,
1995). There are two classes of proteins that can dephosphorylate Cofilin, the Sling-
shots and Chronophin (Huang et al., 2006). Slingshot is a family of atypical Ser-
ine/Threonine protein phosphatases, encoded by at least three genes in mammals
(Niwa et al., 2002; Ohta et al., 2003). The long isoform of Slingshot-1 (SSH1L) could
dephosphorylate Cofilin and regulate chemotaxis of hematopoietic cells (Nishita et al.,
2005), consistent with the observations that active Cofilin defines the direction of
migration in cancer cells (Ghosh et al., 2004). The other known Cofilin phosphatase,
Chronophin, is a HAD-type Serine phosphatase which plays an important role in
cytokinesis (Gohla et al., 2005). Recent evidence suggest that activation of Cofilin on
the membrane depends on PIP2 hydrolysis by phospholipase C (PLC). Local activa-
tion of Cofilin by PLC generates asymmetry of actin remodeling, which is required
for chemotaxis (Mouneimne et al., 2006).
1.5 Coronin, a seven bladed mystery
Coronins are a conserved family of actin-binding proteins that regulate cell motility
in a variety of contexts (Uetrecht and Bear, 2006). Coronin was first identified inDic-
tyostelium, and similar proteins have been found inmany other species. Dictyostelium
Coronin has a molecular weight of 55 kDa, and is highly associated with the actin
enriched compartment. It was named because of its association with crown-shaped
cell surface projections (de Hostos et al., 1991). The first mammalian Coronin was
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cloned during a study of phosphatidylinositol-specific PLC (Suzuki et al., 1995). The
protein was named as p57 protein (Coronin 1A) and has absolutely no PLC activ-
ity. CoroninSE (Coronin 1B) was the first Coronin identified as a phosphorylated
protein, and was suggested to regulate cytoskeletal rearrangements in secretory ep-
ithelial cells (Parente et al., 1999). There are at least six Coronin genes in mammals
(Uetrecht and Bear, 2006). Based on sequence similarity, they are named 1A, 1B, 1C
(type I Coronins); 2A, 2B (type II Coronins); and POD (Coronin 7). Coronin 1A is
only expressed in hematopoietic tissues, while type II Coronins have restricted ex-
pression patterns in neural structures. Coronin 1B, 1C and POD are ubiquitously
expressed (Figure 2.1-B).
1.5.1 Domain structure and function of Coronin
Coronins have fiveWD40 repeats close to their N terminus (Figure 1.2-A). TheWD40
repeat is an approximately 40-amino-acid long conserved protein binding motif en-
riched with Tryptophan and Aspartic acid. The flanking regions of WD40 repeats
are conserved as well. The C terminus of Coronins are coiled coil domains. They
are conserved within the classes, and different between type I and type II Coronins.
POD is a protein with two copies of five WD40 repeats but lacking the coiled coil
domain, which is considered as a self-dimerized Coronin. Sequences between the
conserved WD40 region and the coiled coil domain are called the unique region,
which vary between species.
Coronin was thought to assemble into a five bladed structure (de Hostos, 1999;
Rybakin and Clemen, 2005). Recent crystal structure of Coronin 1A and our homol-
ogy model of Coronin 1B indicate that the majority of the Coronin sequence partic-
ipates a seven bladed β-propeller structure, with both the N and C terminal exten-
sions of the five WD40 repeats forming two “extra” blades (Figure 1.2-B). Coronin
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Figure 1.2: Coronin 1B domain structure
A- Coronin 1B domains structure based on sequence alignment. Between differentmammalian Coro-
nin genes, N/C-terminal extensions and five WD40 repeats are highly conserved. Unique region
varies between genes. The coiled coil domain is responsible for oligomerization.
B- Predicted Coronin 1B domain structure based on the crystall structure of Coronin 1A. Majority of
the N/C-terminal extensions, together with the five WD40 repeats, form a seven-blade β-propeller
structure. Part of the unique region lies on the bottom of the propeller.
has a seven bladed globular structure, with the remaining region resting on one
side of the molecule. The coiled coil domain could oligomerize between molecules,
which is likely to be exclusively homo-oligomerization (Figure 2.1-D). Truncated
mutants used in later chapters were designed based on these structural features and
have minimal interference with the holy propeller (Figure 1.3).
Actin-binding sites of Coronins have been mapped multiple times, and almost
the entire molecule was thought to participate in F-actin binding. Due to the re-
quirement of Coronin 1A for mycobacterial persistence in vivo, Coronin 1A is the
most extensively studied protein in the family (Kaul, 2007). Three groups have
mapped the F-actin binding site of Coronin 1A to three different regions. Based
on actin cosedimentation results of glutathione S-transferase (GST) tagged trunca-
tions, it was proposed that there were two actin-binding sites: the weak binding site
was in the 3rd and 4th WD40 repeats, and the strong binding site is in the first 34
amino acids (Oku et al., 2003). Subsequent similar experiments pointed out another
actin-binding site that is located in the last 170 amino acids (Liu et al., 2006). Us-
ing in vivo Triton X-100 insolubility assays, another group suggested that 16 amino
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Figure 1.3: Coronin 1B constructs
Various Coronin 1B mutation or truncation constructs used in this work, with their names list on the
left.
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acids within the unique region of Coronin 1A were important for its association
with the cytoskeleton (Gatfield et al., 2005). Attempts have also been made to ad-
dress the actin-binding mechanism of other Coronins. Coronin 1C had its actin-
binding site mapped to within the last 160 amino acids, and outside of the coiled
coil domain (Spoerl et al., 2002). Xenopus Coronin had its actin-binding site mapped
to outside of the five WD40 repeats. (Mishima and Nishida, 1999). Data from Sac-
charomyces cerevisiae demonstrated that the first 400 amino acid of the yeast Coro-
nin contains the F-actin binding site (Goode et al., 1999). Due to the fact that all
these studies were based on the historical five bladed model of Coronin (de Hostos,
1999; Rybakin and Clemen, 2005), these results should be evaluated with caution.
Although multiple F-actin binding sites have been suggested in the literature, the
biological significance of actin binding for Coronin function is still not clear. 5
Despite the controversy regarding its F-actin binding site, the coiled coil do-
main of Coronin has always been thought to been important for oligomerization
(Gatfield et al., 2005; Oku et al., 2005; Yan et al., 2005; Spoerl et al., 2002; Asano et al.,
2001). Two different models have been proposed. One model suggested that a
Leucine zipper motif in the coiled coil domain is responsible for oligomerization
(Suzuki et al., 1995; Oku et al., 2005). Based on crystal structure of the coiled coil
domain, the other model suggested that a novel conserved trimerization motif is
the reason for oligomerization (Kammerer et al., 2005). If the model proposing the
trimerization motif is correct, since many Coronins have the same motif, it is likely
that most of the Coronins form trimeric oligomers. Both models suggested a high
affinity interaction between Coronin molecules. Currently, there is no evidence sup-
porting either the existence of regulatable oligomerization or any unique function
5 In the case of yeast Coronin, it was suggested that F-actin binding was not essential
(Humphries et al., 2002). Due to the lack of appropriate control for the experiments, that conclusion
cannot stand.
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associated with monomer Coronin protein.
1.5.2 Coronin plays important roles in a variety of cellular pro-
cesses
Coronins have been shown to be important for a variety of biological processes. The
founding member of the Coronin family was discovered in Dictyostelium as an F-
actin binding protein present in a contracted myosin-actin preparation (de Hostos et al.,
1991). Null mutants lacking coronin grow and migrate more slowly than wild type
cells, and have severe problems in cytokinesis (de Hostos et al., 1993), which is con-
sistent with Coronin’s localization at the leading edge of motile cells. As an ex-
ample of early application of green fluorescent protein fusion, Coronin-GFP dy-
namically accumulates and is released from vesicles during phagosome maturation
(Gerisch et al., 1995; Maniak et al., 1995). Mutant cells lacking coronin have greatly
reduced vesicle uptake rate, indicating that Coronin contributes to the efficiency of
phagocytosis (Maniak et al., 1995). In addition, Coronin null cells also have strong
defects in fluid phase endocytosis (Hacker et al., 1997).
As in Dictyostelium, there is only one coronin gene in yeast. Saccharomyces cere-
visiaemutants lacking coronin have increased sensitivity to themicrotubule-destabilizing
drug benomyl and an increased number of large-budded cells with short spindles,
suggesting that yeast Coronin may also interact with the microtubule cytoskeleton
(Heil-Chapdelaine et al., 1998). Consistent with this notion, purified yeast Coro-
nin protein not only bundles actin filaments, but also binds to microtubules and
crosslinks actin filaments with microtubules (Goode et al., 1999). Although, a null
mutant of Coronin (∆Crn1) does not cause detectable defects in actin-based pro-
cesses, synthetic lethality was observed in ∆Crn1 and cof1-22 double mutant cells,
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suggesting there is a functional linkage between Coronin and actin depolymeriza-
tion processes driven by Cofilin (Goode et al., 1999). Interestingly, overexpression of
Coronin in yeast causes growth arrest due to abnormal distribution of the Arp2/3
complex. Since purified Coronin directly interacts with the Arp2/3 complex via its
coiled coil domain and inhibits Arp2/3-mediated actin nucleation activity in vitro,
Coroninwas proposed to be the first direct inhibitor of Arp2/3 complex (Humphries et al.,
2002). In support of these in vitro studies, mutations in the CRN1 gene genetically
synergize with mutations in the subunits of the Arp2/3 complex. However, the pre-
cise inhibition mechanism between Coronin and the Arp2/3 complex has not been
addressed.
There are six Coronin genes in mammals. Coronin 1A was identified from pro-
teins co-purified with the Arp2/3 complex (Machesky et al., 1997), suggesting an
evolutionary conserved function with the Arp2/3 complex. Other known binding
partners of Coronin 1A are phox proteins of the NADPH oxidase. Coronin 1A has
been shown to associate with the NADPH oxidase complex and this interaction
could be disrupted by phosphatidylinositol 3-kinase (PI3K). During phagocytosis,
both Coronin 1A and PI3K are recruited and colocalize with the actin cytoskeleton
on the phagosomes (Didichenko et al., 2000). Consistent with its role in phagocy-
tosis, phosphorylation of Coronin 1A is required for proper phagosome-lysosome
fusion. Upon treatment of PKC inhibitor chelerythrine, but not inhibitors for other
kinases, such as wortmannin, genistein or H-89, the phosphorylation of Coronin 1A
is inhibited and the maturation of phagosomes is blocked (Itoh et al., 2002). Since
phagosome-lysosome fusion is used by host cells to defend against pathological in-
fections, certain types of pathogens have evolved to utilize the function of host Coro-
nin 1A protein to block lysosomal delivery. One examples of such a pathogen isMy-
cobacterium tuberculosis. Pathogenic mycobacteria can survive within macrophages
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by avoiding the phagosome-lysosome fusion, and Coronin 1A is actively recruited
to these mycobacterial phagosomes. In the absence of Coronin 1A, after infection,
mycobacteria containing phagosomes mature and successfully fuse with lysosomes,
which leads to the elimination of the pathogen (Jayachandran et al., 2007). The re-
cruitment of Coronin 1A to mycobacterial phagosomes is achieved by a secreted
mycobacterial protein, lipoamide dehydrogenase C (Deghmane et al., 2007). Inter-
estingly, Coronin 1B has also been shown to localize on the phagosomal structures
in macrophages (Morrissette et al., 1999).
Coronin 1A not only affects phagocytosis, but also other intracellular processes.
During spreading, Coronin 1A becomes concentrated in the leading edge of lamel-
lipodia, suggesting an important role of Coronin 1A during lamellipodium exten-
sion (Mishima and Nishida, 1999). Coronin 1A also exerts an inhibitory effect on
cellular steady-state F-actin levels. T cells prepared from Coronin 1A deficient mice
failed to migrate to lymph nodes, which is due to severely compromised actin dy-
namics (Foger et al., 2006). In Listeria monocytogenes infected cells, Listeria ActA pro-
tein promotes Arp2/3 complex-mediated actin polymerization and assembles rock-
eting actin tails. Multiple host cell components required for the tail formation have
been identified, including Coronin 1A (David et al., 1998). Coronin 1A, together
with AIP1, has been shown to promote Cofilinmediated disassembly of Listeria actin
tails (Brieher et al., 2006). However, the precise mechanism behind this activity re-
quires further investigation.
POD is a Coronin with two copies of five WD40 repeats. The precise role of
POD in vivo is not clear. Different mechanisms have been proposed. Elimination of
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Caenorhabditis elegans POD from embryos results in a loss of physical and molecu-
lar asymmetries along the anterior-posterior axis, and also gives rise to the forma-
tion of abnormal cellular structures, such as large endocytic vesicles, strange mem-
brane protrusions, unstable cell divisions, etc (Rappleye et al., 1999). These results
suggest that POD is important for polarity. Another group reported that purified
Drosophila POD crosslinked both actin and microtubules, and in vivo it localizes to
axonal tips where actin and microtubules interact. Depletion or overexpression of
POD in flies causes outgrowth defects during growth cone targeting, indicating that
POD is required for proper axon guidance, probably due to its crosslinking activity
(Rothenberg et al., 2003). It has been shown that a significant portion of POD pro-
tein localizes to vesicle-like cytoplasmic structures and cis-Golgi networks, suggest-
ing possible roles of POD in intracellular vesicle trafficking as well (Rybakin et al.,
2004). Future studies are required to resolve the confusion.
Little or none has been known about the function of type II Coronins. The only
information in the literature is that Coronin 2B was identified as a brain-enriched
protein, and accumulates at focal adhesions as well as stress fibers (Nakamura et al.,
1999).
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Chapter 2
Phosphorylation of Coronin 1B by
PKC regulates interaction with Arp2/3
and cell motility
Coronins are a conserved family of WD40 repeat-containing, actin binding pro-
teins that regulate cell motility in a variety of model organisms. Our results show
that Coronin 1B is a ubiquitously expressed member of the mammalian Coronin
gene family that co-localizes with the Arp2/3 complex at the leading edge of fibrob-
lasts, and co-immunoprecipitates with this complex. Pharmacological experiments
show that the interaction between Coronin 1B and the Arp2/3 complex is regulated
by protein kinase C (PKC) phosphorylation. Coronin 1B is phosphorylated by PKC
both in vitro and in vivo. Using tryptic peptide mapping and mutagenesis, we have
identified Serine 2 (Ser2) on Coronin 1B as themajor residue phosphorylated by PKC
in vivo. Rat2 fibroblasts expressing the Coronin 1B S2A mutant show enhanced ruf-
fling in response to phorbol-12-myristate-13-acetate (PMA) and increased speed in
single cell tracking assays. Cells expressing the Coronin 1B S2D mutant have atten-
uated PMA-induced ruffling and slower cell speed. Expression of the S2A mutant
partially protects cells from the inhibitory effects of PMA on cell speed, while ex-
pression of the S2D mutant renders cells hypersensitive to its effects. These data
demonstrate that Coronin 1B regulates leading edge dynamics and cell motility in
fibroblasts, and that its ability to control motility and interactions with the Arp2/3
complex are regulated by PKC phosphorylation at Ser2. Furthermore, Coronin 1B
phosphorylation is responsible for a significant fraction of PMA’s effects on fibrob-
last motility. 1 2
2.1 Background
The dynamic re-organization of the actin cytoskeleton is required for many pro-
cesses including migration, endocytosis and intracellular junction formation. Coro-
nins are a conserved family of WD40 repeat-containing, actin-binding proteins that
regulate migration and other actin-dependent processes in model organisms. Mam-
malian genomes contain at least six Coronin genes, however, little is known about
the molecular function or regulation of Coronins in mammalian cell motility.
Coronin has been studied in multiple model organisms. In Drosophila, mutations
in Coronin cause disruptions in the actin cytoskeleton of the embryonic imaginal
disks and an early pupal lethal phenotype, indicating that this gene is essential for
morphogenesis in this organism (Asano et al., 2001). In Xenopus, Coronin localizes
to the periphery of fibroblastic cells and, like Dictyostelium and yeast Coronins, co-
sediments with F-actin in vitro (Mishima and Nishida, 1999). Also, the coiled coil
1 We wish to thank Frank Gertler for his support in this project. We would also like to thank
Ned Sharpless and Janakiraman Krishnamurthy for the mouse RNAs and help setting up qRT-PCR,
Matt Welch for p41Arc antibodies, Brian Harms for sharing Matlab macros for calculating directional
persistence, and Kris DeMali, Tom Marshall and Carol Otey for helpful discussions and comments
on the manuscript. This work was supported by funds from the V Foundation Scholar award to J.E.B.
and N.I.H grants CA90901 & HL45100 to M.D.S.
2 Most of the data presented in this Chapter have been publish in J Biol Chem, Cai et al. (2005).
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domain at the C-terminus of Xenopus Coronin has been shown to mediate oligomer-
ization (Asano et al., 2001). Expression of a putative dominant negative construct
containing the five canonical WD40 repeats from Xenopus Coronin leads to defects
in cell spreading and Rac-induced lamellipodial formation (Mishima and Nishida,
1999).
Several mammalianmembers of the Coronin family have been described (de Hostos,
1999). For clarity, we have adopted the Human Genome Organization (HUGO)
nomenclature for mammalian Coronin genes. Coronin 1A (also known as p57 or
Coronin-1) was the first Coronin to be identified in mammals and is highly ex-
pressed in cells of the hematopoietic lineage as well as parts of the nervous system
(Nal et al., 2004). This protein is a substrate for PKC both in vitro and in vivo; how-
ever, the sites that are phosphorylated are unknown and the functional significance
of phosphorylation has not been well characterized (Itoh et al., 2002). Coronin 1B
(also known as CoroninSE or Coronin-2) was discovered as a carbachol-stimulated
phosphoprotein in rabbit parietal cells (Parente et al., 1999). Carbachol acts via a
PKC pathway in this cell type to regulate secretion. Recently, this gene was iden-
tified in a microarray-based screen for genes up regulated in a neural regeneration
model (Giovanni et al., 2005). Overexpression of Coronin 1B induced neurite exten-
sion in several neuronal cell lines, while reduced expression via RNA interference
caused a reduction in outgrowth. Two-dimensional gel electrophoresis studies sug-
gest that Coronin 1C (Coronin-3) is also phosphorylated in vivo (Spoerl et al., 2002).
The potential PKC regulation of mammalian Coronins is intriguing since this
family of Ser/Thr kinases regulates migration in many cell types. Activation of
classic and novel isoforms of PKC by the phorbol ester PMA in some cell types in-
creases cell migration, whereas in other cell types, it is inhibitory (Fridman et al.,
1990). These opposing effects are likely due to the complement of PKC isoforms
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Figure 2.1: Expression, oligomerization, and localization of Coronin 1B
A- Schematic diagram of Coronin 1B
B- Quantitative heat map of Coronin gene expression across mouse tissues using quantitative real-
time PCR. Color scale indicates log10 value of copy number of mRNA per ng of total RNA for each
Coronin gene based on cDNA standard curves derived as described in Methods.
C- Homo-oligomerization of Coronin 1B. HEK293 were transfected with the complete set of GFP
tagged Coronins, immunoprecipitated using a GFP antibody and blotted with GFP antibody or affin-
ity purified Coronin 1B antibody.
D- Exclusive homo-oligomerization of Coronin 1B-GFP and Coronin 1B-Myc. HEK293 cells were
co-transfected with the complete set of GFP-tagged Coronin genes and Coronin 1B-Myc, immuno-
precipitated using a Myc antibody and blotted for GFP or Myc. Asterisks indicate IgG heavy chain
as a loading control.
E- Localization of GFP-tagged and endogenous Coronin 1B in Rat2 fibroblasts.
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and/or substrate proteins expressed in a given cell type (Jackson et al., 2005). PMA
is thought to exert its effects on migration by changing adhesiveness and/or actin
architecture at the leading edge (Dugina et al., 1987; Ng et al., 1999). PMA also reg-
ulates other actin-based motility events such as neurite outgrowth and endosome
rocketing (Glowacka et al., 1992; Taunton et al., 2000). Despite PKC’s clear impor-
tance in cell motility, a relatively small number of PKC substrate proteins have been
thoroughly characterized in terms of the residues phosphorylated and functional
significance of their phosphorylation in the control of motility. In this chapter, we
have identified Serine 2 as the major in vivo PKC phosphorylation site on Coronin
1B and demonstrate that phosphorylation regulates the interaction between Coro-
nin 1B and the Arp2/3 complex. Furthermore, we show that Ser2 phosphorylation
of Coronin 1B regulates PMA-induced ruffling and cell migration.
2.2 Results
2.2.1 Coronin 1B is ubiquitously expressed and forms homo-oligomer
in vivo
As a first step in understanding the role of mammalian Coronins in cell motility, we
used quantitative real-time PCR (qRT-polymerase chain reaction (PCR)) to compare
expression patterns of the genes across mouse tissues. An advantage of this tech-
nique is the ability to quantitatively compare expression between genes, as well as
across tissues. Our data indicate that the most widely expressed mammalian Coro-
nin gene is Coronin 1B, which is expressed at high levels across most tissues (Figure
2.1-B). To study Coronin 1B at the protein level, a polyclonal antibody was raised
against the unique region and coiled coil region of humanCoronin 1B (4245.Exp, Fig-
ure 2.1-A). HEK293 cells were transient transfected with all six Coronin genes tagged
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with GFP at the C-terminus. The different Coronins were enriched by immunopre-
cipitation (IP) using a GFP antibody and blottedwith the affinity purified Coronin 1B
antibody. This antibody specifically recognizes Coronin 1B and does not cross-react
with the other related Coronins (Figure 2.1-C). Interestingly, the endogenous Coro-
nin1B was co-immunoprecipitated with Coronin 1B-GFP. The endogenous protein
was co-immunoprecipitated only from cells transfected with Coronin 1B-GFP and
not with any of the other Coronin constructs suggesting only homo-oligomerization
had occurred. To confirm this result, we co-transfected cells with the complete set
of Coronin genes tagged with GFP and Coronin 1B-Myc. Immunoprecipitation with
a Myc antibody co-precipitated only Coronin 1B-GFP and none of the other Coro-
nins (Figure 2.1-D). Together, these experiments strongly suggest that Coronin 1B
exclusively homo-oligomerizes and does not form complexes with the other Coro-
nins. While other Coronins have been shown to homo-oligomerize via their coiled
coil motif in vivo (Oku et al., 2005), these data are the first to address the specificity
of oligomerization between members of this protein family.
2.2.2 Coronin 1B enriches in lamellipodia and interacts with the
Arp2/3 complex
To examine the localization of Coronin 1B, we used our affinity purified antibody
for immunofluorescent staining and compared the localization of the endogenous
protein to the GFP-tagged form in Rat2 fibroblasts (Figure 2.1-E). Coronin 1B is lo-
calized to the leading edge in fibroblasts, as well as weakly along actin stress fibers.
The localization of the GFP-tagged form is indistinguishable from the endogenous
protein. This observation, along with the co-IP experiment described above, sug-
gests that Coronin 1B can tolerate tagging with GFP at the C-terminus.
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Figure 2.2: PMA stimulates Coronin 1B phosphorylation in vivo
HEK293 cells were stimulated with PMA for 30 minutes. Endogenous Coronin 1B was immunopre-
cipitated and treatedwithout or with antarctic phosphatase (labeled as AP in the figure, New England
Biolabs). Samples were separated by SDS-PAGE and immunoblotted with indicated antibodies.
In yeast, Coronin and the Arp2/3 complex interact both biochemically and ge-
netically, but this interaction has not been demonstrated in mammalian systems
(Humphries et al., 2002). To examine this interaction, we first performed immunoflu-
orescent co-localization between Coronin 1B and p34Arc (a component of the Arp2/3
complex). These two proteins strongly and completely co-localize at the leading
edge of fibroblasts (Figure 2.3-A). To test for a biochemical interaction between Coro-
nin 1B and the Arp2/3 complex, we performed a reciprocal co-IP between Coronin
1B and the p34Arc subunit of the Arp2/3 complex. We saw a robust, reciprocal co-IP
between the endogenous Coronin 1B and p34Arc in Rat2 fibroblasts (Figure 2.3-B).
This result was also obtained in HEK293, Swiss 3T3, NIH3T3 cells suggesting that
this interaction is generally observed in many cell types (data not shown). Control
rabbit antibodies did not IP either protein (Figure 2.3-B,C).We also detected co-IP be-
tween Coronin 1B and the Arp2 and p41Arc subunits of the Arp2/3 complex (data
not shown), suggesting that our results are not specific for p34Arc, but reflect an
interaction between Coronin 1B and the Arp2/3 complex. As an additional control,
we were also able to show co-IP between GFP-tagged Coronin 1B and p34Arc using
GFP antibodies (Figure 2.8-B). We could not detect actin in the immunocomplex by
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blotting, but to exclude the possibility that this interaction is simply bridged through
F-actin, we pretreated cells with latrunculin B to disrupt F-actin prior to making the
lysate for IP and saw no dramatic change in the interaction.
2.2.3 Coronin 1B is phosphorylated by PKC in vivo, and this phos-
phorylation regulates the interaction with Arp2/3 complex
Since Coronins have been shown to be PKC substrates in vitro and in vivo (Parente et al.,
1999; Spoerl et al., 2002; Itoh et al., 2002) and we found that Coronin 1B is phospho-
rylated in vivo under PMA stimulation (Figure 2.2), we tested whether phospho-
rylation modulates the interaction between Coronin 1B and the Arp2/3 complex.
With 100 nM PMA treatment, this interaction is strongly decreased relative to un-
treated Rat2 cells (Figure 2.3-C). To establish that the PMA stimulation was acting
through a kinase pathway, we used an anti-phosphoserine antibody raised against a
phospho-peptide corresponding to the PKC consensus site. This antibody (pSerPKC,
Cell Signaling Technologies) recognizes phosphorylated Coronin 1B immunoprecip-
itated by our affinity-purified Coronin 1B antibody (Figure 2.3-C). Mutant analy-
sis described below confirmed the specificity of this antibody for phospho-Coronin
1B. Further evidence for the specific involvement of PKC in regulating Coronin 1B-
Arp2/3 interactions comes from treatment with two well-established PKC inhibitors
(Martiny-Baron et al., 1993; Wilkinson et al., 1993). Pretreatment of cells with a pan-
PKC inhibitor (Ro32-0432) blocked PMA-stimulated phosphorylation of Coronin 1B
and restored the co-IP with p34Arc. Interestingly, Go¨6976 (which inhibits the α and
β1 isoforms of PKC) did not block phosphorylation or restore co-IP of p34Arc sug-
gesting that a novel isoform of PKC δ, ε or θ may be responsible for the PMA-induced
phosphorylation of Coronin 1B in vivo. Using mouse embryonic fibroblast (MEF)
from PKCδ knockout mice, we shown PKCδ is not the in vivo kinase for Coronin
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Figure 2.3: Coronin 1B interacts in vivowith the Arp2/3 complex in a PKC phospho-
rylation dependent manner
A- Coronin 1B co-localization with the p34Arc subunit of the Arp2/3 complex at the leading edge of
Rat2 fibroblasts.
B- Reciprocal co-immunoprecipitation between endogenous Coronin 1B and p34Arc in Rat2 cell
lysates. Rabbit IgG was used as a control for immunoprecipitation in panels B and C.
C- Pharmacological modulation of interaction between Coronin 1B and p34Arc. Upon PMA stim-
ulation (100 nM), Coronin 1B is phosphorylated (pSerPKC blot) and the co-IP between Coronin 1B
and the Arp2/3 complex strongly decreases (p34Arc blot). Both effects are blocked by the pan-PKC
inhibitor, Ro32-0432 (1 µM), but not by Go¨6976 (30 µM) that inhibits only PKCα and β1.
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Figure 2.4: Coronin 1B is robustly phosphorylated both in vitro and in vivo
A- Recombinant His-Coronin 1B is phosphorylated by PKCα in vitro (arrow). The phosphorylation
of chicken vinculin tail (Vt; aa 881-1135) served as a positive control. PKCα auto-phosphorylation is
indicated by arrowhead.
B- In vitro phosphorylated His-Coronin 1B subjected to tryptic peptide mapping. Asterisk indicates
origin. Spots a through e showed a consistent pattern across multiple experiments.
C- GFP-tagged Coronin 1B was immunoprecipitated from 32P metabolically-labeled HEK293 cells
treated with and without 100 nM PMA (arrow indicates Coronin 1B-EGFP).
D- Tryptic peptide map of sample from panel C.
1B (Figure 2.5). Together, these experiments suggest that the interaction between
Coronin 1B and the Arp2/3 complex is regulated through PKC phosphorylation of
Coronin 1B.
2.2.4 Coronin 1B is phosphorylated on Serine 2
Since the phosphorylation status of Coronin 1B is critical for interaction with the
Arp2/3 complex, we sought to identify the residues that are phosphorylated in vivo.
As a first step, we did an in vitro kinase assay using purified PKC and His-tagged
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Figure 2.5: PKCδ is not the in vivo kinase of Coronin 1B
MEFs were prepared from either wild type (+/+) or PKCδ deletion (-/-) mice. Cells were subjected
to PMA stimulation without or with Ro32-0432, a pan PKC inhibitor, for 30 minutes. Endogenous
Coronin 1B were immunoprecipitated and immunoblotted with indicated antibodies.
Coronin 1B. Recombinant Coronin 1B is strongly phosphorylated in this reaction
(Figure 2.4-A). Similar results were obtained using GST-tagged Coronin 1B (see be-
low). As a positive control, we used a fragment of Vinculin that has been reported
to be an in vitro PKC substrate (Ziegler et al., 2002). Tryptic peptide mapping shows
that 4 to 5 sites on Coronin 1B are phosphorylated in vitro (Figure 2.4-B). To examine
in vivo Coronin 1B phosphorylation, we immunoprecipitated GFP-tagged Coronin
1B from metabolically labeled HEK293 cells. Upon PMA stimulation, Coronin 1B
was strongly phosphorylated (Figure 2.4-C). Tryptic peptide mapping indicated that
there is a single major site phosphorylated in vivo (Figure 2.4-D).
Comparison of the in vitro and in vivo tryptic peptide maps indicated that the
in vivo site did not appear to match any of the in vitro sites. We considered two
possible explanations for this observation: first, that PKC does not phosphorylate
the site in vitro that is utilized in vivo or secondly, that the spot had shifted due to
extra sequence on the peptide from the 6×His or GST tag. Comparison of the tryptic
peptide maps of in vivo phosphorylated Coronin 1B and in vitro phosphorylated
His1B or (GST)1B provide strong evidence for the latter possibility. We used pair-
wise mixing of samples to compare the maps of in vitro and in vivo phosphorylated
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proteins (Figure 2.6-A-D). Both the in vitro samples showed spots b, c, d and e (Figure
2.6-C) that were absent in the in vivo labeled sample. Further, we discovered that
each sample contained a unique spot (a, a’ and a”). It is important to note that,
in the case of (GST)1B, the N-terminal GST tag was removed by cleavage prior to
phosphorylation reaction leaving five residual amino acids. Since each sample has a
uniqueN-terminal tryptic peptide due to the fusion of the His or GST tag (Figure 2.6-
E), we postulated that a Serine or Threonine residue common to all of these peptides,
Ser2 in the native protein, might be the in vivo phosphorylated residue. Further
evidence for this hypothesis came from the predicted migration properties of the N-
terminal peptides. A theoretical peptide map of these peptides, constructed based
on established formulas for the relative migration of tryptic peptides (Boyle et al.,
1991), agreed with our experimental observations (Figure 2.6-F).
Using purified phosphorylated Coronin 1B and mass spectrometry analysis, we
confirmed that Serine 2 is the major in vivo phosphorylation site (Figure 3.12). An-
other group using site-directed mutagenesis showed that Serine 2 on Coronin 1A
protein is phosphorylated in vivo as well, suggesting that N-terminal phosphory-
lation is a general post-modification on Coronins to regulate their activity. While
Coronin 1C, a mammalian Coronin lacking Serine 2 residue and having very simi-
lar protein sequence as Coronin 1B, is found to be up-regulated in multiple highly
metastastic breast cancer samples, suggesting that non-phosphorylated Coronins are
the active forms in vivo.
To test the hypothesis that Ser2 is Coronin 1B’s major in vivo phosphorylation
site, this residue was mutated to Alanine in our GFP-tagged Coronin 1B construct
and transfected into HEK293 cells. This mutant, S2A, was immunoprecipitated from
metabolically labeled cells stimulated with PMA and subjected to peptide mapping
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Figure 2.6: Coronin 1B is phosphorylated on an N-terminal site
Tryptic peptide maps of (GST)1B (panel A), in vivo phosphorylated Coronin 1B (panel B), mixture of
His1B + (GST)1B (panel C), and mixture of His1B + in vivo sample (panel D).
E- Sequences of N-terminal tryptic peptides of the various samples. Ser2 is indicated with bold and
italics.
F- Theoretical map of peptides from panel E.
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(Figure 2.7-A). The prominent phospho-peptide spot a’ was absent in the S2A sam-
ple suggesting that this is the major phosphorylation site in vivo. To exclude the pos-
sibility that the Ser2 mutation changes the conformation of Coronin 1B and masks
the actual phosphorylation site, we did an in vitro kinase assay on immunoprecipi-
tated wild type or S2A Coronin 1B-GFP from unlabeled HEK293 cells (Figure 2.7-B).
No phosphorylation was observed in the absence of purified PKC indicating that
no endogenous PKC was co-immunoprecipitated under these conditions. The wild
type Coronin 1B-GFP showed a prominent band at the correct molecular weight,
while the S2A sample had no detectable band at the equivalent area of the gel. These
samples were blotted with our Coronin 1B antibody to confirm that both proteins
were present (data not shown). The tryptic peptide maps generated from the Coro-
nin 1B-GFP bands exhibited a similar pattern of spots as the recombinant prepara-
tion studied previously (spots b-e). However, the wild type sample did not exhibit
peptides a or a”, but rather contained a peptide corresponding to a’. This spot was
absent from the S2A sample (Figure 2.7-C). Together, these data indicate that Ser2 is
the major site phosphorylated by PKC on Coronin 1B in vivo.
2.2.5 Coronin S2Amutantmimics non-phosphorylated protein, and
has enhanced interaction with Arp2/3 complex
Our experiments using PMA and PKC inhibitors demonstrated that phosphoryla-
tion of Coronin 1B regulates its interaction with the Arp2/3 complex. If Ser2 is the
critical phosphorylation site, then mutations in Ser2 should modulate the Coronin
1B-Arp2/3 interaction. In addition to the S2A mutation described above, we also
made a second mutant, S2D, in which Ser2 was mutated to Aspartic acid to mimic
phosphorylated Coronin 1B. These mutants, along with the wild type version, were
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Figure 2.7: Ser2 of Coronin 1B is the site directly phosphorylated by PKC in vivo
A- In vivo phosphorylation of either wild type (WT) or S2A mutant form of Coronin 1B expressed in
HEK293 cells, and stimulated with 100nM PMA.
B- In vivo phosphorylation of immunoprecipitated wild type or S2A mutant Coronin 1B tagged with
GFP from unlabeled HEK293 cells by purified PKCα. Arrow indicates GFP-tagged Coronin and ar-
rowhead indicates PKCα autophosphorylation.
C- Tryptic peptide maps of GFP-tagged Coronins from B. Note similar pattern of b, c, d and e spots
to in vitro samples from Figure 2.6 and absence of a’ spot in S2A mutant. Equal counts of both the
wild type and S2A samples were loaded on the TLC plates to reveal any detectable phosphorylation
of peptide a’ in the S2A sample.
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transiently expressed in HEK293 cells and immunoprecipitated with GFP antibod-
ies. The IP samples were blotted for p34Arc to detect associated Arp2/3 complex.
The Coronin 1B S2Amutant showed a stronger interaction with the Arp2/3 complex
relative to wild type, while the S2D mutant had weaker interaction (Figure 2.8-A).
This trend is consistent with our observation that increasing Coronin 1B phosphory-
lation by PMA treatment decreases the interaction with Arp2/3. Interestingly, these
mutants did not affect oligomerization of the GFP-tagged formwith the endogenous
Coronin 1B, suggesting that this interaction is not regulated by phosphorylation at
Ser2.
2.2.6 Coronin 1B S2A mutant promotes membrane ruffling
To further characterize these mutant versions of Coronin 1B, we created stable Rat2
cell lines expressing the mutants via retroviral transduction. These lines were sorted
for equal levels of GFP expression by FACS and equal expression levels of Coronin
1B-GFP were verified by western blotting (Figure 2.8-B). We looked for changes in
Coronin 1B-Arp2/3 interactions in these cell lines by co-IP. Unlike the transiently
transfected HEK293 cells, there was no increase in the p34Arc interaction with the
S2A mutant, but there was a reproducible decrease with the S2D mutant (Figure
2.8-C). When these IP’s were probed with the pSerPKC antibody described above,
we noted that the pSerPKC antibody does not cross react with either the S2A or S2D
mutant (Figure 2.8-C). These data demonstrate that this antibody specifically recog-
nizes Coronin 1B phosphorylated on Ser2. In cells expressing the S2A mutant, we
observed a hyper-phosphorylation of the endogenous Coronin 1B. This may reflect
a compensatory mechanism in this stable cell line. Since phospho-Coronin 1B does
not interact as well with Arp2/3, this may explain why we did not observe an in-
crease in p34Arc interaction in the S2A-expressing cell line. When we examined the
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Figure 2.8: Ser2 mutants affect the interaction between Coronin 1B and the Arp2/3
complex, but not subcellular localization
A- Transient transfection of Ser2 mutants into HEK293 cells. Samples were immunoprecipitated with
GFP antibody and blotted with Coronin 1B or p34Arc antibodies. Arrowhead indicates GFP-tagged
Coronin 1B and arrow indicates endogenous Coronin 1B.
B- Lysates from Rat2 stable cell lines expressing GFP tagged wild type, S2A or S2D mutant Coronin
1B blotted as indicated.
C- GFP IP’s of samples in (B) blotted as indicated. Note lack of cross-reactivity of pSerPKC antibody
with either Ser2 mutant.
D- GFP-tagged Ser2 mutants have the same localization pattern as the wild type Coronin 1B in Rat2
cells. Cells were stained with antibodies to p34Arc to label Arp2/3 and phalloidin to label F-actin.
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localization of the mutants in these stable Rat2 lines, we saw no difference between
either of the mutant proteins and the wild type Coronin 1B-GFP. There was also
no discernable change in p34Arc or F-actin staining with expression of the mutants
(Figure 2.8-B). This suggests that phosphorylation of Coronin 1B does not affect its
subcellular localization properties, although it is formally possible that the mutants
are localizing via oligomerization with the endogenous Coronin 1B.
To address the importance of Ser2 phosphorylation for Coronin 1B function, we
used a PMA-induced ruffle formation assay. Previous studies indicated that PMA
stimulation of serum-starved cells induces a transient activation of the Rac GTPase
and that this Rac activity is required for PMA-induced ruffling activity (Kurokawa et al.,
2004; Ridley et al., 1992). In our stable Rat2 lines expressing wild type or Ser2-
mutated Coronin 1B, we observed striking differences in the ability of PMA to in-
duce ruffles in serum-starved cells (Table 2.1). About 41% of the Rat2 control cells
show ruffling at 10 min after stimulation, while 60% of cells over-expressing wild
type Coronin 1B show ruffling under the same conditions. Both the Rat2 control
cells and wild type Coronin 1B over-expressers had diminished ruffling by 30 min
after stimulation suggesting that this response adapts over time. Cells expressing
the S2A mutant version of Coronin 1B had the highest level of ruffling (71%) at 10
min and had sustained high levels of ruffling at all time points tested. Interestingly,
cells expressing the S2D mutant version of Coronin 1B had suppressed ruffling with
only about 26% of cells showing ruffling activity at 10 min. The S2D cells did show a
peak of ruffling activity at 20 min that returned to control levels by 30 min, suggest-
ing that these cells have diminished ruffling rather than a total loss. Together, these
data suggest that overexpression of wild type or S2A Coronin 1B enhances the early
phase of the ruffling response, and that Coronin 1B phosphorylation at Ser2 may
be a major factor in the adaptation of PMA-induced ruffling at later times. Further,
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Table 2.1: PMA-induced ruffling response
Data presented are the combined results from two independent experiments. Cells were counted in 6
fields of view with ruffling cells / total cells counted are reported in parentheses. Chi-square values
for each time point range from 38.5-82.9, indicating that each time point contains statically significant
deviation from expected Rat2 control proportion (p<0.000001).
these data suggest that, consistent with its localization pattern, Coronin 1B exerts a
strong effect on actin-dependent processes at the leading edge.
2.2.7 Coronin 1B S2A mutant promotes random cell migration
To further explore Coronin 1B function and the role of Ser2 phosphorylation in reg-
ulating Coronin function, we turned to the single cell tracking assay. In this assay,
individual cells undergoing random cell movement are tracked in time-lapsemovies
and information about speed and directional persistence are extracted. Overexpres-
sion of wild type Coronin 1B caused a slight, but statistically significant increase
in average cell speed (ANOVA F=106.7, p<0.0001; Dunnett’s multiple comparison
test, p<0.05) (Figure 2.9-A). Expression of the S2A mutant caused a much stronger
increase in cell speed, while expression of the S2D mutant suppressed cell speed
below that of the parental Rat2 cells (Dunnett’s multiple comparison test, p<0.01).
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None of the cell lines showed significant differences in directional persistence (data
not shown).
2.2.8 Coronin 1B S2A mutant partially protects from PMA’s effect
To understand the relative contribution of Ser2 phosphorylation to PMA’s overall ef-
fect on cell migration, we first examined the dose relationship of PMA treatment to
Coronin 1B phosphorylation by western blotting. In this experiment, the cells were
treated with PMA for 30min in serum-containing media. For examining phosphory-
lation status, we used Rat2 cells expressing wild type Coronin 1B taggedwith GFP to
examine the phosphorylation of both the GFP tagged and endogenous forms. Cells
were stimulated with different doses of PMA and the Coronin 1B-GFP immunopre-
cipitated with GFP antibodies. These samples were blotted either with the pSerPKC
antibody to detect phosphorylated Coronin 1B or the Coronin 1B antibody to de-
tect total immunoprecipitated Coronin protein (Figure 2.9-B). Both GFP-tagged and
endogenous Coronin 1B are phosphorylated in a dose dependent manner with the
greatest increase occurring between 1 and 5 nM PMA.
To address the importance of Ser2 phosphorylation in mediating PMA’s effects
on cell migration, we did a dose-response single cell tracking experiment in our
cell lines expressing the wild type or mutant forms of Coronin 1B (Figure 2.9-C). For
Rat2 control cells, a steady decrease in cell speedwas observed with increasing PMA
dose. This is consistent with studies of other cells lines showing an inhibitory effect
of PMA on cell speed (Keller et al., 1989). Cells over-expressing the wild type Coro-
nin 1B showed a similar overall dose-dependent decrease in cell speed, but showed
a sharper drop between 1 and 5 nM PMA relative to controls. This is consistent with
the phospho-specific western blot analysis where the sharpest increase in phospho-
rylation occurred between these two doses. Cells expressing the S2Amutant showed
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Figure 2.9: Phosphorylation of Coronin 1B at Ser2 regulates cell migration
A-Migration speed of Rat2 stable cell lines measured by single cell tracking method (number tracked
per cell type in parentheses). Data were analyzed by one-way ANOVA (p<0.0001) and individual
treatments were analyzed with Dunnett’s multiple comparison post-test (⋆ p<0.05, ⋆⋆ p<0.01; error
bars show 95% confidence intervals).
B- PMA induces a dose-dependent increase in Coronin 1B phosphorylation. Rat2 cells expressing the
GFP-tagged wild type Coronin 1B were treated with the indicated dose of PMA for 30 min. Lysates
were immunoprecipitated with GFP antibodies and blotted as indicated. Arrowhead indicates GFP-
tagged Coronin 1B and arrow indicates endogenous Coronin 1B.
C- Migration speeds of Rat2 stable cell lines treated with different doses of PMA. Cells were treated
with PMA for 30 min prior to the beginning of the movies and drug was present throughout. Speed
measured by single cell tracking method (at least 100 cells tracked for each data point).
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a dose-dependent decrease in cell speed to a point, but the decline in cell speed lev-
eled off by 5 nM and showed no further decrease after this point. This suggests that
a mutant of version of Coronin 1B that cannot be phosphorylated confers a partial
resistance to the inhibitory effects of PMA on cell speed. Conversely, the S2Dmutant
rendered the cells hypersensitive to the inhibitory effects of PMA with the majority
of the inhibitory effect occurring by the 5 nM dose. Together, these data indicate
that Coronin 1B phosphorylation at Ser2 plays a significant role in mediating PMA’s
effects on cell migration speed in fibroblasts.
2.3 Discussion
Coronins are a highly conserved family of proteins that regulate actin-dependent
processes such as migration and endocytosis; however, little is known about the
function or regulation of these molecules in mammalian systems. In this work, we
show that Coronin 1B interacts in vivo with the Arp2/3 complex and that this inter-
action is inhibited by PKC phosphorylation. We have identified the single major in
vivo phosphorylation site, Ser2, and demonstrated that mutations in this site cause
striking effects on fibroblast motility. In addition, we show that Coronin 1B phos-
phorylation mediates a significant fraction of PMA-induced changes in fibroblast
motility.
2.3.1 Coronin 1B is an important member of mammalian Coronins
Mammalian genomes contain at least six Coronin genes that can be broken down
into three subclasses based on sequence homology and localization (Uetrecht and Bear,
2006). Coronins 1A, 1B and 1C form a distinct group and are most similar to the
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Coronin genes in single-cell eukaryotes. The Coronin 1B and 1C genes are ubiqui-
tously expressed, but Coronin 1B is expressed at 2- to 10-fold higher levels at the
mRNA level depending on the tissue. This suggests that Coronin 1B may the pre-
dominant Coronin of this subclass in many cell types and tissues.
Since Coronin 1B is expressed at such high levels across tissues, we examined a
number of molecular interactions that have been seen with other Coronins for this
protein. First, our data show that Coronin 1B oligomerizes with itself and that this
interaction is exclusively homo-oligomeric in nature. It will be interesting to see if
all mammalian Coronins display this degree of specificity in their oligomerization.
Second, like all other Coronins tested from any species, recombinant Coronin 1B
co-sediments with F-actin in vitro (Figure 4.5-A). Third, our reciprocal co-IP and co-
localization data show that Coronin 1B interacts in vivowith the Arp2/3 complex in
all cell types tested. Furthermore, we see similar interactions between Coronin 1C
and Arp2/3 (Holoweckyj and Bear, unpublished observation). While Coronin 1A
was identified as a major co-purifying protein in preparations of the Arp2/3 com-
plex from neutrophils, the data reported in this work are the first to directly confirm
that the Coronin-Arp2/3 interaction, first demonstrated in yeast, is conserved in
mammals.
2.3.2 Coronin 1B activity is regulated by Serine 2 phosphorylation
Our data is the first direct demonstration that phosphorylation regulates Coronin
function. Other groups have reported PKC phosphorylation of Coronins 1A & 1B
and, for Coronin 1A, there is an increased localization of the protein on phagosomes
in HL-60 cells treated with high doses of PKC inhibitors, but none of these studies
directly shows regulation by phosphorylation (Parente et al., 1999; Itoh et al., 2002).
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Our studies reveal that the in vivo interaction between Coronin 1B and Arp2/3 com-
plex is strongly inhibited by PKC phosphorylation. We mapped the major in vivo
PKC phosphorylation site on Coronin 1B to Ser2 using tryptic peptide analysis and
confirmed this result using site-directed mutagenesis. Expressing Ser2 mutants has
striking effects on fibroblast motility. The S2A mutant has stronger interaction with
Arp2/3, increases PMA-induced ruffling and cell speed relative to the wild type
Coronin 1B, suggesting that this mutant is constitutively active. Conversely, the S2D
mutant has reduced interaction with Arp2/3, inhibits ruffling and suppresses cell
speed below that of the parental Rat2 cells, suggesting that this mutation creates a
dominant negative Coronin.
Although our data show regulation of Coronin function by PKC, several out-
standing issues remain to be resolved. The precise isoform or isoforms of PKC that
phosphorylate Coronin 1B in vivo remain to be delineated. Furthermore, the up-
stream signaling pathways that ultimately regulate Coronin 1B phosphorylation also
remain unclear. In rabbit parietal cells, carbachol (a muscarinic agonist) stimulates
Coronin 1B phosphorylation (Parente et al., 1999), but we were unable to stimulate
Coronin 1B phosphorylation in HEK293 cells with this agonist (data not shown).
However, this may simply reflect poor/absent expression of the necessary receptor
or G-protein in this cell type. A second unresolved issue concerning the PKC regu-
lation of Coronin 1B function is the nature of the dominant negative effect observed
with the S2Dmutant. At least two possible explanations could account for this effect.
First, this pseudo-phosphorylated version may be non-functional, but still able to
bind to and sequester key Coronin 1B binding partners. Second, phospho-Coronin
1B may have a distinct function from the dephospho-form that does not involve
Arp2/3 complex and is inhibitory for ruffling and migration. More experiments
will be needed to resolve these issues.
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2.3.3 Coronin 1B inhibits theArp2/3 complex in vitro, but promotes
cell migration in vivo
While the mechanistic details of mammalian Coronin function remain unclear, it is
worth considering data on Coronin function from yeast in developing a working
hypothesis about Coronin 1B function in mammalian cell motility. In yeast, Coronin
binds directly to the Arp2/3 complex in vitro and, more specifically, to the p35Arc
subunit in two-hybrid assays (Humphries et al., 2002). When added to in vitro poly-
merization assays, Coronin inhibits the Arp2/3-mediated nucleation of actin fila-
ments. Recent structural data indicate that the addition of Coronin to Arp2/3 prepa-
rations (visualized by EM and single particle reconstruction) causes Arp2/3 to adopt
an open or inactive conformation (Rodal et al., 2005). Together, these data led the
Goode lab to propose that yeast Coronin is a direct inhibitor of the Arp2/3 complex.
Our data indicate that overexpression of mutant form of Coronin 1B (S2A) that inter-
acts more robustly with Arp2/3 drives the actin-dependent processes of membrane
ruffling and cell migration.
Superficially, these datasets seem inconsistent, but there are numbers of possible
models in which both could be correct or at least consistent within a particular cellu-
lar context. One possibility is that Coronin inhibits Arp2/3 activity in both yeast and
mammalian cells, but that in fibroblasts, this results (indirectly) in the disassembly of
actin networks through other mechanisms such as ADF/Cofilin. This would result
in accelerated actin network turnover, and that could lead to enhanced cell motil-
ity (Chapter 3). Such a mechanism would be consistent with the genetic synergy
between mutations in the Coronin and Cofilin genes in yeast (Goode et al., 1999).
Another possibility is that Coronin recruits inactive Arp2/3 to the sides of actin fil-
aments at specific locations within cells where it can be acted upon by activators
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such SCAR/WASP proteins as previously suggested (Humphries et al., 2002). Phos-
phorylation of Coronin (and subsequent loss of interaction with Arp2/3 complex)
could act as a switch to expose “activatable” Arp2/3 had been previously docked
on filaments at specific locations within the cell. Neither of these models, however,
completely explains why Coronin is a biochemical inhibitor of Arp2/3, but a cellu-
lar “activator” of Arp2/3-dependent processes such as membrane ruffling and cell
migration in fibroblasts. Alternately, mammalian Coronins and yeast Coronin may
both interact with Arp2/3 complex, but have evolved divergent mechanisms for reg-
ulating the complex. Experiments are underway to rigorously test these and other
possible models (Chapter 5).
One of our most striking findings is that Coronin 1B phosphorylation mediates
a significant fraction of PMA’s effects on fibroblast ruffling and migration. This is
a somewhat surprising result since PMA activates all of the conventional and novel
isoforms of PKC, and likely stimulates the phosphorylation of a large number of
protein substrates. When considering our results with PMA, it is important to take
into account the precise conditions of treatment and the different phenomenon be-
ing observed. The PMA-induced ruffling is highly dependent on serum-starvation
and may represent a different effect than the 2-3 hour treatments in the presence of
serum that we used for the cell tracking studies. Our ruffling data are consistent with
Coronin 1B playing at least two distinct roles in this process. First, overexpression
of wild type (or S2A) Coronin 1B enhances the PMA-induced ruffling response that
is initiated by an unknown PMA target and presumably involves a Rac-dependent
pathway. Second, subsequent phosphorylation of Coronin 1B appears to be critical
for an adaptation of the PMA-induced ruffling response as demonstrated by the sus-
tained ruffling observed in the cells expressing the S2A mutant. In the cell tracking
experiments, PMA was added 30 min before the start of the movies in the presence
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of serum. This treatment did not induce continuous ruffling, but rather seemed to
cause a dose dependent reduction of the polarized morphology normally seen in
migrating fibroblasts. The reduction in cell speed likely arises from the failure to
maintain the polarized morphology necessary for effective migration. Expression of
the S2A mutant version of Coronin 1B partially protected the cells from this loss of
polarity induced by PMA (data not shown). This suggests that, in this assay, Coronin
1B phosphorylation may have an important role in regulating cell polarity. Future
experiments will explicitly test this hypothesis.
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Chapter 3
Coronin 1B coordinates Arp2/3
complex and Cofilin activities at the
leading edge
Actin filament formation and turnover within the treadmilling actin filament ar-
ray at the leading edge of migrating cells are interdependent and coupled, but the
mechanisms coordinating these two activities are not understood. We report that
Coronin 1B interacts simultaneously with Arp2/3 complex and Slingshot (SSH1L)
phosphatase, two regulators of actin filament formation and turnover, respectively.
Coronin 1B inhibits filament nucleation by Arp2/3 complex and this inhibition is
attenuated by phosphorylation of Coronin 1B at Serine 2, a site targeted by SSH1L.
Coronin 1B also directs SSH1L to lamellipodia where SSH1L likely regulates Cofilin
activity via dephosphorylation. Accordingly, depleting Coronin 1B increases phospho-
Cofilin levels, and alters lamellipodial dynamics and actin filament architecture at
the leading edge. We conclude that Coronin 1B’s coordination of filament forma-
tion by Arp2/3 complex and filament turnover by Cofilin is required for effective
lamellipodial protrusion and cell migration. 1 2
3.1 Background
Coronins are highly-conserved F-actin-binding proteins (Uetrecht and Bear, 2006).
Functional studies in Dictyostelium amoeba and thymocytes indicate that Coronins
play an important role in cell motility and chemotaxis (de Hostos et al., 1991; Foger et al.,
2006; Mishima and Nishida, 1999), but the mechanism(s) by which Coronins influ-
ence motility are unknown. In yeast, one mechanism may be through inhibition
of Arp2/3 complex (Humphries et al., 2002; Rodal et al., 2005), but the effects of
mammalian Coronins on actin nucleation activity by Arp2/3 complex are unknown.
Mammalian Coronin 1B is ubiquitously expressed and localizes to the leading edge
of migrating fibroblasts (Chapter 2). The interactions of Coronin 1B (Chapter 2) or
Coronin 1A (Foger et al., 2006) with Arp2/3 complex are regulated by phosphory-
lation of Serine 2 via PKC, where phosphorylation of Ser2 reduced the interaction
with Arp2/3 and diminished cell motility .
ADF/Cofilin proteins (hereafter referred to as Cofilin) control actin filament turnover
at the leading edge and at other cellular locations (Bamburg, 1999). Mechanisti-
cally, Cofilin severs and potentially enhances depolymerization of filaments by co-
operatively binding along the sides of actin filaments and inducing conformational
1 We are grateful to J. Bamburg (Colorado State University) for providing antibodies to pCofilin
(4321) and Cofilin (MAB22) and the protocol to quantify active Cofilin by ratio imaging prior to
publication, to A. Makhov and H. Mekeel for help with electron microscopy, to K. Burridge, M.
Schaller, F. Gertler, J. Bamburg and D. Roadcap for critical reading of the manuscript, to E. Izaurralde,
M. Wilm, Y. Durocher for reagents and to T. Kotova and F. Tariq for technical assistance. Electron
microscopy work was supported by NIH grant CA-16086 to J.D. Griffith. This work was supported
by NIH (GM067222) to D.A.S. and funds from the V Foundation, Melanoma Research Foundation
and Carolina Center for Cancer Nanotechnology Excellence (NCI; 1U54CA119343) to J.E.B.
2 Most of the data presented in this chapter have been publish in Cell, Cai et al. (2007b).
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changes in filament structure (Bamburg, 1999). In vivo, Cofilin regulates the dynam-
ics of actin-based structures such as stress fibers, dendritic spines and lamellipodia
(Dawe et al., 2003; Hotulainen et al., 2005; Zhou et al., 2004). The activity of Cofilin
is regulated in a variety of ways including phosphorylation, PIP2 binding, intracel-
lular pH changes and interactions with binding partners such as AIP1 (Bamburg,
1999).
Phosphorylation of Cofilin Serine 3 by LIM Kinase or TESK leads to decreased F-
actin binding and inactivation of Cofilin (Stanyon and Bernard, 1999). Dephospho-
rylation of Serine 3 on Cofilin enhances F-binding and activates its severing/ depoly-
merization activity (Agnew et al., 1995). Two classes of phosphatases act on Cofilin
– the Slingshots and Chronophin (Huang et al., 2006). Slingshot is a family of atyp-
ical Serine/Threonine protein phosphatases that in mammals includes Slingshot-
1, -2 and -3; Slingshot-1 and -2 exist as long and short isoforms (Niwa et al., 2002;
Ohta et al., 2003). The long isoform of Slingshot-1 (SSH1L) functions during chemo-
taxis of hematopoeitic cells (Nishita et al., 2005). Regulation of SSH1L activity may
occur via phosphorylation of Serine residues in its C-terminus and binding of in-
hibitory 14-3-3 proteins (Nagata-Ohashi et al., 2004). In addition, SSH1L activity is
greatly enhanced by its interaction with actin filaments (Nagata-Ohashi et al., 2004;
Soosairajah et al., 2005). The other known Cofilin phosphatase, Chronophin, is a
HAD-type Serine phosphatase that plays an important role in cytokinesis (Gohla et al.,
2005).
Considerable evidence suggests that the activities of Arp2/3 complex and Cofilin
are coordinately regulated at the leading edge of motile cells. Studies using correla-
tive microscopy (Svitkina and Borisy, 1999) suggest an array treadmilling model for
actin assembly and turnover within lamellipodia in which Arp2/3-dependent fila-
ment nucleation at the front of the lamellipodia was balanced by Cofilin-dependent
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depolymerization of filaments at the rear. Arp2/3 complex and Cofilin also work to-
gether to promote lamellipodial protrusion in quiescent adenocarcinoma cells stim-
ulated with growth factors, albeit via a different mechanism (DesMarais et al., 2005).
MTLn3 cells stimulated with EGF initiate protrusion when Cofilin severs filaments
creating new barbed ends that are preferred sites for Arp2/3-dependent filament nu-
cleation (Ichetovkin et al., 2002). Together, filament severing and filament nucleation
synergize to produce a burst of new barbed ends at the leading edge that support
lamellipodial protrusion (DesMarais et al., 2004). Finally, studies using quantitative
fluorescent speckle microscopy in epithelial cells suggest that Arp2/3 complex and
Cofilin activities within lamellipodia may be coupled (Ponti et al., 2005), but very
little is known about how this occurs. In this chapter, we describe a molecular con-
nection between the Arp2/3 complex and Cofilin activities at the leading edge of
motile cells that involves Coronin 1B.
Figure 3.1: SSH1L localizes to the back of lamellipodia
A- Rat2 fibroblasts expressing either WT SSH1L-GFP or CS SSH1L-GFP (green) were imaged for F-
actin with AlexaFluor 568 phalloidin (red).
B,C,D- Rat2 fibroblasts expressing WT SSH1L-GFP (panel B, green in E and F) were serum starved
overnight and stimulated with 2 µg/ml EGF for 15 minutes. The cells were immunostained with
Coronin 1B (panel A, red in E and F) and Cortactin (panel C, blue in E and F). Insets are magni-
fied regions of the leading edge. Image resolution under these conditions (60× objective NA 1.45,
wavelet-based extended depth of focus projection of confocal stacks) is ∼220 nm.
E,F- Merged image of B, C and D. Interior and exterior contours drawn at different distances from the
perimeter of the cell were generated using a custom macro in ImageJ (Section C.20) and presented as
white lines. E is a magnified inset of the framed region in panel F.
G- The binary mask, which was used in the analysis for the cell in panel F, was automatically gener-
ated by threshold using a macro in ImageJ.
H- The average pixel intensity of each labeled component along the contour lines in F is plotted as a
function of distance from the edge of the cell. Error bars are standard error of the mean for each con-
tour line at each point. Cortactin is in blue; Coronin 1B is in red and SSH1L-GFP is in green. Arrows
indicate the maximum signal for each component.
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3.2 Results
3.2.1 Depletion of Coronin 1B reduceswhole cellmotility andmod-
ulates lamellipodial dynamics
To test the role of Coronin 1B in motility, we depleted Coronin 1B in Rat2 cells
and monitored the effects on whole cell migration and lamellipodial dynamics. An
shRNA that selectively targets mouse and rat, but not human, Coronin 1B (Figure
3.2-A,B) decreased the level of Coronin 1B in mouse or rat cells (Figure 3.2-C, 3.10-J).
Depletion of Coronin 1B leads to ∼33% decrease in cell speed relative to uninfected
cells, cells infected with a control shRNA (NS) or cells expressing the Coronin 1B
shRNA and human Coronin 1B-GFP that is refractory to the shRNA (Figure 3.2-D).
Since the decreased rate of cell motility was rescued by expressing human Coronin
1B-GFP, this effect is specifically due to loss of Coronin 1B and not off-target silenc-
ing. Thus, Coronin 1B is required for normal whole cell motility.
Figure 3.2: Depletion of Coronin 1B slows whole cell migration and alters lamellipo-
dial dynamics
A- Target sequence of an shRNA designed to deplete mouse or rat, but not human, Coronin 1B.
B- HEK293 cells were co-transfected with the Coronin 1B shRNA and GFP-tagged human or mouse
Coronin 1B. Lysates were blotted with anti-GFP to verify the efficiency and species specificity of
knockdown. p34Arc protein was detected as a loading control.
C- NIH3T3 cells were transfected with Coronin 1B shRNA (indicated by GFP) for 72 hours, and im-
munostained for Coronin 1B (red) to verify endogenous gene knockdown.
D- Mean cell speeds of Rat2 cells expressing Coronin 1B shRNA (KD-1B, without or with (rescue)
expression of GFP-tagged human Coronin 1B) or control shRNA (NS). Newman-Keuls multiple com-
parison test was used after one-way ANOVA to generate the p values (p<0.001); Error bars = 95% CI.
E-Method for kymography analysis. Minimal intensity projection of a 300-frame 1-sec interval movie
is presented on the right. Pixel intensities along a 1-pixel wide line (blue) were used to generate the
kymograph presented in the blue box; a magnified region (outlined in green) is displayed on the
right. Red dashed lines indicate the parameters for one protrusion. D is protrusion distance, P is
protrusion persistence, and tan(α) is protrusion rate.
F- Protrusion parameters of Rat2 cells expressing the Coronin 1B shRNA without or with co-
expression of human Coronin 1B (rescue). Sample kymographs are shown above each bar; red lines
indicate persistence time for each protrusion. Mean value is presented; error bars = 95%CI. Newman-
Keuls multiple comparison test was used after one-way ANOVA to generate the p values (p<0.001
compared to Rat2).
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Since Coronin 1B is concentrated at the leading edge (Figure 3.1), we reasoned
that the effects of Coronin 1B depletion on whole cell motility might arise from de-
fects in lamellipodial dynamics. We used kymography to quantify the effects of
Coronin 1B depletion on lamellipodial dynamics (Figure 3.2-E). Three parameters of
lamellipodial behavior were analyzed: protrusion rate, protrusion persistence and
protrusion distance (Hinz et al., 1999). Depletion of Coronin 1B increased the pro-
trusion rate and decreased the protrusion persistence and the distance protruded
(Figure 3.2-F). Thus, Coronin 1B modulates lamellipodial dynamics, but is not abso-
lutely required for protrusions to form.
Figure 3.3: Depletion of Coronin 1B slows retrograde actin flow, influences barbed
end distribution and filament architecture at the leading edge
A- Representative kymographs showing retrograde actin flow are shown for Rat2 cells co-expressing
either Coronin 1B (KD-1B) or control (NS) shRNA and GFP-actin. Red bar = 1.14 µm; white bar = 30
sec.
B- Average retrograde flow rates in KD-1B and NS expressing cells (3 measurements/cell) for each
condition are presented as box and whisker plots (Dot = mean, middle line = median, top & bottom
of box = 75% and 25%, whiskers = full data range). Unpaired student t-test indicates a signification
difference between samples (p<0.0001).
C- KD-1B- and NS-expressing Rat2 cells were subjected to the barbed end assay using AlexaFluor 568
labeled G-actin. Two cells for each condition are shown. Scale bar = 10 µm.
D- Quantification of free barbed ends in KD-1B and NS cells. Pixel intensities of AlexaFluor 568 actin
around the leading edge were plotted as described in Figure 3.1. The region encompassing the top
50% of the barbed end signal was defined as the barbed end zone (Figure 3.4). Width of this zone in
KD-1B and NS cells is presented as a box and whisker plot. Unpaired student t test p=0.0165.
E- The normalized ratio of barbed ends (AlexaFluor 568 actin) to total actin (AlexaFluor 647 phal-
loidin) was determined as a function of distance from the cell edge (Figure 3.4). Data were from cells
shown in D and presented as mean ± SEM. Paired Student’s t-test p=0.013 for the region 0.3 µm - 1.4
µm from the edge.
F- Platinum replica electron micrographs of lamellipodia in Coronin 1B-depleted and control Rat2
fibroblasts. Expanded view of each cell is presented as an inset. Branched actin filaments are pseudo
colored with yellow and green. Scale bar = 500 nm.
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3.2.2 Depletion of Coronin 1B slows retrograde actin flow, influ-
ences barbed end distribution and density, and actin archi-
tecture at the leading edge
The assembly and disassembly of actin filament networks underlie the dynamic be-
havior of lamellipodia. Since Coronin 1B depletion affects lamellipodia and Coro-
nins bind F-actin, we tested if Coronin 1B depletion affects actin dynamics at the
leading edge. The network of actin filaments assembling at the cell margin moves
rearwards towards the cell body via retrograde flow. Using kymography of cells
expressing GFP-actin to visualize actin, the rate of retrograde actin flow in Coronin
1B-depleted cells was reduced to∼50% the rate in control cells (Figure 3.3-A,B), sup-
porting the idea that Coronin 1B modulates the dynamics of the actin network at the
leading edge.
A zone of rapidly growing filament barbed ends is a hallmark of the actin net-
work at the leading edge (Condeelis et al., 1988). To measure the distribution and
density of barbed ends in Coronin 1B depleted cells, we used an established assay
to monitor barbed ends in situ (Symons and Mitchison, 1991). Depletion of Coronin
1B leads to a striking narrowing of the zone of barbed ends near the cell edge com-
pared to control cells (Figure 3.3-C,D). In addition to altering the spatial distribution
of barbed ends, Coronin 1B depletion increased the density of barbed ends relative
Figure 3.4: Barbed end assay quantification
Figure shows a flowchart of the steps involved in processing and quantifying the barbed end images
used to derive the data in Figure 3.3-D,E. Cells were plated on fibronectin coated glass coverslips for 4
hours before barbed end assay was performed (barbed ends are colored red in image). Cells were im-
munostained with AlexaFluor 647 phalloidin (pseudo-colored green) to visualize F-actin distribution
in the cell. Hand drawnmasks (white lines) were used to limit extraction of information to lamellipo-
dial subregions without overlap with other cells. Pixel intensities around the leading edge of the cells
were extracted as described in Figure 3.1 and two different channels were plotted separately using
raw value, which was used to calculate the ratio, normalized and grouped for presentation in Figure
3.3-E. The width of the barbed end zone was calculated from the point at which 50% of the barbed
end signal had decayed as indicated.
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to total F-actin (Figure 3.3-E). Thus, Coronin 1B inhibits the generation of barbed
ends at the leading edge and alters their spatial distribution.
To examine the underlying actin filament architecture at the leading edge of
Coronin 1B depleted cells, we used platinum replica electron microscopy. Rat2 cells
have a robust and uniform dendritic network of actin filaments at the leading edge
that is approximately 2 µm wide (Figure 3.3-F). Cells depleted of Coronin 1B have
an abnormal actin network characterized by densely branched filaments at the cell
margin and a relative paucity of actin filaments at the rear of the lamellipodium
(Figure 3.3-F). These changes in the organization of actin filaments are not observed
in cells expressing a control shRNA or in Coronin 1B-depleted cells rescued with
human Coronin 1B-GFP (Figure 3.5). Thus, Coronin 1B appears to plays a role in
coordinating assembly of actin filaments at the cell edge and disassembly of actin
filaments at the rear of the lamellipodium.
3.2.3 Coronin 1B inhibits Arp2/3 complex activity in a phosphory-
lation dependent manner
Yeast Coronin inhibits actin nucleation byArp2/3 complex in vitro (Humphries et al.,
2002). To determine if human Coronin 1B inhibits Arp2/3 complex nucleation ac-
tivity, we added recombinant Coronin 1B to pyrene actin polymerization reactions.
Coronin 1B had no effect on the rates of spontaneous actin assembly or of assembly
nucleated from Spectrin-F-actin seeds (Figure 3.9). However, in reactions containing
Figure 3.5: Depletion of Coronin 1B alters actin ultra-structure at the leading edge
Platinum replica electron microscopy images of lamellipodia in Rat2 fibroblasts infected with the
Coronin 1B shRNA (KD-1B, without or with rescue construct expressing GFP fusion human Coronin
1B) or the control shRNA (NS). Expanded view of each cell is presented on the corner of the image.
Two cells infected with Coronin 1B shRNA (KD-1B) were presented here to show the thinner archi-
tecture in the leading edge as a supplement to Figure 3.3-F. Some filaments are pseudo colored with
yellow or green to show dendritic branch structures. White Bar = 500 nm.
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Figure 3.6: Coronin 1B protein purification
A- Diagram of Coronin 1B protein expression vector.
B- Visualization of Coronin 1B purification steps by Coomassie Blue staining of SDS-PAGE. Lane 1,
whole cell lysate clarified by centrifugation; Lane 2, flow through from the Talon column; Lane 3,
Talon beads; Lane 4, StrepTactin beads.
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Figure 3.7: Coronin 1B’s inhibition of Arp2/3 nucleation is dependent on phospho-
rylation at Serine 2
These data were used to generate the dose response curve in Figure 3.8-B. Plotted are actin polymer
concentrations versus time in reactions containing 1.5 µM actin (5% pyrene labeled), 20 nM Arp2/3,
10 nM GST-VCA, and Coronin 1B as indicated beside each curve: no Coronin 1B, red; 0.5 µM S2D,
light purple; 1 µM S2D, purple; 2 µM S2D, dark purple; 0.5 µM p-WT, light orange; 1 µM p-WT,
orange; 2 µM p-WT, dark orange. The curve labeled actin (yellow) and Arp2/3+actin (khaki) con-
tained neither Coronin 1B nor GST-VCA. p-WT, wild type Coronin 1B purified from PMA stimulated
cells, which has Serine 2 as the major phosphorylated site and 75% of the protein is phosphorylated;
S2D, a mutant version of Coronin 1B, whose Serine 2 was mutated to Aspartic acid to mimic the
phosphorylated protein.
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Figure 3.8: Coronin 1B inhibits actin nucleation by Arp2/3 complex in vitro
A- Actin polymer concentrations vs. time in reactions containing 1.5 µm actin (5% pyrene labeled),
20 nM Arp2/3 complex, 10 nM GST-VCA, and Coronin 1B as indicated. The curves labeled actin
(yellow) and Arp2/3+actin (tan) contained neither Coronin 1B nor GST-VCA.
B- The maximal rates of actin polymerization at varying Coronin 1B concentrations. WT, wild
type Coronin 1B (no detectable phosphorylation); p-WT, wild type Coronin 1B purified from PMA-
stimulated cells (∼75% phosphorylated); S2D, a mutant Coronin 1B with a phospho-mimetic aspar-
tate substitution at Ser2. Maximal assembly rates were calculated as described in Section C.9.
C- His-tagged Coronin 1B or Coronin 1B (S2D) was bound to Ni-NTA beads and mixed with 20 nM
Arp2/3 complex. Immunoblotting detected Arp2/3 complex bound to the beads.
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Figure 3.9: Effects of Coronin 1B on spontaneous actin assembly and barbed end
elongation induced by Spectrin-actin seeds
Plotted are actin polymer concentrations versus time in reactions containing 1 µM actin (5% pyrene
labeled) with or without Spectrin-actin seeds (SAS) and Coronin 1B (wild type protein, WT; phos-
phorylated protein, p-WT) as indicated beside each curve: no Coronin 1B with SAS, red; 0.5 µMWT
with SAS, purple; 1 µM WT with SAS, blue; 0.5 µM p-WT with SAS, green; 1 µM p-WT with SAS,
orange; 0.5 µMWT, gray; 2 µMWT, dark gray; 0.5 µM p-WT, khaki. The curve labeled actin (yellow)
contained neither Coronin 1B nor SAS.
Coronin 1B and GST-VCA-activated Arp2/3 complex, the rate of actin polymeriza-
tion was reduced (Figure 3.8-A,B). To determine if phosphorylation at Ser2 regulates
Coronin 1B’s inhibition of Arp2/3 complex, we compared wild type Coronin 1B
(WT), phosphorylated Coronin 1B (p-WT) and a phosphomimetic S2D mutant of
Coronin 1B. In contrast to WT Coronin 1B, phosphorylated Coronin 1B (p-WT) and
the S2D mutant Coronin 1B weakly inhibit Arp2/3 complex nucleation activity at
all doses tested (Figure 3.7, 3.8-B). Furthermore, purified Arp2/3 complex bound di-
rectly to wild type Coronin 1B, but did not bind to the phosphomimetic S2D Coronin
1B mutant (Figure 3.8-C). Thus, Coronin 1B inhibits Arp2/3 complex nucleation in
vitro and phosphorylation of Coronin 1B on Ser2 regulates this activity.
3.2.4 Coronin 1B is dephosphorylated by an okadaic acid-insensitive
phosphatase
The phosphatase that dephosphorylates and activates Coronin 1B is unknown. To
identify this 1B phosphatase, we developed an assay in which cells were first treated
with PMA to stimulate maximal phosphorylation, followed by PMAwashout in the
presence of a pan-PKC inhibitor (Ro32-0432) to block further phosphorylation. Us-
ing this regime, dephosphorylation of Coronin 1B was detected within one minute
and phospho-Coronin 1B returned to basal levels by 10 minutes (Figure 3.10-A). We
examined the sensitivity of this phosphatase to the Ser/Thr phosphatase inhibitor
okadaic acid, which potently inhibits PP1 and PP2A (Cohen et al., 1990). Okadaic
acid at concentrations from 100 nM (Figure 3.10-B) to 1 µM (data not shown) had no
effect on the rate of Coronin 1B dephosphorylation, making it unlikely that phospho-
Coronin 1B is a substrate of either PP1 or PP2A.
3.2.5 Coronin 1B is a substrate of the Slingshot-1L phosphatase
We considered whether the Coronin 1B phosphatase might be Slingshot, which acts
on Cofilin. Slingshots are among a small number of Ser/Thr phosphatases resistant
to okadaic acid (Niwa et al., 2002). To test this hypothesis, we performed in vitro and
in vivo dephosphorylation assays using Slingshot-1L (SSH1L). Recombinant Coronin
1B phosphorylated in vitrowith purified PKCα was efficiently dephosphorylated by
SSH1L (Figure 3.10-C). Since phosphatases often exhibit promiscuous activity on
purified proteins, we tested whether SSH1L dephosphorylates Coronin 1B in cell
lysates. Coronin 1Bwas phosphorylated by stimulating cells with PMA prior to lysis
and increasing amounts of SSH1L-myc were then added; the phosphorylation sta-
tus of Coronin 1B and other substrates was monitored by immunoblotting. Coronin
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1B was dephosphorylated by SSH1L in a dose-dependent manner (Figure 3.10-D).
Cofilin was also efficiently dephosphorylated and may be a preferred substrate. In
contrast, no detectable dephosphorylation of phospho-Erk1/2 or phospho-Paxillin
was detected, suggesting that the SSH1L phosphatase activity is highly specific un-
der these conditions.
To determine if Coronin 1B is a substrate of SSH1L in vivo, we performed dephos-
phorylation assays in two different cell types. First, HEK293 cells were transiently
Figure 3.10: Interactions between Coronin 1B and Slingshot 1L
A- Rat2 fibroblasts expressing Coronin 1B-GFP were treated with 100 nM PMA to stimulate Coro-
nin 1B phosphorylation. Cells were washed with fresh media and incubated with the pan-PKC in-
hibitor Ro32-0432 (1 µm) to inhibit further phosphorylation. Coronin 1B was immunoprecipitated
from lysates at the indicated times and blotted with anti-pSerPKC to monitor dephosphorylation ki-
netics.
B- Dephosphorylation assay carried out as in (A) +/- okadaic acid (100 nM).
C- Recombinant Coronin 1B was phosphorylated in vitro by PKC and subjected to in vitro dephos-
phorylation with immunoprecipitated SSH1L-myc. Phospho-Coronin 1B was detected with anti-
pSerPKC.
D- Lysates from Rat2 cells that were treated with 100 nM PMA for 30 min were subjected to de-
phosphorylation in vitro by increasing concentrations of SSH1L-myc. Phospho-Coronin 1B was de-
tected following immunoprecipitation as described above. Phosphorylation of PaxillinS126, Erk1/2
and Cofilin were monitored by immunoblotting the unbound fraction after Coronin 1B immunopre-
cipitation using phospho-specific antibodies. Blots shown are representative of at least three inde-
pendent experiments.
E- Phospho-Coronin 1B was detected in control or HEK293 cells expressing myc-tagged dominant
negative mutant SSH1L C393S (CS) as described in B.
F- Lysates of control Rat2 cells or cells expressing either WT SSH1L-GFP or SSH1L-CS-GFPwere blot-
ted with the indicated antibodies.
G- Rat2 cells expressing either WT SSH1L-GFP or CS SSH1L-GFP were subjected to the in vivo de-
phosphorylation assay. Phospho-Coronin 1B was detected by anti-pSerPKC and quantified by den-
sitometry relative to total Coronin 1B. Results from three independent experiments are presented as
means ± SEM.
H- Lysates from HEK293 cells expressing SSH1L-myc were immunoprecipitated with antibodies to
Coronin 1B, SSH1L-myc or control IgG and blotted with the indicated antibodies.
I- Endogenous Coronin 1B was immunodepleted from lysates of Rat2 cells expressing SSH1L-GFP.
Control rabbit IgGwas used formock depletion. Residual SSH1L-GFPwas immunoprecipitated from
the immunodepleted lysates using anti-GFP antibody and blotted with the indicated antibodies.
J- Rat2 cells expressing SSH1L-GFP were infected with lentivirus expressing Coronin 1B shRNA
(KD-1B) or a control shRNA (NS). Arp2/3 complex was immunoprecipitated using anti-p34Arc and
blotted for SSH1L using anti-GFP. Similar results were obtained using anti-GFP to immunoprecitate
SSH1L-GFP (not shown).
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Figure 3.11: Quantification of the concentration of Coronin 1B in HEK293 cells
Quantification of Coronin 1B and p34Arc (a subunit of the Arp2/3 complex) concentrations were
determined by immunoblotting and densitometry. Only bands with signals within the linear detec-
tion range of the film were used for calculations. Dilutions of cell extract from HEK293 were blotted
together with standards of purified human Coronin 1B and bovine Arp2/3. The p34Arc antibody
used was raised against a peptide that is conserved between human and bovine. Average diameter
of suspension HEK293 cells is 17 µm, and the average diameter of their DAPI stained nuclei is 9 µm,
which were used to calculate the cytoplasm volume.
transfected with dominant negative mutant form of SSH1L (SSH1L-CS), which har-
bors a mutation (C393S) in the phosphatase domain that renders it catalytically in-
active (Ohta et al., 2003). In the presence of SSH1L-CS, phospho-Coronin 1B was el-
evated after PMA stimulation and the return to basal levels after washing out PMA
was delayed (Figure 3.10-E). Since ectopic SSH1L expression is relatively high in
HEK293 cells, we confirmed these observations using Rat2 cells stably expressing
lower levels of either wild type (WT) SSH1L-GFP or dominant negative SSH1L-CS-
GFP (Figure 3.10-F). As expected, the level of phospho-Cofilin decreased in lysates
from Rat2 cells expressing WT SSH1L-GFP and increased in lysates from Rat2 cells
expressing CS SSH1L-GFP. We conclude that, like Cofilin, Coronin 1B is a substrate
of the SSH1L phosphatase in vitro and in vivo.
73
74
3.2.6 Coronin 1B, Slingshot 1L and Arp2/3 form a complex in vivo
that is bridged by Coronin 1B
Coronin 1B and Arp2/3 complex interact in vivo (Chapter 2). To determine if Sling-
shot 1L is part of this complex, we immunoprecipitated SSH1L and probed for Coro-
nin 1B and Arp2/3 complex. SSH1L-myc interacted with endogenous Coronin 1B
using reciprocal co-immunoprecipitations (Figure 3.10-H). Arp2/3 complex (as re-
ported by the p34 subunit) was detected in both the Coronin 1B and SSH1L im-
munoprecipitates. Notably, actin was not detected, despite the fact that Coronin 1B,
SSH1L and Arp2/3 complex all bind F-actin, indicating that the interaction among
these components is not bridged by residual F-actin.
While these results are consistent with the existence of a ternary complex contain-
ing Coronin 1B, SSH1L and Arp2/3 complex, they do not exclude the possibility of
two bivalent complexes (a Coronin 1B-Arp2/3 complex and a SSH1L-Arp2/3 com-
plex). To identify a ternary complex, we used a two-step immunoprecipitation pro-
tocol in which Coronin 1B was first immuno-depleted from the lysates derived from
Figure 3.12: Protein production of wild type and phosphorylated Coronin 1B
A- 3 µg of purified Coronin 1B purified from HEK293 cells was run on SDS-PAGE and stained with
Coomassie Blue.
B- HEK293 cells over-expressing Coronin 1B were stimulated with 50 nM PMA for 30 minutes prior
to protein purification. Based on Chapter 2, PMA stimulation specifically promotes Serine 2 phos-
phorylation in vivo. Blotting with a phospho-specific antibody (pSerPKC) reveals that the purified
p-WT Coronin 1B protein is heavily phosphorylated.
C- 10 µg of purified wild type (WT) and phosphorylated (p-WT) Coronin 1B samples were dialyzed
into water, digested with AspN overnight and subjected to mass spectrometry analysis at the UNC
proteomic facility. The MS/MS spectra confirms the N terminus sequence of Coronin 1B and discov-
ers a novel peak in p-WT sample, which matches the expected 80 Da increase for phosphorylation.
D- 1 µg of p-WT protein was immunoprecipitated with either Coronin 1B (total Coronin 1B) or
pSerPKC (phospho-Coronin 1B) antibodies. From pilot experiments, we determined that the Coronin
1B antibody immunoprecipitated the protein with 10-15× greater efficiency than the pSerPKC anti-
body (not shown). Using this information, we adjusted the loads to bring the pSerPKC IP’d samples
into the same range as the Coronin 1B IP’d samples and blotted the samples with both antibodies.
Using densitometry, we compared the intensity of bands to calculate the stoichiometry of phospho-
rylation and find that ∼75% of the p-WT protein is phosphorylated.
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Figure 3.13: SSH1L directly binds to Coronin 1B
A- Coronin 1B tagged with StrepTagII and V5 and SSH1L CS mutant tagged with StrepTagIII and
His×8 were purified to homogeneous by affinity columns.
B- Purified Coronin 1B was mixed with either buffer (ctrl) or purified SSH1L. Ni-NTA beads was
used to pull down SSH1L, and samples were immunoblotted with indicated antibodies.
Rat2:SSH1L-GFP cells followed by a second immunoprecipitation of SSH1L-GFP
from the depleted lysate (Figure 3.10-I). In the first step, anti-Coronin 1B antibodies
(but not control IgG) immunoprecipitated both SSH1L-GFP and Arp2/3 complex.
When SSH1L-GFP was immunoprecipitated from the Coronin 1B-depleted lysate,
no additional Arp2/3 complex was co-immunoprecipitated. In contrast, SSH1L-
GFP co-immunoprecipitated both Coronin 1B and Arp2/3 complex from a mock-
depleted lysate.
To confirm this result, we tested for an interaction between SSH1L and Arp2/3
complex in Coronin 1B-depleted cells. No SSH1L was detected when Arp2/3 com-
plexwas immunoprecipitated from lysates derived fromCoronin 1B-depleted, SSH1L-
GFP expressing Rat2 (Figure 3.10-J). We conclude that SSH1L, Coronin 1B andArp2/3
exist in a ternary complex that is bridged by Coronin 1B.
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Figure 3.14: SSH3 localizes to the leading edge during PMA stimulation
Rat2 cells were infected with retrovirus expressing SSH3GFP fusions. Cells were stimulated with 100
nM PMA for 30 minutes before the fixation, and immunostained with indicated antibodies.
3.2.7 Coronin 1B directly interacts with Slingshot 1L in vitro
Using mammalian protein expressing system, we purified both Coronin 1B and
SSH1L (CS mutant, not the wild type protein) to homogeneous (Figure 3.13-A). Us-
ing pull-down experiments, we found that SSH1L directly interacts with Coronin 1B
in vitro (Figure 3.13-B). Similar as the direct interaction between Coronin 1B and the
Arp2/3 complex, We demonstrated that SSH1L directly binds to Coronin 1B.
We briefly tested the domain requirement of Coronin 1B to interact with SSH1L.
A truncation mutant lacking the N terminal 24 amino acids loses its ability to bind
to SSH1L. A careful examination is required in the future to further dissect the inter-
action between Coronin 1B and SSH1L.
There are three SSH genes in mammals. We wonder whether the interaction
between Coronin 1B and SSH1L is a reflection of general interactions between Coro-
nins and SSHs. We expressed SSH3 GFP fusions in cells, and found that upon
PMA stimulation SSH3 enriched in lamellipodia (Figure 3.14). Although under
normal culture conditions, the distribution of SSH3-GFP is dispersed, the leading
edge enrichment upon stimulation is very intriguing. We tested the interaction be-
tween Coronin 1B and SSH3 using immunoprecipitation (Figure 3.15). CS mutants
of SSH1L and SSH3 were used to facilitate the expression of the SSH protein, which
do not affect the interaction between Coronin 1B and SSH1L.We did not observe any
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Figure 3.15: Coronin 1B only interacts with SSH1L not SSH3
HEK293 cells were transfected with constructs expressing SSH1L or SSH3. Cell lysates were used for
immunoprecipitation using Coronin 1B antibodies. Indicated antibodies were used to immunoblot
the immunoprecipitants.
interaction between Coronin 1B and SSH3, suggesting that the interaction between
Coronin 1B and SSH1L is unique and may play specific role during actin dynamics.
3.2.8 Depletion of Coronin 1B inhibits SSH1L-induced membrane
ruffling
Expression of SSH1L-GFP in Rat2 cells induces constitutive hyper-ruffling at the
cell periphery (Figure 3.17-A). Lamellipodia in SSH1L-expressing cells protrude at
approximately twice the rate and protrusions are short-lived compared to control
cells, with no difference in protrusion distance. Remarkably, depletion of Coronin
1B completely suppressed SSH1L-induced hyper-ruffling. One possible explanation
is that Coronin 1B generally influences lamellipodial dynamics by a mechanism un-
related to SSH1L activity. To address this possibility, we investigated lamellipodia in
Coronin 1B-depleted cells expressing FP4-CAAX, which induces hyper-ruffling by
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Figure 3.16: N terminus of Coronin 1B is required for its interaction with SSH1L
HEK293 cells were transfected with constructs expressing SSH1L-myc and different Coronin 1B GFP
fusions: WT, wild type protein; ∆Ne, Coronin 1B lacking the first 24 amino acids; Ne, 1-24th amino
acids of Coronin 1B. Cell lysates were immunoprecipitated with GFP antibodies, and immunoprecip-
itants were blottedwith indicated antibodies. N terminus of Coronin 1B is necessary but not sufficient
to support its interaction with SSH1L.
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targeting Ena/VASP proteins to the plasma membrane (Bear et al., 2000, 2002). As
expected, expression of FP4-CAAX increased protrusion rate and shortened protru-
sion persistence, similar to the effects of SSH1L expression, but depletion of Coronin
1B had no effect on the ruffling induced by FP4-CAAX. Thus, the suppression of
the SSH1L-induced ruffling in Coronin 1B-depleted cells is a specific, rather than a
general, effect on lamellipodial dynamics.
Suppression of SSH1L-induced ruffling upon Coronin 1B depletion may occur
via dephosphorylation of Coronin 1B by SSH1L. Thus, a phosphomimetic mutant
form of Coronin 1B would be predicted to suppress SSH1L-induced hyper-ruffling
by competing with endogenous substrates. To test this hypothesis, lamellipodial
dynamics were examined in cells expressing Coronin 1B S2D and SSH1L. To our
surprise, the Coronin 1B S2D mutant is ineffective in suppressing SSH1L-induced
hyper-ruffling (Figure 3.17-B). In contrast, expression of the phosphomimetic Cofilin
S3D mutant suppresses SSH1L-induced hyper-ruffling (Figure 3.17-B), confirming
that SSH1L-induced ruffling is due to the phosphatase activity of SSH1L. While
these results do not preclude a contribution of SSH1L dephosphorylation of Coronin
1B in regulating lamellipodial behavior, they do suggest that regulation of Cofilin
by SSH1L influences lamellipodial behavior. Alternately, Cofilin S3D may be a more
effective competitor of SSH1L phosphatase than Coronin 1B S2D. Nonetheless, we
sought another explanation for the potent suppression of the ectopic SSH1L-induced
ruffling upon Coronin 1B depletion.
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Figure 3.17: Depletion of Coronin 1B inhibits SSH1L-induced membrane ruffling
A- Rat2 cells expressing SSH1L or FP4-CAAX were transfected with the Coronin 1B shRNA, and
subjected to kymography analysis as described in Figure 3.2-E. Newman-Keuls multiple comparison
test was used after one-way ANOVA to generate the p values; Error bars = 95% CI.
B- Phospho-mimetic mutants of either Coronin 1B (S2D) or Cofilin (S3D) were co-expressed in Rat2
cells with SSH1L-GFP; kymography analysis was carried out as in Figure 3.2-E; Error bars = 95% CI.
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3.2.9 Depletion of Coronin 1B disrupts normal Slingshot 1L target-
ing to the leading edge
Coronin 1Bmay act upstream of SSH1L and thereby influence SSH1L-induced hyper-
ruffling. For example, Coronin 1B may allow SSH1L to reach its substrate (Cofilin)
and thereby influence lamellipodial dynamics. To test this idea, we compared the
localization of SSH1L-GFP in control and in Coronin 1B-depleted cells. shRNAs
were co-expressed with SSH1L-GFP using a single lentirviral vector (Figure 3.18-A),
so that every cell expressing SSH1L-GFP also expressed either Coronin 1B-specific
or control shRNA. SSH1L-GFP was not as enriched at the leading edge of Coronin
1B-depleted cells as in the control cells (Figure 3.18-B) when compared to the dis-
tribution of Cortactin (Figure 3.1). In control shRNA expressing cells, the maximal
peaks of Cortactin and SSH1L-GFP were separated by an average of 0.35 µm. In
Coronin 1B-depleted cells, Cortactin was distributed identically to that in control
cells, but the peak of SSH1L-GFP signal was approximately twice as far rearward
from the peak of Cortactin than in control cells (Figure 3.18-C). These data suggest
that Coronin 1B is required to target SSH1L to a distinct region within lamellipodia
and that proper targeting of SSH1L is required to exert an effect on lamellipodial
Figure 3.18: Depletion of Coronin 1B disrupts targeting of Slingshot 1L to the lead-
ing edge
A- Diagram of the lentiviral vector combining Coronin 1B (KD-1B) or NS control shRNA and SSH1L-
GFP expression.
B- Rat2 cells infected with lentivirus described in A were stimulated with EGF and stained for Coro-
nin 1B and Cortactin. Regions boxed by yellow dash lines are magnified in the upper panels. Pixel
intensities around the cell edge were extracted and plotted as described in Figure 3.1. The relative
intensities of Cortactin (blue) and SSH1L-GFP (green) are plotted for Coronin 1B depleted cells (KD-
1B, upper panel) and for two control cells (NS, lower panels).
C- The distance between the maximal intensity of SSH1L-GFP and that of Cortactin staining was de-
termined for Coronin 1B-depleted or control cells (N = 27 cells). Data is presented a box and whisker
plot; unpaired Student’s t-test p<0.001.
D- Cells prepared as described in panel B were stained with anti-Coronin 1B and AlexaFluor 568
phalloidin. RG-merge shows overlap between SSH1L-GFP and F-actin.
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dynamics.
Previous studies suggested that binding of SSH1L to F-actin targeted it to the
leading edge (Nagata-Ohashi et al., 2004). To examine the role of F-actin in localiz-
ing SSH1L within lamellipodia, we stained cells expressing SSH1L-GFP (+/- Coro-
nin 1B shRNA) with phalloidin (Figure 3.18-D). In control cells, SSH1L-GFP and
F-actin co-localized within lamellipodia. However in Coronin 1B-depleted cells, the
distribution of F-actin was indistinguishable from that in control cells at the level of
light microscopy, but SSH1L-GFP was excluded from the most distal, F-actin rich
region near the leading edge. This result indicates that F-actin is insufficient to
target SSH1L to the leading edge, but does not exclude a contribution of F-actin-
SSH1L interactions for stimulating phosphatase activity (Nagata-Ohashi et al., 2004;
Soosairajah et al., 2005).
3.2.10 Depletion of Coronin 1B inhibits endogenous Cofilin phos-
phatases
To test whether Coronin 1B depletion also inhibited endogenous Cofilin phosphatase
activity, we compared the phospho-Cofilin levels in cells expressing Coronin 1B-
shRNAand control shRNA. Cells depleted of Coronin 1B had higher levels of phospho-
Cofilin relative to controls (Figure 3.19-A). This effect is not due activation of Cofilin
kinases because Coronin 1B-depletion does not alter the level of active LIMK 1/2.
To confirm the effect of Coronin 1B depletion on phospho-Cofilin levels, we deter-
mined the ratio of active-to-total Cofilin in Coronin 1B-depleted cells using ratio-
metric imaging (Figure 3.19-B). In control cells, the ratio of active-to-total Cofilin
was similar to that in surrounding uninfected cells; in Coronin 1B-depleted cells, the
ratio of active-to-total Cofilin is lower than in uninfected cells, particularly in lamel-
lipodial regions (Figure 3.19-B). The ratio of active-to-total Cofilin across the whole
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cell is approximately two fold lower in Coronin 1B-depleted cells (Figure 3.19-C).
Together, these results indicate that Coronin 1B enhances dephosphorylation and
activation of Cofilin. Moreover, these findings are consistent with the biochemical
and cellular effects of ectopic expression of SSH1L-GFP and suggest Coronin 1B in-
fluences Cofilin activity via a Slingshot-dependent mechanism.
Recent unpublished data from our laboratory show that Coronin 2A, a type II
mammalianCoronin highly expressed in brain and neural structures, regulates Cofilin
activity as well. Interestingly, Coronin 2A only localizes to stress fibers and does
not have any lamellipodial localization. Depletion of Coronin 2A not only influ-
ences Cofilin phosphorylation, but also affects SSH1L’s localization to stress fibers,
strongly suggesting that Coronins regulate SSH1L in different cellular compartments
and play an general role in regulating Cofilin activity and actin depolymerization
machinery.
3.2.11 Activated Cofilin partially rescues the effects of Coronin 1B
depletion on lamellipodial dynamics
Since Coronin 1B-depletion increases the amount of phospho-Cofilin, we postulated
that the effects on lamellipodial dynamics might be due, in part, to a failure to ac-
tivate Cofilin at the leading edge. To test this idea, we co-expressed an activated
Cofilin mutant (S3A) along with Coronin 1B or control shRNA. Lamellipodial pro-
trusions extended faster andwere shorter-lived in cells expressing Cofilin (S3A)-GFP
than those in either control cells expressing no Cofilin (S3A)-GFP or non-transfected
cells (Figure 3.19-D), similar to the effects of expressing SSH1L-GFP. Co-expression
of Cofilin (S3A)-GFP and Coronin 1B shRNA partially suppressed the effects on
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Figure 3.19: Depletion of Coronin 1B increases phosphorylation of Cofilin and ex-
pression of activated Cofilin (S3A) partially rescues the effects of Coronin 1B deple-
tion on lamellipodia dynamics
A- Lysates from Rat2 cells expressing either the Coronin 1B shRNA (KD-1B) or control shRNA (NS)
were blotted with the indicated antibodies.
B- Cells generated as described in panel A were immunostained for total Cofilin (MAB22) and
phospho-Cofilin (4321) and subjected to ratio imaging. GFP-positive cells in the DIC image express
either Coronin 1B (KD-1B) or control (NS) shRNA. Ratios of Active/Total Cofilin were calculated
from [(Total Cofilin - pCofilin) / Total Cofilin)] and presented using a rainbow look-up table.
C- Active/total Cofilin ratios in whole cells expressing Coronin 1B shRNA (KD-1B) or control shRNA
(NS). Whole cell average ratio from 17 and 23 cells is presented as a box and whisker plot; unpaired
Student’s t-test p<0.0001.
D- Rat2 cells expressing activated Cofilin (S3A) and/or Coronin 1B shRNAwere subjected to kymog-
raphy analysis. Protrusion parameters were determined as described in Figure 3.2-E. ANOVA test
shows significant difference between the samples. Newman-Keuls multiple comparison tests were
used to generate p values; Error bars = 95% CI.
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lamellipodial dynamics of Coronin 1B depletion. Lamellipodial protrusion rate de-
creased and protrusion persistence was modestly increased, but did not reach con-
trol levels. It is important to note that, although Cofilin S3A rescued the lamellipo-
dial dynamics associated with depletion of Coronin 1B, it did not rescue the effects
on whole cell motility (data not shown). Together, these data suggest that Coronin
1B promotes the activation of Cofilin at the leading edge.
3.3 Discussion
3.3.1 The cellular function of Coronin 1B
Our data indicate that Coronin 1B is a key regulator of whole cell motility and lamel-
lipodial dynamics. Although Coronin 1B is not absolutely required for cells to move
or lamellipodia to protrude, it enhances these processes and is a likely target of signal
transduction cascades that regulate motility. Coronin 1B influences motility through
control of actin filament dynamics and architecture at the leading edge. In the ab-
sence of Coronin 1B, retrograde actin flow is reduced and the dendritic actin mesh-
work of the lamellipodia is abnormal. These two observations are likely to be as-
pects of the same underlying phenomenon, as the architecture of the actin network
reflects the balance of actin assembly at the front and disassembly at the back of the
lamellipodia. Future studies will dissect the relative contributions of actin assem-
bly/disassembly and myosin-based contraction to Coronin 1B’s effect on retrograde
flow.
Most striking is the different distribution and density of actin barbed ends in the
lamellipodia of cells lacking Coronin 1B. Cells depleted of Coronin 1B have higher
barbed end density than controls and the barbed ends are concentrated in a narrower
zone at the leading edge. Increased barbed ends could arise by three mechanisms:
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failure to cap or uncapping of existing filaments, severing of filaments or de novo
nucleation of new filaments. Since Coronin 1B has no detectable capping activity
(Figure 3.9), failure to cap filaments can be eliminated from consideration. The in-
creased barbed ends observed with Coronin 1B depletion are also unlikely to result
from increased filament severing since Cofilin is less active in the lamellipodia of
knockdown cells. We cannot exclude an effect on Cofilin-independent severing (eg.
Gelsolin), but since Cofilin is required for protrusion, it is probably the predominant
severing factor in lamellipodia. We suggest that increased nucleation of filaments
most likely results in increased barbed ends in lamellipodia of Coronin 1B-depleted
cells.
3.3.2 Coronin 1B inhibits Arp2/3-mediated nucleation in a phospho-
regulated manner
Consistent with the increased density of barbed ends in lamellipodia of Coronin 1B-
depleted cells, recombinant Coronin 1B inhibits the nucleation activity of Arp2/3 in
vitro. This inhibitory effect on Arp2/3 activity is a conserved property of Coronins
from yeast to humans (Humphries et al., 2002). Other proteins such as Tropomyosin,
Caldesmon and EPLIN inhibit Arp2/3 complex nucleation activity, but these pro-
teins are thought to bind tightly to the sides of actin filaments and compete with
binding of Arp2/3 to the mother actin filament (Blanchoin et al., 2001; Maul et al.,
2003; Yamakita et al., 2003) to indirectly inhibit filament-dependent Arp2/3 nucle-
ation activity. In contrast, inhibition by Coronin 1B appears to arise from direct
binding of Coronin to Arp2/3 complex and stabilization of its “open”, inactive form
(Rodal et al., 2005). Our findings support this notion since Coronin 1B S2D binds
poorly to Arp2/3 and has weaker inhibitory activity. Further studies will be re-
quired to elucidate the molecular mechanism of Coronin 1B’s inhibition of Arp2/3
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complex.
Our results suggest that limiting filament nucleation activity via Coronin 1B is
important for efficient lamellipodial protrusion. This conclusion is consistent with
other studies in which lamellipodial protrusions formed in response to EGF were
blocked in cells microinjected with the Arp2/3 complex activating VCA (WA) do-
main of SCAR or WASP (Shao et al., 2006). Coronin 1B apparently serves to tem-
per filament nucleation by Arp2/3 complex in lamellipodia, especially close to the
membrane where several WASP/SCAR co-activating factors, such as Rac, Cdc42
and PIP2, are enriched. In the absence of Coronin 1B, nucleation by Arp2/3 complex
may be overactive, leading to the increased free barbed ends and the faster rate of
protrusion observed in Coronin 1B depleted cells. Without a means to limit Arp2/3
complex activity, explosive generation of new filaments could result in short-lived
protrusions that stall as G-actin becomes limiting, consistent with the decreased pro-
trusion persistence and distance observed in the Coronin 1B-depleted cells. Previous
models for the control of filament nucleation in lamellipodia focused on the local-
ized activation of WASP/SCAR/Formin proteins by inositol lipids and Rho-type
GTPases. Our studies suggest that nucleation control is more complex than current
models predict and involves a balance between nucleation promoting factors and
inhibitors.
3.3.3 Coronin 1B regulates SSH1L localization and Cofilin activity
Coronin 1B is required for SSH-induced lamellipodial activity and for targeting SSH1L
within lamellipodia. Through these processes, Coronin 1B could significantly influ-
ence the activity of Cofilin at the leading edge. Thismechanism for regulating Cofilin
activity is analogous to the mechanisms regulating many kinases and phosphatases
89
via targeting subunits and scaffolds (Cohen, 2002; Sim and Scott, 1999). It is impor-
tant to note that targeting of SSH1L does not override other mechanisms of Slingshot
regulation such as phosphorylation or F-actin binding (Nagata-Ohashi et al., 2004).
Rather, it is likely that appropriate targeting of SSH1L works in conjunction with
these other regulatory events to control Slingshot’s activity spatially and temporally.
Our studies in fibroblasts link Coronins and Cofilin activities via SSH, however
there is precedence for such a connection in other systems (Goode et al., 1999). Mu-
tations in the single yeast Coronin gene are benign except when combined with mu-
tations in the Cofilin gene. F-actin accumulates in abnormal aggregates in double
Coronin/Cofilin mutants, but not with each single mutant, suggesting that these
proteins function together to promote actin turnover in this organism. Recent stud-
ies also identified Coronin 1A as a factor leading to actin depolymerization in Lis-
teria actin tails (Brieher et al., 2006). This study suggested that Coronin 1A-bound
F-actin has increased affinity for Cofilin, perhaps due to altered helical twist. One
prediction of this idea is that Cofilin may not be recruited to the leading edge in the
absence of Coronin. We observed no change in Cofilin distribution at the leading
edge in Coronin 1B-depleted cells (Figure 3.20), but future studies are needed to ex-
plicitly test whether Coronin 1B has similar activity to Coronin 1A in this regard. It
is possible that Coronins direct Cofilin recruitment and activation via SSH targeting
to synergistically control Cofilin activity. Regardless of the precise mechanistic de-
tails, a conserved functional connection between Coronins and Cofilin in regulating
filament dynamics exists from yeast to humans.
Although the interactions between Coronin 1B – SSH1L andCoronin 1B –Arp2/3
complex are direct, phosphorylation regulation of the interaction between Coronin
1B – Arp2/3 complex (Figure 2.3-C) and the fact that SSH1L is an in vivo phosphatase
for Coronin 1B (Figure 3.10-E,F) make the regulations of these interactions complex.
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Figure 3.20: Depletion of Coronin 1B does not alter the distribution of endogenous
Cofilin and Cortactin in Rat2 fibroblasts
Rat2 fibroblasts were infectedwith lentivirus expressing shRNA specific for Coronin 1B co-expressing
soluble GFP (labeled KD-1B in figure) and surrounding uninfected, GFP-negative cells were used as
control. Cells were plated on fibronectin-coated glass coverslips for 4 hours before 4% paraformalde-
hyde fixation. Fixed cells were treated with methanol for 5 minutes and immunostained for Cofilin
(red, polyclonal antibody from Cytoskeleton) and Cortactin (blue, 4F11 monoclonal antibody). Re-
gions boxed by white dash lines are magnified.
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Figure 3.21: In the presence of SSH1L-GFP, PMA stimulation enhances the interac-
tion between Coronin 1B and Arp2/3 complex
Rat2 cells stably expressing SSH1L GFP fusions were treated with PMA for 30 minutes. Cell lysates
were immunoprecipitated with antibodies against endogenous Coronin 1B. Precipitates were sepa-
rated by SDS-PAGE and immunoblotted with indicated antibodies.
We found that in SSH1L expressing cells, under PMA treatment, Coronin 1B has
stronger interaction with Arp2/3 complex (Figure 3.21). Since the expression of ex-
ogenous SSH1L may have already altered intracellular actin dynamics, it is possible
that these cells utilize enhanced Coronin 1B – Arp2/3 interaction to against the PMA
effect. Adapting to the surrounding environment quickly is the key to survival, un-
der different conditions, cells may use slightly different strategies to balance the
actin assembly and disassembly machinery and remodel actin cytoskeleton.
3.3.4 The coordination of Arp2/3 complex and Cofilin activity in
lamellipodia
Why is a factor that coordinates the activities of Arp2/3 complex and Cofilin in
lamellipodia necessary? Cell motility is a system-based process that requires precise
spatial and temporal control of the individual components. Chemotaxis requires
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localized and coordinate cytoskeletal remodeling to achieve directional movement
towards a chemotactic signal. Our work identifies Coronin 1B as a link between
two major components, Cofilin and Arp2/3 complex, that control actin remodeling
in many cells. Since factors that coordinate cytoskeletal dynamics are likely to be
crucial for directional sensing and motility, Coronin 1B is likely regulated by chemo-
tactic signaling pathways. This idea is supported by the recent observations that
thymocytes from Coronin 1A knockout mice are severely defective in chemotaxis
towards chemokines (Foger et al., 2006). Future studies will focus on the role that
Coronin 1B plays in directed cell motility and on elucidating the molecular mecha-
nism of Coronin 1B action.
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Chapter 4
F-actin binding is essential for
Coronin 1B function in vivo
Coronins are conserved F-actin binding proteins that have been implicated in a va-
riety of processes including fibroblast migration, phagocytosis, and chemotaxis. We
have shown that Coronin 1B coordinates Arp2/3-dependent actin filament nucle-
ation and Cofilin-mediated filament turnover at the leading edge of migrating fi-
broblasts. Analysis of Coronin function has been hampered by the lack of a clear
understanding of how Coronin interacts with F-actin. Here, we identify a surface-
exposed conserved residue, Arginine 30 (R30), which is critical for Coronin 1B bind-
ing to F-actin both in vitro and in vivo. Using actin co-sedimentation, we demonstrate
that Coronin 1B binds with high affinity to ATP/ADP-Pi F-actin (170 nM) and with
47-fold lower affinity to ADP F-actin (8 µM). In contrast to a previous study, we find
no evidence for enhanced Cofilin binding to F-actin in the presence of either Coro-
nin 1B or Coronin 1A. Instead, we find that Coronin 1B protects actin filaments from
Cofilin-induced depolymerization. Consistent with an important role for Coronin
1B – F-actin interactions in vivo, the R30Dmutant that lacks F-actin binding localizes
inefficiently to the leading edge. Furthermore, our analysis indicates that F-actin
binding is absolutely required for Coronin 1B to exert its effects on whole cell motil-
ity and lamellipodial dynamics. 1 2
4.1 Background
The dynamic reorganization of the actin cytoskeleton is a crucial component in nearly
all aspects of cell motility (Pollard and Borisy, 2003). Actin polymerization itself is
thought to provide the driving force during leading edge protrusion. Dynamic actin
reorganization also plays an important role in other processes such as host-pathogen
interactions and endocytosis (Bear et al., 2001; Engqvist-Goldstein and Drubin, 2003).
The molecular mechanisms of actin assembly and dynamics have been the target of
intense study for decades. A host of cellular proteins control the nucleation, growth,
organization and disassembly of actin filaments. Coronins are F-actin binding pro-
teins that are highly conserved across species and regulate a number of motility
processes (Uetrecht and Bear, 2006). However, the mechanism by which Coronins
affect cell motility has not been fully elucidated.
Functional studies from multiple species indicate that Coronins play important
roles in many processes involving actin dynamics. Coronin was originally identi-
fied in Dictyostelium as an F-actin binding protein that is enriched at the leading
edge and at phagocytic cup structures (de Hostos et al., 1991). Dictyostelium mu-
tants lacking Coronin have defects in cell migration, cytokinesis and phagocytosis
1 We gratefully acknowledge Eric Vitriol for help with FRAP microscopy; Andrea Uetrecht and
Steve Rogers for RNAi inDrosophila S2 cells; Ken Jacobson for helpful discussions about FRAP analy-
sis; HaoWu, Steve Rogers, David Roadcap for critical reading of the manuscript; Dorothy Schafer for
reagents and assistance with the pyrene actin depolymerization assay; Yves Durocher and Keith Bur-
ridge for reagents. Circular dichroism measurement was performed at Macromolecular Interaction
Facility in UNC, with the help from Ashutosh Tripathy. Electron microscopy work was supported by
NIH grant CA-16086 to Dr. Jack D. Griffith (UNC). This work was supported by funds from Carolina
Center for Cancer Nanotechnology Excellence (NCI; 1U54CA119343) and the Sontag Foundation.
2 Most of the data presented in this Chapter have been publish in J Cell Sci, Cai et al. (2007a).
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(de Hostos et al., 1993; Maniak et al., 1995). Yeast Coronin cross-links actin filaments
and microtubules, and overexpression induces the formation of abnormal actin loop
structures (Goode et al., 1999; Humphries et al., 2002). Mammals have six Coronin
genes that are divided into three subclasses (Uetrecht and Bear, 2006). Coronin 1B
is a ubiquitously expressed isoform that localizes to the leading edge of migrating
fibroblasts (Chapter 2). Depletion of Coronin 1B influences lamellipodial protru-
sion and whole cell motility by altering the actin dynamics and architecture at the
leading edge (Chapter 3). Coronin 1B was also identified as an important factor for
neurite outgrowth in a neuronal regeneration model (Giovanni et al., 2005). Dele-
tion of Coronin 1A, a hematopoietic specific isoform, in mice leads to severe defects
in lymphocyte homeostasis and T-cell chemotaxis (Foger et al., 2006).
One mechanism by which Coronins exert an effect on motility is through the
inhibition of the Arp2/3 complex. This observation was originally made in yeast
where Coronin interacts with the Arp2/3 complex in vivo and in vitro and directly in-
hibits Arp2/3 complex mediated actin nucleation (Humphries et al., 2002). Human
Coronin 1B also interacts with the Arp2/3 complex in vivo and specifically inhibits
Arp2/3 complex induced actin nucleation in vitro (Chapter 2,3). The interaction be-
tween Coronin 1B and the Arp2/3 complex is regulated by phosphorylation of Ser-
ine 2 (Ser2) via PKC (Chapter 2). Ser2 phosphorylation also controls the interaction
of Coronin 1A with the Arp2/3 complex (Foger et al., 2006).
Another important mechanism by which Coronins affect motility is through the
regulation of Cofilin. Cofilin promotes the disassembly of actin filaments primar-
ily through severing, although other evidence suggests that these proteins may also
promote enhanced pointed end depolymerization (Bamburg, 1999). Coronin 1B tar-
gets the Cofilin-activating phosphatase Slingshot-1L to the leading edge and thus
indirectly regulates Cofilin activity in vivo (Chapter 3). In addition to regulating
96
Slingshot-1L targeting, Coronin 1B can also be dephosphorylated on Ser2 by Slingshot-
1L. Genetic studies in yeast have shown that the combination of Coronin gene dele-
tion with a mutation in the Cofilin gene causes lethality, suggesting a functional
linkage between Coronin and Cofilin in this organism (Goode et al., 1999). Recent
work using reconstituted Listeria actin comet tails as a model system for actin assem-
bly/disassembly identified Coronin 1A as a factor that enhances Cofilin-dependent
actin depolymerization (Brieher et al., 2006). The authors of this study postulated
that Coronin 1A promotes Cofilin severing activity by enhancing its binding to the
sides of actin filaments.
Although Coronin was originally identified by its ability to bind F-actin, the
precise actin-binding site has yet to be identified. In fact, actin-binding sites have
been mapped to nearly every part of the protein (Uetrecht and Bear, 2006). The re-
cent crystal structure of Coronin 1A demonstrated that the majority of the protein
participates in a seven bladed β-propeller (Appleton et al., 2006). Many of the ear-
lier attempts to map Coronin’s F-actin binding site utilized truncation mutants that
contained fragments of this compact structure (Gatfield et al., 2005; Liu et al., 2006;
Mishima and Nishida, 1999; Oku et al., 2003; Spoerl et al., 2002). These fragments
may not adopt physiological conformations and the results of these studies must be
confirmed (Appleton et al., 2006). Since no clear consensus about the F-actin binding
site has been established, the requirement for the F-actin binding activity of Coronin
in vivo has not yet been tested. The work presented here describes the identification
of a conserved residue (R30) that is critical for binding to F-actin, and establishes the
importance of F-actin binding activity for Coronin 1B function in vivo.
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Figure 4.1: Sequence similarity between Coronin 1A and 1B
Alignment between human Coronin 1A and 1B was performed using ClustalX 1.83, combined with
the secondary structural information from the pdb file (2AQ5) of murine Coronin 1A, and presented
by ESPRIPT.
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4.2 Results
4.2.1 Ectopic expression of Coronin 1B in Drosophila S2 cells in-
duces F-actin cables
While generating a stable Drosophila S2 cell line to produce recombinant human
Coronin 1B, we observed that ectopic expression of this protein induced the forma-
tion of F-actin containing cable-like structures. These actin cables stain with phal-
loidin and contain most of the ectopic Coronin 1B (Figure 4.2-A). Previous studies
of yeast Coronin showed that over-expression of this protein induced the formation
of Arp2/3-containing aberrant F-actin loop structures (Humphries et al., 2002). In
the case of ectopic Coronin 1B expression in S2 cells, we cannot detect Arp2/3 com-
plex in these Coronin 1B - actin cables (Figure 4.2-B). To test whether the Coronin
1B-induced actin cables in S2 cells require the presence of functional Arp2/3 com-
plex, we depleted the p20Arc subunit of the Arp2/3 complex in S2 cells using an
established siRNA (Rogers et al., 2003). Depletion of p20Arc blocks the spreading
of S2 cells on Con A-coated surfaces as reported previously, but does not appear
to inhibit the formation of Coronin 1B-containing actin cables (Figure 4.2-C, yellow
arrowhead). Thus, ectopic Coronin 1B expression in insect cells induces the forma-
tion of heavily bundled actin structures without a strict requirement for wild type
levels of Arp2/3. We postulate that the ability to form these cables is a reflection of
Coronin 1B’s F-actin binding and/or bundling activity in vivo.
Interestingly, ectopic expression of another mammalian Coronin, Coronin 2A,
does not induce actin cables (Figure 4.2-A). Consistent with this, Coronin 2A ap-
pears to interact weakly with F-actin in vitro (unpublished observation). We ex-
ploited this difference between Coronin 1B and 2A to identify the portion of Coronin
1B that confers the ability to induce actin cable formation and thus F-actin binding
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Figure 4.2: Coronin 1B induces F-actin cables in Drosophila S2 cells independently of
the Arp2/3 complex
A- S2 cells were transfected with GFP tagged Coronin 1B/Coronin 2A expression constructs, plated
on con A treated coverslips, and stained for F-actin using phalloidin. (White bar = 10 µm)
B- S2 cells transfected with GFP tagged Coronin 1B expression constructs were immunostained for
Arp2, a subunit of the Arp2/3 complex.
C- Endogenous Drosophila p20Arc was depleted by RNAi for 7 days. S2 cells were transfected with
Coronin 1B expression constructs and stained with phalloidin. Arrowheads show a co-localization
between F-actin and Coronin 1B in p20Arc depleted S2 cells.
D- Diagram of Coronin 1B/2A chimeras and cable formation ability of each construct. Fragments
fromCoronin 1B are in black, and fragments fromCoronin 2A are in white. Red numbers in the panel
are the start positions of each region according to Coronin 1B’s amino acid sequence. Corresponding
Coronin 2A regions were chosen by sequence alignment using ClustalX 1.83.
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and/or bundling. Based on the recently published Coronin 1A structure and homol-
ogy modeling (Appleton et al. (2006), Figure 4.1), we designed a series of Coronin
1B/2A chimeras to map the region on Coronin 1B that is responsible for actin cable
formation (Figure 4.2-D). We find that the β-propeller region of Coronin 1B is both
necessary and sufficient to induce the formation of actin cables. Using the chimera
c5-1B567, we further narrowed our search for the actin cable forming region to the
first four blades of Coronin 1B’s β-propeller.
4.2.2 Identification of a critical F-actin binding residue on the sur-
face of the propeller
Using our structural model of Coronin 1B, we systematically mutated charged, sur-
face exposed residues that differ between Coronin 1B and 2A in the first four blades
of the β-propeller. We used both Alanine substitutions and charge reversal muta-
tions, and tested the ability of these mutants to induce actin cables in S2 cells (Fig-
ure 4.3-A, B). Mutation of Arginine 30 to Alanine (R30A) attenuated the ability of
Coronin 1B to induce cables, while charge reversal mutation of this residue (R30D)
completely abolished cable formation. According to our homology model, R30 is a
surface exposed residue, has no predicted side-chain interactions with surrounding
residues, and directly faces the Lysine 73 (K73) residue (Figure 4.3-D,E). A charge
reversal mutation of K73 also greatly reduced actin cable formation, supporting the
importance of a charged patch containing R30 in actin cable formation. Based on
multiple sequence alignments of Coronin proteins from different species, we find
that R30 is a highly conserved charged residue that is invariably flanked by two
hydrophobic residues Isoleucine/Leucine and Valine/Leucine (Figure 4.3-C).
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4.2.3 R30 is essential for Coronin 1B binding to F-actin in vitro
In order to directly test the role of R30 in Coronin 1B’s binding to F-actin, we first
characterized the F-actin binding properties of wild type Coronin 1B using high-
speed actin co-sedimentation assays. We purified full-length recombinant Coro-
nin 1B to >99% purity using a mammalian protein expression system (Figure 3.6).
Recombinant Coronin 1B binds robustly to F-actin in vitro (Figure 4.5-A). The stoi-
chiometry of Coronin 1B binding to F-actin (∼2.6 : 1) exceeds a 1 : 1 ratio, an effect
likely due to oligomerization of Coronin 1B via its coiled coil domain. We also ex-
amined the salt-sensitivity of the Coronin 1B-F-actin interaction (Figure 4.5-B). This
interaction occurs at physiological salt concentrations (100 mM KCl) and lower, but
is reduced under high salt conditions (150 mM KCl).
Interestingly, we noticed that the S2D mutant of Coronin 1B, which mimics the
phosphorylated protein, has slightly decreased F-actin binding activity. Since stud-
ies have shown that the N terminal Ser structure is sensitive to S atom in solution,
Figure 4.3: A conserved surface exposed residue, R30, in Coronin 1B is responsible
for actin cable formation
A- Charged, surface exposed residues within the 1st - 4th blades of the Coronin 1B β-propeller were
mutated to Alanine or the amino acid with an opposite charge (ie. R to D). The cable formation
capability was scored as follows: over 99% transfected cells having GFP positive actin cable is scored
as +++; <50% having actin cables and the rest having phalloidin positive small GFP aggregates is
scored as +/-; less than 1% having phalloidin positive GFP aggregates and majority having high
level cytoplasmic GFP signal is scored as -.
B- S2 cells were transfected with the indicated GFP tagged Coronin 1B mutants and stained with
phalloidin. (White bar, 10 µm)
C- Multiple sequence alignment shows R30 is a highly conserved charged residue in Coronins, and
locates between the first and second β-sheet in the propeller structure. M-1B,Mus musculus Coronin
1B (gi:12229769); R-1B, Rattus norvegicus Coronin 1B (gi:12229732); H-1B, Homo sapiens Coronin 1B
(gi:21263481); H-1C, Homo sapiens Coronin 1C (gi:7656991); Celegans, Caenorhabditis elegans Coronin
(gi:3121874); Spombe, Schizosaccharomyces pombe Coronin (gi:3121869); Scerev, Saccharomyces cerevisiae
Coronin (gi:3121873); DICDI, Dictyostelium discoideum Coronin (gi:116950). The multiple alignment
was generated by ClustalX 1.83 and illustrated by ESPRIPT.
D- Top view of Coronin 1B homology model. N-terminus is colored in blue, and C terminus is colored
in red. The side chain of residue R30 is presented in stick form. Homology model was generated in
InsightII-2005 using HOMOLOGY model, and evaluated by Profile 3D function. Illustration was
generated using Pymol (http://www.pymol.org).
E- Side view of Coronin 1B structural model showing the postions of R30 and K73.
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Figure 4.4: Pelleting of actin filaments polymerized from ATP and ADP G-actin
Filaments were polymerized from the indicated concentrations of ATP and ADP G-actin and pelleted
as described in the Section C.8.
we examined this possibility by performing actin co-sedimentation assay with 10
mMNa2SO4 (Figure 4.18). Results suggest that Coronin 1B is not sensitive to S atom
in solution, and altered F-actin binding may reflect a structural change upon Ser2
phosphorylation. Future studies are required to elucidate the significance of this
structural alteration upon Ser2 phosphorylation.
To test whether the nucleotide state of the actin filaments regulates Coronin 1B
binding, we polymerized filaments from ADP G-actin or ATP G-actin and repeated
the co-sedimentation assays (Figure 4.4). After polymerization, bound ATP on in-
dividual actin subunits is hydrolyzed to ADP-Pi at a rate of 0.3 sec−1, followed by
the slow release of inorganic phosphate (Pi) at a rate of 0.002 sec−1 to form ADP
F-actin (Pollard et al., 2000). As a result of this 150× rate differential, newly poly-
merized filaments generated from ATP G-actin are composed mainly of ATP and
ADP-Pi actin. Actin filaments assembled from ADP G-actin are composed entirely
of ADP F-actin. Coronin 1B binds preferentially to filaments prepared from ATP G-
actin over filaments prepared from ADP G-actin (Figure 4.5-C-E). To calculate the
affinity of Coronin 1B binding to F-actin, we used an established supernatant deple-
tion method (Bryce et al., 2005). Bound Coronin 1B was calculated from the amount
depleted from the supernatant as detected by immunoblotting and densitometry. To
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facilitate the affinity measurements and avoid the complicating factor of oligomer-
ization, a sub-stoichiometric amount of Coronin 1B (0.1 µM) was used in these re-
actions. Our results show that Coronin 1B binds to ATP/ADP-Pi F-actin with 170
nM affinity, and to ADP F-actin with 8 µM affinity. Thus, Coronin 1B binds to actin
filaments containing ATP/ADP-Pi ∼47-fold more strongly than actin filaments con-
taining ADP.
To test whether the R30D mutant binds to F-actin, we prepared a recombinant
version of this protein and performed co-sedimentation assays. The R30D mutant
displays extremely poor F-actin binding capability in vitro (Figure 4.5-F,G). The small
amount of R30Dmutant protein that pellets with actin filaments may reflect residual
low affinity F-actin binding or non-specific entrapment of the protein in the F-actin
pellet. To exclude the possibility that the R30Dmutation leads to protein misfolding,
we compared wild type Coronin 1B to the R30D mutant using both limited proteol-
ysis and circular dichroism analysis (Figure 4.6). Results show that the two proteins
have indistinguishable protease K digestion patterns, and similar molar ellipticity
profiles, indicating the R30D mutation does not grossly affect protein structure. To
further confirm this result, we tested the ability of the R30D mutant to oligomer-
ize with wild type Coronin 1B, to be phosphorylated and dephosphorylated, and to
bind directly to purified Arp2/3 complex in vitro (Figure 4.7-A-D). In all cases, the
R30D mutant behaves identically to the wild type protein, indicating that this mu-
tation selectively affects F-actin binding, but not other molecular interactions. Inter-
estingly, the co-immunoprecipitation between Coronin 1B and the Arp2/3 complex
from cell lysates is reduced by the R30D mutation, suggesting that F-actin binding
increases the Coronin 1B-Arp2/3 interaction in vivo (Figure 4.7-E).
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4.2.4 Full-length Coronin 1B does not enhance Cofilin binding to
F-actin
Recent evidence suggests that Coronin 1A and Cofilin synergize to promote actin
depolymerization in an in vitro Listeria tail assay (Brieher et al., 2006). To test this
observation for Coronin 1B, we used a dilution induced pyrene actin depolymer-
ization assay. We observed that Coronin 1B alone cannot induce actin filament de-
polymerization (Figure 4.8-A) and Coronin 1B protects actin filaments from depoly-
merization by Cofilin (Figure 4.8-B). Brieher and colleagues showed that Coronin 1A
enhanced the binding of Cofilin to Listeria tails and purified actin filaments. To test
this mechanism for Coronin 1B, we used high-speed actin co-sedimentation assays.
In contrast to the previous study, we find that Coronin 1B binding to actin filaments
is inhibited in the presence of Cofilin, and we see no evidence for enhanced Cofilin
binding to filaments in the presence of Coronin 1B (Figure 4.8-C). The inhibition of
Coronin 1B binding by Cofilin is reversible by the addition of phalloidin that blocks
Figure 4.5: Coronin 1B preferentially binds to ATP/ADP-Pi F-actin and mutation of
R30 abolishes binding
A- Representative Coomassie Blue stained gel showing the near saturation binding of Coronin 1B to
ATP/ADP-Pi F-actin (1 µM total actin). Upper band is Coronin 1B and lower band is actin. Numbers
below bands indicate protein concentrations in µM as determined by densitometry.
B- Representative Coomassie Blue stained gel showing Coronin 1B’s F-actin binding at the indicated
KCl concentrations (1.1 µM total actin, 1.3 µM Coronin 1B).
C, D- Representative immunoblots (upper) show F-actin bound Coronin 1B in the pellets of high-
speed co-sedimentation experiments, and Coomassie Blue stained gels (below) show the correspond-
ing actin pellets. A constant amount of Coronin 1B (0.1 µM)was used and concentrations of total ADP
and ATP G-actin used for each lane are indicated above the blots. In this experiment, the ATP G-actin
used was recharged from ADP G-actin as described previously (Pollard, 1986).
E- Equilibrium binding of Coronin 1B to ADP or ATP/ADP-Pi actin filaments. Bound Coronin 1B
was calculated from the depletion of Coronin 1B from the supernatant fraction of experiments simi-
lar to those shown in C and D, and quantified by densitometry. Three protein preparations were used
to generate the data points with error bars and presented as means ± SEM.
F- Representative Coomassie Blue stained gels comparing the F-actin binding capability of wild type
Coronin 1B and the R30D mutant.
G- Equilibrium binding of wild type Coronin 1B or the R30Dmutant to ATP/ADP-Pi F-actin (1.5 µM
F-actin in pellets).
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Figure 4.6: The R30D mutation does not disrupt Coronin 1B protein structure
A- Limited protease K digestion of Coronin 1B. 6 µg either wild type or the R30Dmutant protein was
mixed with 20 ng protease K and incubated 55◦C. Reactions were stopped at fixed time points by
mixing with 2×SDS sample buffer and immediately boiling. Samples were separated by PAGE and
visualized by silver staining.
B- Circular dichroism profiles of both wild type Coronin 1B and the R30D mutant protein.
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Figure 4.7: The R30Dmutation does not perturb other known Coronin 1B molecular
interactions
A- HEK293 cells were co-transfected with myc tagged Coronin 1B and various GFP tagged Coro-
nin 1B mutants: wild type (WT), the R30D mutant, the coiled coil domain (CC, 451-489) alone or a
deletion mutant lacking the coiled coil domain (∆CC, 1-450). We immunoprecipitated myc tagged
Coronin 1B with myc antibodies and blotted with either GFP or myc antibodies. The results demon-
strate that the coiled coil domain of Coronin 1B is both necessary and sufficient for oligomerization
and that the R30D mutation does not affect oligomerization.
B- Rat2 fibroblasts were infected with the knockdown/rescue lentivirus expressing the Coronin 1B
shRNA and either wild type Coronin 1B or the R30D mutant (Figure 4.13-B). Cells were subjected to
the in vivo phosphorylation and dephosphorylation assay described in the Methods section.
C- In vitro direct binding assay using purified Coronin 1B immobilized on Ni-NTA beads and puri-
fied bovine Arp2/3 complex in solution (5 nM).
D- Amount of bound Arp2/3 complex on beads from experiments described in panel C were quan-
tified by densitometer and normalized to the amount of Coronin 1B. Results from three independent
experiments are presented as means ± SD.
E- Cells as described in panel B were lysed and GFP tagged Coronin 1B was immunoprecipitated us-
ing GFP antibodies. In order to visualize the co-immunoprecipitated Arp2/3 complex, the R30D lane
was intentionally over-loaded. Arrowhead: GFP tagged Coronin 1B; arrow: endogenous Coronin 1B.
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the binding of Cofilin to actin filaments (Nishida et al., 1987). To test this poten-
tial competition more rigorously, we incubated filaments with a constant amount
of Coronin 1B (1 µM) and increasing concentrations of Cofilin (up to 10 µM). In-
creasing Cofilin decreased the amount of Coronin 1B associated with filaments in
a dose dependent manner (Figure 4.8-D). In a converse experiment, we incubated
filaments with a constant amount of Cofilin (1 µM) and increasing concentrations
of Coronin 1B (up to 4 µM). As with the Cofilin dose-response experiment, increas-
ing concentrations of Coronin 1B decreased the binding of Cofilin to actin filaments
(Figure 4.8-E). Similar results were obtained with recombinant Coronin 1A (Figure
4.9), indicating this competitive binding is not an isoform-specific property. Thus,
our results indicate that Coronin 1B and Cofilin do not synergize directly to promote
actin depolymerization and that their binding to actin filaments is antagonistic.
In an effort to reconcile our results with the published results for Coronin 1A,
we tested a number of Coronin 1B mutants in the actin co-sedimentation assay de-
scribed above. Interestingly, we found that the Coronin 1B ∆CC mutant slightly
enhanced the binding of Cofilin to actin filaments (Figure 4.8-F), despite the fact that
this mutant lacks high affinity F-actin binding (Figure 4.11-B).
Figure 4.8: Coronin 1B protects filament from Cofilin-induced depolymerization and
binds antagonistically with Cofilin to F-actin
A- Time course of actin polymer concentration (assembled from rabbit smooth muscle ATP G-actin,
30% pyrene labeled) after dilution from 5 µM to 0.1 µM alone, with phalloidin or in the presence of
Coronin 1B/Cofilin.
B- Same experimental conditions as in (A) with phalloidin, Coronin 1B and Cofilin, or in the presence
Cofilin alone.
C- Representative Coomassie Blue stained gels showing the F-actin binding ability of Coronin 1B in
the presence of 2 µM Cofilin, with or without pre-incubating actin filaments with 5 µM phalloidin.
D- Equilibrium binding of Cofilin to actin filaments (assembled from 2 µMATP G-actin and stored at
4◦C overnight) in the presence of 1 µM Coronin 1B.
E- Equilibrium binding of Coronin 1B to 2 µM actin filaments in the presence of 1 µM Cofilin.
F- Representative Coomassie Blue stained gel showing the high-speed actin co-sedimentation assay
using increasing concentrations of the ∆CCmutant (Coronin 1B lacking the coiled coil domain), with
2 µM actin and 1 µM Cofilin.
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Figure 4.9: The binding of both Coronin 1A and Coronin 1B to F-actin is antagonized
by Cofilin
A- Representative Coomassie Blue stained gel showing the F-actin binding ability of Coronin 1A/1B
in the presence of 2 µM Cofilin.
B- Representative Coomassie Blue stained gel showing the F-actin binding ability of Coronin 1A/1B
in the presence of 2 µM Cofilin and 5 µM phalloidin.
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Figure 4.10: Coronin 1B cannot oligomerize post-lysis
A- Diagram of post-lysis oligomerization test. In order to confirm that post-lysis oligomeriza-
tion of Coronin 1B does not occur, we separately transfected HEK293 cells with either myc or
GFP tagged Coronin 1B, prepared lysates and mixed them together. We then tested for cross-
immunoprecipitation with antibodies against the different tags.
B- Results of post-lysis oligomerization test described above. No cross IP is observed with post-lysis
mixing. Arrow head: GFP tagged Coronin 1B; arrow: myc tagged version; line: endogenous protein;
asterisk: mouse IgG bands.
4.2.5 Coronin 1B can bundle F-actin in vitro
Since ectopically expressed Coronin 1B induces actin cables in S2 cells and yeast
Coronin is known to bundle actin filaments in vitro (Goode et al., 1999), we tested
Figure 4.11: Coronin 1B ∆CC mutant binds poorly to F-actin, loses leading edge en-
richment, and fails to rescue Coronin 1B depletion induced slow motility
A- S2 cells were transfectedwith Coronin 1B ∆CCmutant taggedwith V5-6×His and immunostained
for F-actin (probed by phalloidin) and the ∆CC mutant (probed by anti-V5 antibody).
B- Representative Coomassie Blue stained gel showing the F-actin binding ability of Coronin 1B ∆CC
mutant (1.1 µM total actin).
C- Rat2 cells were infected with retrovirus expressing GFP tagged Coronin 1B ∆CC mutant and im-
munostained for endogenous Coronin 1B and Cortactin.
D- Rat2 cells were infected with retrovirus expressing GFP tagged either wild type or ∆CC mutant
Coronin 1B. Cells were lysed and exogenous expressed protein was immunoprecipitated using GFP
antibodies. Immunoprecipitates were subjected to immunoblotting for endogenous Coronin 1B and
Arp2/3 complex (probed by p34Arc subunit).
E- Rat2 fibroblasts were infected with lentivirus expressing Coronin 1B shRNA (KD1B, without or
with co-expression of GFP tagged wild type or ∆CC mutant Coronin 1B) or the control shRNA (NS),
and the cells were subjected to single cell tracking. Data are presented as mean cell speed with error
bars indicating the 95% confidence intervals.
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whether Coronin 1B can bundle F-actin in vitro using two assays. First, we used neg-
ative staining and electron microscopy on actin filaments incubated with various
concentrations of Coronin 1B. While actin filaments alone occasionally have regions
that lie in close apposition (inset of Figure 4.12-A), 10 nM Coronin 1B appeared to
increase the bundling of actin filaments (Figure 4.12-B). When Coronin 1B (1 µM)
was mixed with an equimolar concentration of F-actin, we observed large actin bun-
dles (Figure 4.12-C). In contrast, the R30Dmutant that lacks F-actin binding does not
induce any actin bundles under the same experimental conditions (Figure 4.12-D).
We confirmed this observation by low-speed actin co-sedimentation (Figure 4.12-E).
Since the Coronin 1B ∆CC mutant cannot form either actin cables in S2 cells or actin
bundles in vitro (Figure 4.11-A, data to shown), both coiled coil mediated oligomer-
ization and high affinity F-actin binding are required for Coronin 1B’s actin bundling
activity.
4.2.6 High affinity F-actin binding is required for Coronin 1B’s sta-
ble leading edge localization
To study the importance of high affinity F-actin binding for Coronin 1B function
in vivo, we utilized an established lentiviral knockdown/rescue system to generate
cells that express only the R30D mutant, but not endogenous Coronin 1B (Chapter
3). Briefly, we identified an shRNA that specifically depletes rat/mouse Coronin
1B (Figure 4.13-A) and co-expressed it along with human Coronin 1B tagged with
GFP (Figure 4.13-B). Human Coronin 1B is refractory to the shRNA due to multiple
sequence mismatches. In cells infected with the lentivirus expressing GFP tagged
Coronin 1B, the endogenous protein was efficiently silenced and the GFP tagged
”rescue“ protein was expressed at physiological levels (Figure 4.13-5C,D).
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To test whether high affinity actin binding contributes to the localization of Coro-
nin 1B to the lamellipodia, we compared wild type Coronin 1B-GFP with the R30D
mutant using the knockdown/rescue system in Rat2 fibroblasts. The localization
pattern of the Arp2/3 complex (visualized by p34Arc immunostaining), Cortactin,
F-actin (visualized by phalloidin staining) and VASP were not affected upon expres-
sion of either wild type Coronin 1B or the R30D mutant (Figure 4.15-A,B). The lead-
ing edge localization of the R30D mutant was diminished relative to the wild type
protein (Figure 4.15-B). To quantify the localization differences between these pro-
teins, we performed lamellipodial co-localization analysis across multiple cells (Fig-
ure 4.15-C). An index of leading edge enrichment relative to the cell body was calcu-
lated for cells expressing GFP alone, wild type Coronin 1B or the R30Dmutant. GFP
tagged wild type Coronin 1B has a similar distribution profile to the endogenous
protein, while the R30Dmutant has reduced leading edge enrichment. Similarly, the
Coronin 1B ∆CC mutant (which lacks high affinity F-actin binding) localizes poorly
to the leading edge 4.11-C), despite the fact that this mutant is capable of interacting
with the Arp2/3 complex in vivo (Figure 4.11-D). Together, these results indicate that,
while other Coronin 1B interactions may contribute to targeting, F-actin binding is
required for normal leading edge localization of Coronin 1B.
To test the contribution of F-actin binding to the dynamics of Coronin 1B protein,
we utilized fluorescence recovery after photobleaching (FRAP) analysis. In the case
Figure 4.12: Coronin 1B can bundle actin filaments in vitro
A- Electron micrograph of actin filaments, inset = 4×zoom. Actin filaments (1 µM) were negatively
stained and examined by transmission electron microscopy. Arrowheads indicate areas where fila-
ments lie with close apposition. (White bar = 100 nm)
B- Electron micrograph of actin filaments (1 µM) with Coronin 1B (10 nM). (White bar = 100 nm)
C, D- Electron micrograph of actin filaments (1 µM) with either wild type Coronin 1B or the R30D
mutant (1 µM). (White bar = 1 µm)
E- Representative Coomassie Blue stained gel showing low-speed co-sedimentation of Coronin 1B
with F-actin. Samples were prepared as described in C and D, then subjected to centrifugation for 5
minutes at 13,000×g.
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of wild type protein, a spot at the leading edge (#1) was compared to a spot in the
cytoplasm (#2). The leading edge has a slower rate of fluorescence recovery and a
larger immobile fraction than the cytoplasm, suggesting that Coronin 1B stably in-
teracts with a factor in the lamellipodium (Figure 4.15-D-G, 4.16-B,C). In contrast, the
recovery kinetics of the R30D mutant were identical between the leading edge and
the cytoplasm (Figure 4.15-F,G 4.16-C), indicating that high affinity F-actin binding
is required for the stable leading edge localization of Coronin 1B.
4.2.7 F-actin binding mutants fail to rescue Coronin 1B depletion-
induced motility phenotypes
To test the requirement of F-actin binding for Coronin 1B’s function in vivo, we com-
pared the motility of cells expressing either wild type Coronin 1B or the R30D mu-
tant generated using our knockdown/rescue system. We analyzed the whole cell
motility of these cells by single cell tracking. As observed previously, depletion of
Figure 4.13: Lentiviral based knockdown/rescue system for Coronin 1B
A- Target sequence of an shRNA designed to specifically knock down mouse or rat, but not human
Coronin 1B.
B- Diagram of the modified lentiviral vector combining shRNA expression from the Pol III U6 pro-
moter with GFP tagged Coronin 1B expression from the MSCV 5’ LTR promoter, which is used as the
rescue construct and replaces endogenous Coronin 1B with a GFP tagged version.
C- Rat2 fibroblasts were infected with the knockdown/rescue lentivirus (green), which replaces the
endogenous Coronin 1B with the GFP tagged coiled coil deletion mutant (lacking the epitope for the
Coronin 1B antibody). Cells were immunostained for endogenous Coronin 1B (red) to check the effi-
ciency of knockdown.
D- Rat2 fibroblasts were infected with the knockdown/rescue lentivirus which co-expresses the
Coronin 1B shRNA and the GFP tagged human Coronin 1B. GFP-positive cells were isolated by
fluorescent-activated cell sorting. Cell lysate from these cells or uninfected control cells were com-
pared by immunoblotting for Coronin 1B expression. Our Coronin 1B antibody (4245.Exp) has 5-fold
higher affinity for human Coronin 1B than the endogenous rat protein (data not shown), indicating
that re-expression levels are close to physiological. A complete set of Rat2 clonal lines generated is
shown in Figure 4.14. Please notice that different re-expressing levels observed in these ”rescue“ cell
lines.
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Figure 4.14: Replacing endogenous Coronin 1B with GFP fusions
Rat2 cells were infected with lentivirus simultaneously expressing shRNA against endogenous Coro-
nin 1B and RNAi resistant GFP fusions. Clonal cell lines were prepared from FACS, and lysates were
immunoblotted with indicated antibodies.
Coronin 1B in fibroblasts leads to ∼33% decrease in whole cell speed relative to un-
infected control cells, cells infected with a non-specific shRNA (NS) or cells rescued
with shRNA resistant human Coronin 1B-GFP (Figure 4.17-A, Chapter 3). The R30D
mutant failed to rescue the defect in whole cell motility observed in Coronin 1B-
depleted cells (Figure 4.17-A). Identical results were obtained with the Coronin 1B
∆CC mutant (Figure 4.11-E), indicating that F-actin binding is required for Coronin
1B to exert an effect on whole cell motility in vivo. We also employed kymography
analysis to examine the lamellipodial protrusion dynamics of cells expressing wild
type or R30D Coronin 1B. Depletion of Coronin 1B leads to increased protrusion
rate, reduced protrusion persistence and decreased protrusion distance (Figure 4.17-
B-D). Whereas the wild type Coronin 1B can rescue these defects, the R30D mutant
cannot, indicating that high affinity F-actin binding activity is required for Coronin
1B to regulate lamellipodial dynamics at the leading edge. Together, these results
demonstrate that the interaction of Coronin 1B with F-actin is important for its lo-
calization and is essential for in vivo function.
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4.3 Discussion
Our results support a number of conclusions about the interaction of Coronin 1B
and F-actin. First, Coronin 1B interacts with F-actin via a charged patch on the top
surface of its β-propeller domain that contains the highly conserved R30 residue.
Second, Coronin 1B binds selectively and with high affinity to actin filaments com-
posed of ATP/ADP-Pi subunits. Consistent with this nucleotide preference, Coro-
nin 1B and Cofilin bind antagonistically to actin filaments. Third, the interaction of
Coronin 1B with F-actin is responsible for a significant fraction of the lamellipodial
enrichment observed with this protein. Finally, the interaction of Coronin 1B with
F-actin is absolutely required for its physiological function at the leading edge of
motile cells.
Figure 4.15: F-actin binding is required for efficient and stable leading edge localiza-
tion of Coronin 1B
A- Rat2 fibroblasts expressing GFP tagged R30D mutant and lacking endogenous Coronin 1B were
EGF stimulated (2 minutes) and stained for the Arp2/3 complex (p34Arc subunit), Cortactin, F-actin
(phalloidin) and VASP.
B- Rat2 fibroblasts lacking endogenous Coronin 1B and expressing GFP tagged wild type protein
(WT) or R30D mutant protein were stained for the Arp2/3 complex (p34Arc subunit) and Cortactin
following recovery from ATP depletion.
C- The lamellipodial co-localization analysis was performed on the protruding areas of the Rat2 fi-
broblasts prepared as in (B). Fluorescence intensity values were normalized, combined frommultiple
cells (N = number of cells analyzed per treatment), and graphed as the means ± SEM. Top panel
shows endogenous Coronin 1B, soluble GFP and Cortactin. Middle and lower panels show GFP
tagged Coronin 1B (WT or R30D), p34Arc (Arp2/3) and Cortactin. The indexes of relative leading
edge enrichment of GFP signals from various cells were calculated and presented as the percentile
means ± SD. in the center of the graphs.
D- A representative Rat2 fibroblast, whose endogenous Coronin 1B was replaced with GFP tagged
wild type protein, was subjected to fluorescence recovery after photobleaching (FRAP) analysis. Dif-
ferential interference contrast (DIC) image is presented on the left and individual frames from time-
lapse imaging of GFP are presented on the right. Bleached regions are circled (#1 = lamellipodia; #2
= cytoplasm).
E,F- Representative fluorescent intensity profiles from the two-spot FRAP analysis of Rat2 fibroblasts
whose endogenous Coronin 1B was replaced with GFP tagged either wild type protein or the R30D
mutant.
G- Statistical analysis of the FRAP immobile fraction across multiple cells. Data are presented as the
means with error bars indicating the 95% confidence intervals. Dunnett multiple comparison test
was performed as the post-test for one-way ANOVA using the first column as control. (N = number
of cells analyzed per treatment; ⋆⋆ = p<0.01; ⋆⋆⋆ = p<0.001)
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Figure 4.16: Coronin 1B recovery kinetics in FRAP
A- In FRAP analysis, circled regions in DIC image and fluorescence images were subjected to bleach-
ing: Spot1 = lamellipodia, and Spot2 = cytoplasm.
B- One-phase exponential decay (Y=Span×exp(-K×X)+Plateau) was used to fit the fluorescence data
from Figure 4.15-E.
C- Experiments listed in Figure 4.15-G were subjected to curve fitting as described in B. Recovery
half-life (0.69/K) were calculated from the kinetics and presented as means ± SEM. (⋆⋆ = p<0.01.)
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Figure 4.17: The R30D mutant cannot rescue Coronin 1B depletion phenotypes
A- Rat2 fibroblasts were infected with lentivirus expressing Coronin 1B shRNA (KD-1B, without or
with co-expression of GFP tagged wild type or R30D Coronin 1B) or the control shRNA (NS), and
the cells were subjected to single cell tracking. Data are presented as mean cell speed with error bars
indicating the 95% confidence intervals. (N = number of cells tracked per treatment; ⋆⋆ = p<0.01.)
B, C, D- Cells described in A were subjected to kymography analysis. Protrusion parameters were
determined from at least 6 randomly selected cells with the number of protrusion events analyzed
listed as n per treatment. Data are presented as the means with error bars indicating the 95% confi-
dence intervals. Dunnett multiple comparison test was performed as a post-test for one-way ANOVA
using the first column as control. (⋆ = p<0.05; ⋆⋆ = p<0.01.)
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Figure 4.18: Na2SO4 does not interfere Coronin 1B’s F-actin binding
The N-terminus of Cofilin involves an interaction with S atom, and this interaction regulates its F-
actin binding. Considering the fact that Coronin 1B has very similar N-terminal sequence as Cofilin,
we tested the effect of SO4
2− to Coronin 1B’s F-actin binding. Coronin 1B 0.7 µM was mixed with
1.5 µM actin without or with 10 mM Na2SO4. Reactions were performed in room temperature for 1
hour and separated by high-speed centrifugation. Samples were run on PAGE and Coomassie Blue
stained.
4.3.1 The interaction of Coronin 1B with F-actin in vitro
Coronins have been known as actin-binding proteins since the discovery (de Hostos et al.,
1991) and the work presented here addresses a number of significant gaps in our
understanding of the interaction between Coronins and F-actin. Our results indicate
that Coronin 1B binds preferentially to actin filaments composed of ATP/ADP-Pi
subunits with high affinity (170 nM). This preference for ATP/ADP-Pi filaments is
similar to that of Cortactin, another actin binding protein with a nearly identical
localization pattern in lamellipodia (Bryce et al., 2005). The actin filaments in lamel-
lipodia are highly dynamic and are thought to be composed mainly of ATP/ADP-Pi
subunits. Thus, Coronin 1B’s preference ATP/ADP-Pi filaments may help selec-
tively enrich this protein in the lamellipodia over other actin filament-containing
structures such as stress fibers.
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Not only does Coronin 1B bind to actin filaments, but it also bundles these fil-
aments into parallel arrays as has been observed for other Coronins (Goode et al.,
1999). Although this effect is seen in vitro and with high-level ectopic expression
in Drosophila S2 cells, it is unclear if Coronin 1B plays a significant role in bundling
actin filaments in mammalian cells. In vitro, strong bundling is only observed when
the ratio between Coronin 1B and F-actin approaches 1:1. In vivo, the intercellular
concentration of Coronin 1B is 0.73 µM (Chapter 3), while the concentration of poly-
merized actin is estimated to be near 100 µM (Pollard et al., 2000), suggesting that
stoichiometry does not favor Coronin 1B-driven bundling in the cytoplasm. Further-
more, unlike proteins such as Fascin, Coronin 1B is not strongly enriched in bundled
F-actin structures, even within the lamellipodium (data not shown). The coiled coil
domain of Coronin 1B is required for both bundling and high affinity F-actin bind-
ing in vitro. These results suggest that oligomerization affects bundling as previously
shown (Goode et al., 1999), but also increases the apparent affinity of Coronin 1B’s
interaction with filaments. This increased apparent affinity is likely due to effects
on avidity, rather than a second F-actin binding site since the coiled coil domain
displays no detectable F-actin binding activity on its own (data not shown).
Several lines of experimental evidence suggest that Coronins and ADF/Cofilin
proteins cooperate to enhance actin depolymerization, either directly (Brieher et al.,
2006; Goode et al., 1999) or indirectly (Chapter 3), but the precise mechanism of this
effect is unclear. Unlike a previous study, we see no evidence for direct enhance-
ment of Cofilin binding to F-actin or Cofilin-induced depolymerization of filaments
by Coronins (Brieher et al., 2006). In fact, full-length Coronin 1A and 1B bind an-
tagonistically with Cofilin to F-actin in co-sedimentation assays. At the moment,
the reasons for the discrepancies between these results are unclear. Interestingly, we
do observe a slight enhancement of Cofilin binding to F-actin in the presence of the
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Coronin 1B (CC mutant. While this result is intriguing, we know of no evidence
for regulated oligomerization of Coronins or the existence of truncated (monomeric)
forms of this protein. Therefore, this result is unlikely to represent a physiologically
relevant mechanism for Coronin function.
The antagonism between full-length Coronin and Cofilin for F-actin binding is
unlikely to arise from competition for the same binding site on actin filaments, but
rather reflects the binding preferences of Coronin 1B for ATP/ADP-Pi F-actin and
Cofilin for ADP F-actin (Blanchoin and Pollard, 1999). Since Cofilin enhances the
release of inorganic phosphate from actin, it will convert ADP-Pi F-actin to ADP F-
actin and indirectly inhibit Coronin 1B binding (Blanchoin et al., 2000b). It will be
interesting to test whether Coronin 1B inhibits phosphate release from filaments and
preserves ADP-Pi F-actin. Recent data from our lab indicate that Coronin 1B targets
the Cofilin-activating phosphatase Slingshot-1L to the leading edge of migrating fi-
broblasts, suggesting a more indirect mechanism by which Coronin and Cofilin may
cooperate in vivo (Chapter 3).
The precise location of Coronin’s F-actin binding site is controversial and little
consensus exists among the previous studies (Uetrecht and Bear, 2006). In this study,
we have identified a single, highly conserved residue (R30) on the β-propeller of
Coronin 1B that is critical for F-actin binding both in vivo and in vitro. Mutation of
this residue does not disrupt Coronin 1B structure or interactions with other molecu-
lar partners, indicating that this mutation selectively affects F-actin binding. The fact
that the R30 residue is on the top surface of the β-propeller is not surprising since
this is a common location for binding interfaces on proteins of this type and previous
structural studies of Coronin 1A postulated a potential binding surface containing
this residue (Appleton et al., 2006). Future studies will test whether F-actin interacts
with other residues in this patch.
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4.3.2 The role of Coronin 1B-F-actin interactions in vivo
One logical assumption about the Coronin family of proteins is that they must in-
teract with F-actin in order to localize properly and/or exert their biological effects.
With the R30D mutant of Coronin 1B in hand, we were able to formally test this no-
tion. The R30Dmutant shows reduced localization to the leading edge of fibroblasts
relative to the wild type protein, but does show some enrichment relative to solu-
ble GFP. This suggests that other Coronin 1B interactions such as Arp2/3 binding
may drive some localization to the lamellipodium. Alternately, the residual F-actin
binding activity of the R30Dmutant may be sufficient to provide some leading edge
targeting. Regardless of the precise mechanism of the weak R30D localization, our
FRAP analysis indicates that high affinity F-actin binding is required for stable lo-
calization of Coronin 1B to the leading edge.
Coronin 1B coordinates Arp2/3 complex and Cofilin activities (via Slingshot-1L)
in the lamellipodium of migrating fibroblasts (Chapter 3). Upon Coronin 1B deple-
tion, whole cell motility is reduced and lamellipodial dynamics are altered. These
phenotypes arise from defects in the dynamics and organization of actin filaments
at the leading edge. The results presented here indicate that F-actin binding is ab-
solutely required for Coronin 1B to exert its effects on motility. These data have
important implications for the mechanism of Coronin 1B function. For example,
Coronin function must include an obligate F-actin binding step. The R30D mutant
described in this work will be an invaluable tool for dissecting the mechanism of
Coronin function in future studies.
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Chapter 5
Coronin 1B antagonizes Cortactin and
remodels Arp2/3-containing actin
branches in lamellipodia
The dendritic actin network generated by the Arp2/3 complex in lamellipodia is
important for membrane protrusion, directional sensing and migration. Activation
of Arp2/3 complex and generation of actin branches are essential steps during this
process, but the mechanisms regulating branch disassembly are poorly understood.
We report that Coronin 1B disassembles Arp2/3-containing actin branches by in-
ducing Arp2/3 dissociation from the side of filaments. This effect is potently antag-
onized by Cortactin. Consistent with this biochemical competition, depletion of both
genes rescues lamellipodial defects seen with depletion of either gene alone. Coro-
nin 1B localizes to actin branches in a mutually exclusive manner with the Arp2/3
complex, and live-cell imaging reveals a sequential accumulation of these proteins
during actin network assembly. These data suggest that Coronin 1B replaces Arp2/3
complex at actin branches. Interestingly, depletion of Coronin 1B synchronizes the
dynamics of Arp2/3 complex with the actin network indicating that Coronin 1B-
based branch remodeling contributes to actin network diversity. 1
5.1 Background
Cell migration is critical for a variety of physiological processes such as morpho-
genesis, wound healing, cellular immune response and establishing neuronal con-
nections. Unregulated cell migration contributes to many disease states including
cancer metastasis, birth defects, cardiovascular disease and compromised immune
function. Cytoskeletal remodeling plays an important role during migration, espe-
cially the dynamic regulation of the actin cytoskeleton (Pollard and Borisy, 2003).
Nucleation is a key step during the dynamic remodeling of actin filaments. Spon-
taneous nucleation of actin is very slow, and nucleators are required in vivo to pro-
mote filament formation (Pollard et al., 2000). Multiple factors are known to pro-
mote actin nucleation including Formins, Spire, Cordon-bleu and the Arp2/3 com-
plex (Pruyne et al., 2002; Sagot et al., 2002; Ahuja et al., 2007; Quinlan et al., 2005;
Mullins et al., 1998).
The Arp2/3 complex is a highly conserved seven-subunit protein complex, and
plays a key role in regulating the actin cytoskeleton (Goley and Welch, 2006). Recent
data indicate that genetic deletion of the Arpc3 subunit of this complex in mice leads
to pre-implantation lethality (Yae et al., 2006). On its own, the Arp2/3 complex is in-
active and requires activating proteins to nucleate filaments (Pollard, 2007). Nucle-
ation promoting factors (NPFs) are grouped into two categories (Welch and Mullins,
2002). Type I NPFs, such as WASP and SCAR, directly activate the Arp2/3 complex
by inducing conformational changes in the complex and supplying the first actin
monomer of the new filament. Type II NPFs, such as Cortactin andAbp1, havemuch
1 This chapter is adapted from a manuscript under preparation.
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weaker activation activity on their own, but potently synergize with Type I NPFs
(Weaver et al., 2001; Uruno et al., 2001). Unlike other actin nucleators, the Arp2/3
complex promotes the formation of branched actin networks, and the complex itself
localizes at actin branches and serves a structural role in the network (Mullins et al.,
1998; Svitkina and Borisy, 1999). The convergence of biochemical and cell biological
studies led to the formulation of the dendritic model of actin assembly at the leading
edge of motile cells.
Although the activation of Arp2/3 complex and the formation of branches have
been well studied, the disassembly of the branched network and the recycling of
Arp2/3 complex are poorly understood. At the back of lamellipodia, Cofilin pro-
motes actin disassembly via severing and/or possibly enhanced depolymerization
(Svitkina and Borisy, 1999; Iwasa and Mullins, 2007). In addition, Cofilin has been
shown to have actin debranching activity in vitro, although no in vivo data yet sup-
port this notion (Blanchoin et al., 2000b). Recent work from yeast indicates that ATP
hydrolysis by the Arp2 subunit is required for efficient spontaneous branch dissocia-
tion in vitro and actin patch internalization in vivo (Martin et al., 2005, 2006b). These
data show that the dissociation of Arp2/3 complex from actin branches is critical
for endocytosis and probably other actin dependent processes as well. The factor or
factors that promote actin branch disassembly in vivo are not known.
One factor that is able to stabilize actin branches in vitro is Cortactin (Weaver et al.,
2001). This protein has multiple binding partners including Arp2/3 complex and
plays important roles in various actin dependent processes (Daly, 2004). Cortactin
is upregulated in several aggressive forms of cancer including highly invasive head
and neck squamous carcinomas (Patel et al., 1996). Depletion of Cortactin results in
reduction of dendritic spines in hippocampal neurons (Hering and Sheng, 2003); de-
creased lamellipodial persistence and invapodia formation in cancer cells (Bryce et al.,
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2005; Clark et al., 2007); impaired trans-epithelial migration (Yang et al., 2006); re-
duced receptor internalization (Cao et al., 2003); also, significantly decreased bacte-
ria invasion (Barroso et al., 2006). All of these processes involve Arp2/3 branched
actin networks, but the contribution of Cortactin’s branch stabilization activity to
these processes has never been specifically addressed in vivo.
Coronins are a conserved family of actin-binding proteins that regulate cell motil-
ity in a variety of contexts (Uetrecht and Bear, 2006). Knockout Coronin 1A in mice
results in defects in the immune system including failure of T cell chemotaxis and
homing to lymph nodes (Foger et al., 2006). Coronin 1B, a ubiquitously expressed
isoform, plays important roles in lamellipodial protrusion and whole-cell motil-
ity (Chapter 3). Recent data suggest that Coronin 1B coordinates actin polymer-
ization and depolymerization through regulating activities of the Arp2/3 complex
and Cofilin at the leading edge. In vitro, Coronin 1B inhibits Arp2/3 nucleation,
consistent with previous observations about yeast Coronin (Humphries et al., 2002).
The inhibitory activity of Coronin 1B is regulated through Serine 2 phosphorylation
(Chapter 2). PKC phosphorylates Coronin 1B and reduces its activity, while Sling-
shot 1L (SSH1L) dephosphorylates it and increases its activity (Chapter 3). How-
ever, the mechanistic details of Coronin’s inhibition of Arp2/3 complex are unclear.
In this chapter, we describe a novel molecular antagonism between Coronin 1B and
Cortactin at Arp2/3-containing actin branches.
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5.2 Results
5.2.1 Coronin 1B and Cortactin have distinct leading edge localiza-
tion patterns
We showed previously that Coronin 1B co-localizes with Arp2/3 complex in lamel-
lipodia of migrating fibroblasts (Chapter 2). Here, we performed immunostaining
of endogenous proteins in Rat2 cells, and found that Coronin 1B and Cortactin co-
localize to a large extent in lamellipodia (Figure 5.1-A). Using a previously described
contour-based analysis method, we plotted the distribution of Coronin 1B and Cor-
tactin intensity as a function of distance from the cell edge (Figure 5.1-B, Chapter
3, 4). Coronin 1B and Cortactin have overlapping localization, however Cortactin
consistently localizes more distally than Coronin 1B.
Since the difference in peak intensities approaches the resolution limit of light
microscopy, we used transmission electron microscopy to confirm these results. Im-
munogold staining with two different sized conjugates was used to compare the
distribution of endogenous Coronin 1B and Cortactin (Figure 5.1-B). We observed a
similar peak distribution of these two proteins as in the light microscopy analysis
(Figure 5.1-C,D). Most of labeled the Coronin 1B gold particles localize around 800
nm from the cell edge, while most of the labeled Cortactin gold particles localize
around 500 nm from the cell edge. Thus, we conclude that Coronin 1B and Cortactin
have distinct leading edge localization patterns in lamellipodia.
133
134
5.2.2 Coronin 1B andCortactin interactwith distinct pools of Arp2/3
complex, and influence its distribution differentially
Both Coronin 1B (Chapter 3) and Cortactin (Weed et al., 2000) have been shown to
directly bind to the Arp2/3 complex. One question is whether Coronin 1B, Cortactin
andArp2/3 complex exist in the same complex in vivo. We examined the interactions
of these components by immunoprecipitation of the endogenous proteins (Figure
5.1-E). Consistent with previous observations, we found that both Coronin 1B and
Cortactin reciprocally co-immunoprecipitate with the Arp2/3 complex. However,
the interaction between Coronin 1B and Cortactin is extremely weak, suggesting
that these proteins are interacting with different pools of Arp2/3 complex. This
observation is consistent with the distinct localization of Coronin 1B and Cortactin
at the leading edge.
Previous studies have shown that depletion of Coronin 1B or Cortactin induces
opposite changes in the density of actin barbed ends at the leading edge. Coronin
Figure 5.1: Coronin 1B and Cortactin localize differentially in lamellipodia
A- Rat2 cells were subjected to immuno-staining for endogenous Coronin 1B and Cortactin. Normal-
ized pixel intensities of Coronin 1B and Cortactin were plotted as a function of distance from the cell
edge (mean ± SEM). Scale bar = 10 µm.
B- Negative stained electron micrographs of lamellipodia in Rat2 cells, with immuno-gold staining
for Coronin 1B (18-nm gold particles) and Cortactin (6-nm gold particles). Expanded views of dashed
regions are presented in the upper row, with 6-nm gold particles circled by green rings. Scale bar =
200 nm.
C,D- Histogram of gold particles distribution based on their distance from the cell edge. Bin size
is 100 nm, and frequency is the number of observed particles. Six cells processed as (B) were used
to generate the graphs. In total, 440 Coronin 1B particles and 779 Cortactin particles were counted.
Student’s t test shows p<0.0001.
E- Lysates fromRat2 cells were immunoprecipitated with antibodies to Cortactin, Coronin 1B, p34Arc
or control IgG (ctrl.) and immunoblotted with indicated antibodies.
F,G- The pixel intensity ratio of p34Arc to F-actin (AlexaFluor 647 phalloidin) was determined as a
function of distance from the cell edge, and presented as mean ± SEM. P value was calculated using
paired Student’s t test. Data were collected from 10-12 cells expressing Coronin 1B shRNA (KD-1B),
Cortactin shRNA (KD-CTTN) or control shRNA (NS).
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Figure 5.2: Cortactin protein purification
Visualization of Cortactin purification steps by Coomassie Blue staining of SDS-PAGE. Lane 1, whole
cell lysate clarified by centrifugation; Lane 2, flow through from the StrepTactin (Qiagen) beads; Lane
3, StrepTactin beads; Lane 5, eluted protein from StrepTactin beads.
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1B depletion increases the barbed end density (Chapter 3), while Cortactin deple-
tion decreases the barbed end density (Bryce et al., 2005). Since barbed ends arise in
lamellipodia in part due to the activity of the Arp2/3 complex, we examined the dis-
tribution of Arp2/3 complex relative to F-actin using a ratiometric approach. Coro-
nin 1B depletion does not affect the spatial distribution of Arp2/3 complex (data not
shown), but the leading edge density of Arp2/3 complex, represented by p34Arc/F-
actin ratio, increases significantly (Figure 5.1-F). This observation supports the con-
clusion that Coronin 1B inhibits the activation of the Arp2/3 complex in vivo. Inter-
estingly, Cortactin depletion alters the Arp2/3 complex density by shifting it slightly
towards the cell body (Figure 5.1-G). Together, these data indicate that Coronin 1B
and Cortactin interact with distinct pools of Arp2/3 complex, and that depletion
either one affects the distribution pattern of Arp2/3 complex in different ways.
5.2.3 Coronin 1B antagonizes Cortactin in vitro
TheArp2/3 complex can be activated by at least twomechanisms. Type I Nucleation
Promoting Factors (NPFs) such as the VCAdomain of N-WASP potently activate nu-
cleation on their own. Whereas, Type II NPFs such Cortactin haveweaker activity on
their own, but synergize with Type I NPFs. Previous work from our group demon-
strated that Coronin 1B can inhibit VCA-induced Arp2/3 activation in pyrene actin
polymerization assays, but this requires high concentrations of this protein to be ef-
fective (IC50 ∼1 mM, Chapter 4). We examined whether Coronin 1B is a more potent
inhibitor of type II NPFs such as Cortactin. Consistent with previous studies, we
observed 500 nM Cortactin enhances Arp2/3 nucleation activity stimulated by low
concentrations of VCA (Figure 5.3-B, 5.2). Upon addition of Coronin 1B to these
reactions, and we observed a potent inhibition of the enhanced nucleation induced
by Cortactin (Figure 5.4-A). Using varying concentrations of Coronin 1B protein, we
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Figure 5.3: Cortactin synergizes with VCA to stimulate Arp2/3 activity
A- Reactions with different concentrations of Cortactin, containing 25 nM Arp2/3, 1 nM GST-VCA
and 1.5 µM actin, were subjected to ultra-centrifugation. Samples were separated by PAGE, and
Coomassie Blue stained or immunoblotted with indicated antibodies. These data are representative
of the data used to compute the EC50 value in Figure 5.7-G.
B- Actin polymer concentration versus time in reactions containing 1.5 µM actin (5% pyrene labeled),
20 nM Arp2/3 complex, and indicated amount of GST-VCA and Cortactin. The curves labeled actin-
only (yellow), Arp2/3 (tan) and 1 nM VCA (grey) did not contain Cortactin.
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calculated that the IC50 of this inhibition is 50 nM (Figure 5.4-B). This value is 20-fold
less than the calculated IC50 value for Coronin 1B’s inhibition of Arp2/3 activation
stimulated by VCA alone. Thus, Coronin 1B is a potent inhibitor of the synergistic
effect of Cortactin on Arp2/3 complex activation.
We next tested the requirement for Coronin 1B’s F-actin and/or Arp2/3 binding
activity in this assay using specific mutants. The Coronin 1B R30D mutant, which
cannot bind to F-actin, has an IC50 around 11 µM, indicating that F-actin binding
is critical for Coronin 1B’s inhibition of Cortactin (Chapter 4). Interestingly, we ob-
served that this mutant also cannot inhibit Arp2/3 complex activity induced byVCA
alone (Figure 5.5), suggesting that F-actin binding is essential for all of Coronin 1B’s
biochemical activities. We also tested the Coronin 1B S2Dmutant that displays weak
Arp2/3 binding in vitro and in vivo (Figure 3.8-C, 2.3-C). In contrast to the VCA-
induced activation where this mutant shows attenuated inhibition (Chapter 3), the
Coronin 1B S2D mutant has no detectable ability to inhibit the synergistic activation
of Arp2/3 by VCA and Cortactin. This suggests that Arp2/3 binding is absolutely
required for Coronin 1B’s antagonism of Cortactin. Thus, Coronin 1B requires both
Arp2/3 binding and F-actin binding to antagonize Cortactin in vitro.
5.2.4 Coronin 1B de-branches actin branches, and competes with
the branch stabilization activity of Cortactin
To clarify the mechanism of Coronin 1B’s antagonism of Cortactin, we used total in-
ternal reflection microscopy (TIRFM) to monitor the actin polymerization reaction in
vitro (Amann and Pollard (2001), Figure 5.4-C). Consistent with other studies, we ob-
served extensive nucleation and branching of filaments upon incubation of G-actin
with Arp2/3 complex and the VCA fragment of N-WASP. In the presence of 50 nM
Coronin 1B, total actin filament growth was somewhat slower and branching was
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much less extensive (Figure 5.4-C, 5.6). To ensure that the differences observed were
not due to effects on barbed end dynamics, we analyzed the actin filament elon-
gation rate by kymography and observed no difference with or without Coronin
1B (Figure 5.4-D). A careful examination of the TIRF movies revealed that the lack of
branching observed in the presence of Coronin 1Bwas explained by the instability of
branches. In control samples, branches were generated and the daughter filaments
elongated. In most cases, the actin branches were stable throughout the course of
the experiment (Figure 5.4-E, upper panel). However, we did observe rare dissoci-
ation events between daughter filaments and mother filaments when the daughter
Figure 5.4: Coronin 1B antagonizes Cortactin in vitro and inhibits actin branch for-
mation
A- Actin polymer concentration versus time in reactions containing 1.5 µM actin (5% pyrene labeled),
20 nM Arp2/3 complex, 1 nM GST-VCA, and indicated amount of Coronin 1B and Cortactin. The
curves labeled actin-only (yellow), 1 nM VCA (grey) and Arp2/3 (tan) contained neither Coronin 1B
nor Cortactin.
B- The maximal assembly rates of actin polymerization at various Coronin 1B concentrations were
normalized to the maximal assembly rate of VCA stimulated reaction without Cortactin. Data points
with error bars were from independent experiments and presented as means ± SEM. One-phase ex-
ponential decay was used to fit the data and calculate the IC50.
C- Actin (0.5 µM, 30%Oregon green labeled) filaments grown in the presence of 13.3 nM Arp2/3 and
13.3 nM VCAwere observed by TIRF microscopy, either with 50 nM Coronin 1B or without (control).
Scale bars = 4 µm.
D- Actin filament elongation rates from TIRF movies as in (C) were calculated using kymography
and presented in a box and whisker plot. Student’s t test was used to calculate the p value.
E- High magnification view of filament de-branching events. Red arrows indicate actin branch disas-
sembly events. Scale bars = 3 µm.
F- The number of observed actin branches in each field (1400 µm2) was plotted as a function of time.
Proteins were mixed immediately before the reactions started, and subjected to TIRF microscopy.
Four different fields were analyzed for each condition. Data are presented as means ± SEM.
G- Schematic diagram illustrates the second wave debranching assay: Mix 0.5 µM unlabeled G-actin
with 13.3 nMArp2/3 complex and 13.3 nMGST-VCA (step 0). Actin branches are allowed to form for
10 minutes (step 1). Flow-in of different protein mixtures with 0.8 µMCapping protein (1-6), without
G-actin, VCA or additional Arp2/3 complex into the reaction chambers for 2 minutes (step 2). 0.8
µMCapping protein is used to prevent rapid actin depolymerization at barbed ends. Flush chamber
with Rhodamine-phalloidin in imaging buffer to stop the reactions (step 3), and subject the chambers
to image capture.
H- Blue circles represent the average number of branches per µm total actin filament from 9 fields (2
independent experiments), with red lines indicating the mean values. Experiments were performed
as described in (G). Dunnett’s multiple comparison test was used after one-way ANOVA to generate
the p values (⋆, p<0.05; ⋆⋆, p<0.01).
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Figure 5.5: Coronin 1B R30D mutant cannot inhibit Arp2/3 nucleation activated by
VCA
Actin polymer concentration versus time in reactions containing 1.5 µM actin (5% pyrene labeled),
20 nM Arp2/3 complex, 1 nM GST-VCA, and indicated amount of Coronin 1B. The curves labeled
actin-only (yellow) and Arp2/3 (tan) contained neither Coronin 1B nor GST-VCA.
filaments reached several microns in length. In contrast, 50 nM Coronin 1B induced
rapid debranching of daughter filaments at a high frequency, suggesting that Coro-
nin 1B destabilizes branch structures (Figure 5.4-E, lower panel).
Since Coronin 1B potently inhibits Cortactin in pyrene actin assays, we examined
the activity of Coronin 1B with or without Cortactin in the TIRF assay by counting
the number of actin branches formed during the reaction. As shown in Figure 5.4-
F, adding 42 nM Cortactin into the reactions dramatically increased the number of
actin branches observed (red line) relative to VCA alone (black line). Adding 56
nM Coronin 1B into this reaction suppressed the number of actin branches observed
(yellow line). This dose of Coronin 1B reversed the effects of Cortactin on branching
(orange line). This competition could be overcome by adding increasing amounts of
Cortactin (blue, green lines). Consistent with the pyrene actin assay, Coronin 1B and
Cortactin also antagonize each other in TIRF actin branching assays.
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Figure 5.6: Coronin 1B slightly slows down total actin filament accumulation in
TIRFM
Actin filaments grown in the presence of 13.3 nM Arp2/3 and 13.3 nM VCA were observed by TIRF
microscopy, +/- 50 nM Coronin 1B. Total fluorescence was calculated by threshold filtering in ImageJ
and plotted as a function of time. Data were presented as means ± SEM. Paired Student’s t test was
used to calculate the p value.
Since Cortactin has two known effects on Arp2/3, enhanced nucleation and sta-
bilization of actin branches (Weaver et al., 2001), we developed a second-wave de-
branching assay to further dissect the Coronin 1B/Cortactin antagonism (Figure 5.4-
G). In this assay, branches are formed, followed by flushing the reaction chamber
with buffer or buffer containing various protein mixtures. Capping protein was
added to prevent rapid barbed end depolymerization, but allow pointed end de-
polymerization, which helps to recognize debranched actin filaments. After two
minutes, the reaction was stopped by further flushing the chamber with buffer con-
taining Rhodamine-labeled phalloidin. Under these conditions, adding Coronin 1B
decreased the density of actin branches, while Cortactin did not affect the density
of actin branches. Interestingly, adding 30 nM Cortactin reversed Coronin 1B’s de-
branching effects, suggesting that Cortactin and Coronin 1B affect actin branches in
a manner that is independent of the initial nucleation event. Even though under this
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experimental design, we could not exclude the effect of pointed end depolymeriza-
tion inducing daughter filaments dissociation. We believe it is a direct assessment
of proteins activities towards pre-formed actin branched structures. Together, these
data demonstrate that Coronin 1B destabilizes actin branches in a manner that is
antagonistic with Cortactin.
Figure 5.7: Coronin 1B dissociates Arp2/3 complex from the sides of actin filaments
A- Reactions contain 20 nM Arp2/3, 1 nM GST-VCA and 1.5 µM actin. Polymerization was allowed
to proceed for 30 minutes followed by ultra-centrifugation to pellet the actin filaments. Samples were
separated by SDS-PAGE, and Coomassie Blue stained or immunoblotted with indicated antibodies.
B,C,D- Pre-formed actin filaments stabilized by phalloidin were mixed with 20 nM Arp2/3 complex
and incubated at 4◦C overnight. Mixture was subjected to ultra-centrifugation to pellet the actin fila-
ments. Pellets were resuspended in phalloidin-containing MKEI-50 Buffer. Samples were subjected
to negative staining and visualized by transmission electron microscopy. (B) is the mixture before
centrifugation; (C) is the supernatant; (D) is the pellet. Yellow arrowheads indicate Arp2/3 complex
in association with actin filaments. Scale bars = 100 nm.
E- Actin (1.5 µM) filaments were pre-formed for 30 minutes, either by spontaneous nucleation or
induced by SAS, and mixed with 50 nM Arp2/3 complex and other proteins. The reactions were in-
cubated at room temperature for 30 minutes, and subjected to ultra-centrifugation to pellet the actin
filaments. Samples were separated by SDS-PAGE, and Coomassie Blue stained or immunoblotted
with indicated antibodies.
F- Actin (1.5 µM) filaments were pre-formed by Spectrin F-actin seeds (SAS), and mixed with 25 nM
Arp2/3 complex and different concentrations of Coronin 1B. The reactions were incubated at 4◦C
overnight to reach equilibrium, and subjected to ultra-centrifugation to pellet the actin filaments.
Only the pellet samples were subjected to SDS-PAGE, and Coomassie Blue stained or immunoblot-
ted with indicated antibodies.
G- Similar reactions as in (F) with different concentrations of Cortactin were performed. Arp2/3 com-
plex in pellet was quantified by densitometry and normalized to the reaction containing only actin
filaments and Arp2/3 complex. Data points with error bars were from independent experiments and
presented as means ± SEM. One-phase exponential was used to fit the data and calculate the EC50.
H,I- Similar experiments as in (F) with different concentrations of Coronin 1B were analyzed as in
(G). One-phase exponential decay was used to fit the data and calculate the IC50.
J- Actin (2 µM) filaments were pre-formed by spontaneous nucleation for 1 hour, and mixed with
1 µM Cortactin and different concentrations of Coronin 1B. The reactions were incubated at 4◦C
overnight to reach equilibrium, and subjected to ultra-centrifugation to pellet the actin filaments.
Samples were separated by SDS-PAGE and Coomassie Blue stained.
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5.2.5 Coronin 1B induces dissociation of Arp2/3 complex from sides
of actin filaments
Actin branches generated byArp2/3 complex are stabilized at two interfaces: Arp2/3
mother filament and Arp2/3 daughter filament. To understand the specific molec-
ular interface within a branch that is affected by Coronin 1B, we used centrifuga-
tion to separate and quantify the fraction of Arp2/3 complex associated with actin
filaments in our standard nucleation reactions (Figure 5.7-A, 5.23). With increas-
ing amounts of Coronin 1B in the reaction, decreasing amounts of Arp2/3 com-
plex were found associated with the actin filaments, and this effect could be fully
reversed by adding Cortactin to the reaction. To determine whether VCA activa-
tion is required for the Coronin 1B-induced Arp2/3 dissociation, we added Arp2/3
complex to pre-formed actin filaments in the absence of VCA. Consistent with pre-
vious observations (Mullins et al., 1997), we found that Arp2/3 complex binds to
the sides of pre-formed filaments under these conditions (Figure 5.7-B-E). Similar
to the VCA containing reactions, Coronin 1B induces a dissociation of un-activated
Arp2/3 complex from filaments that can be reversed by Cortactin (Figure 5.7-E).
However, in addition to binding to the sides of filaments, Arp2/3 complex can also
bind to the pointed ends of actin filaments with high affinity (Mullins et al., 1998;
Blanchoin et al., 2000b). To exclude the possibility that Coronin 1B affects Arp2/3-
pointed end binding, we repeated these experiments with pre-formed filaments nu-
cleated by Spectrin-F-actin seeds. These filaments are capped at the pointed end by
Spectrin with extremely high affinity (Schafer and Cooper, 1995). In the presence of
Spectrin, we observed identical results to the assays performed without Spectrin, in-
dicating that Coronin 1B-induced Arp2/3 dissociation does not involve the pointed
end binding (Figure 5.7-E). Consistently, we also used sheared actin filaments which
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contained huge number of actin filaments ends and showed that Coronin 1B’s abil-
ity to dissociate Arp2/3 complex was not altered (Figure 5.9). To test whether this
effect is specific, we used BSA as a control and observed no significant dissociation
of Arp2/3 complex under these conditions (Figure 5.8-C, 5.24).
Building on this assay, we used quantitative immunoblotting to test the dose
requirement of Coronin 1B for this effect (Figure 5.7-F). Wild type Coronin 1B in-
duced Arp2/3 dissociation at half-maximal concentration of 74 nM (Figure 5.7-H).
To test the molecular requirements for this activity, we utilized different mutants of
Coronin 1B in this assay. The S2D mutant (defective for Arp2/3 binding) displayed
∼2 fold lower Arp2/3-dissociating activity, while the R30D mutant (defective for F-
actin binding) displayed ∼5 fold lower activity (Figure 5.7-H). In addition, we also
tested a mutant of Coronin 1B lacking the coiled coil domain in this assay and ob-
served similar results (Figure 5.8-A). Finally, we generated a double S2D, R30D mu-
tant (DD) and found that this protein fails to dissociate Arp2/3 complex from actin
filaments. These data demonstrate that both Arp2/3 binding and F-actin binding
are required for Coronin 1B to efficiently dissociate Arp2/3 complex from filaments.
We also examined the activity of other proteins relevant to branch dynamics in
this assay. Previous studies have implicated Cofilin, an actin depolymerization fac-
tor, in Arp2/3 debranching in vitro (Blanchoin et al., 2000b). We found that Cofilin
does promote Arp2/3 complex dissociation in this assay, but in a much less efficient
way than Coronin 1B (IC50 500 nM compared to IC50 74 nM, Figure 5.8-B). Inter-
estingly, Cortactin increases the association of Arp2/3 complex with actin filaments
with a half maximal concentration of 51 nM, consistent with its ability to stabilize
actin branches (Figure 5.7-G, 5.3-A). One simple explanation for the antagonism be-
tween Coronin 1B and Cortactin in this assay is that both proteins compete for a
common binding site on F-actin. We performed actin co-sedimentation assays with
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Figure 5.8: Coronin 1B dissociates Arp2/3 complex from the side of filaments much
more efficiently than Cofilin
A- Similar reactions as in Figure 5.7-F with different concentrations of Coronin 1B were performed.
∆CC is the Coronin 1B mutant lacking the coiled coil domain (Figure 1.3). Arp2/3 complex in pellet
was quantified by densitometry and normalized to the reaction only had actin filaments and Arp2/3
complex. Data points with error bars were from independent experiments and presented as means
± SEM. One-phase exponential decay was used to fit the data and calculated the IC50.
B,C- Similar experiments as in Figure 5.7-F with different concentrations of Cofilin, Cofilin with phal-
loidin (B) or BSA (C) were analyzed as in (A).
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Figure 5.9: Coronin 1B dissociates Arp2/3 complex from sheared actin filaments
Actin (1.5 µM) was polymerized at room temperature for 30 minutes. 50 nM Arp2/3 complex was
added into the reaction for another 30 minutes. Filaments were sheared by repeated pipetting and
mixed with different concentrations of Coronin 1B and Cortactin. Reactions were processed for 30
minutes at room temperature and subjected to high-speed centrifugation. Samples were separated
by SDS-PAGE, and Coomassie Blue stained or immunoblotted with indicated antibodies.
varying amounts of Coronin 1B and fixed amounts of Cortactin and observed that
Coronin 1B and Cortactin can both simultaneously bind to actin filaments (Figure
5.7-J). Together, these data demonstrate Coronin 1B specifically promotes Arp2/3
complex dissociation from actin filaments in a manner antagonized by Cortactin.
5.2.6 Coronin 1B localizes to actin branches both in vitro and in
vivo
To study the molecular mechanism of how Coronin 1B dissociates Arp2/3 complex
from actin branches, we used transmission electron microscopy to visualize actin
branches in the presence of Coronin 1B. In Arp2/3-generated actin branches mixed
with Coronin 1B, we observed altered branch structure relative to controls (Figure
5.10-A, yellow arrows). We quantified the branch angle in these reactions and ob-
served a striking and significant increase of ∼6 degrees in the angle of branches in
the presence of Coronin 1B (Figure 5.10-B). We also examined branches in the pres-
ence of Cortactin and found no obvious changes in structure or angle relative to the
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control reaction (Figure 5.10-A,B). Thus, Coronin 1B alters Arp2/3-generated actin
branch structures.
Since Coronin 1B affects branch dynamics, dissociates Arp2/3 complex from
actin filaments and alters the branch angle, we postulated that Coronin 1B local-
izes to actin branches. To test this idea, we prepared fluorescently labeled Coro-
nin 1B and flowed this protein into reactions containing pre-formed Arp2/3 branch
structures. As visualized by dual-color TIRF microscopy, labeled Coronin 1B prefer-
entially localized to actin branches (Figure 5.10-C). Occasionally, we observed that,
upon binding of Coronin 1B, the actin branch disassembled. Although there was
Figure 5.10: Coronin 1B localizes to actin branches in vitro and in vivo
A- Reactions, containing 20 nM Arp2/3, 1 nM GST-VCA and 1.5 µM actin, were mixed with 2 µM
phalloidin and incubated at 4◦C overnight to reach equilibrium. Equal volume of 0.56 µM Coronin
1B, 0.63 µM Cortactin or control buffer was added into the reaction 5 minutes before the negative
staining. Samples were visualized by transmission electron microscopy. Yellow arrowheads indicate
abnormal actin branch structures. Scale bars = 100 nm.
B- Angles between the mother filament and the daughter filament were quantified and presented as
mean± 95% CI. Dunnett’s multiple comparison test was used after one-way ANOVA to generate the
p values (⋆⋆⋆, p<0.0001).
C- Actin (0.5 µM, 30% Oregon green labeled) was mixed 26 nM Arp2/3 complex and 37 nM GST-
VCA, and actin branches were allowed to form in the flow chamber and visualized by TIRF mi-
croscopy. After 20 minutes, 0.13 nM AlexaFluor-568 labeled Coronin 1B (∼one dye molecule per
protein labeling efficiency), in imaging buffer, was flowed into the chamber. Scale bars = 1 µm.
D- Reactions containing 20 nMArp2/3, 1 nMGST-VCA and 1.5 µM actin weremixed with 1:100 dilu-
tion of primary antibodies, 1:25 dilution of colloidal gold secondary antibodies and 2 µM phalloidin,
and incubated at 4◦C overnight. 150 nM Coronin 1B or 60 nM Cortactin was used in the reactions.
Samples were prepared by negative staining, and visualized by transmission electron microscopy.
For polyclonal antibodies, 18-nm gold conjugated secondary antibodies were used, while 6-nm gold
conjugated secondary antibodies were used for monoclonals. Stains: 1, polyclonal antibody against
Coronin 1B; 2, monoclonal antibody against His tag (Coronin 1B-His); 3, polyclonal antibody against
p34Arc; 4, monoclonal antibody against Cortactin; 5-6, monoclonal antibody against Cortactin, and
polyclonal antibody against p34Arc. Green rings were used to highlight the 6-nm colloidal gold par-
ticles. Scale bars represent 100 nm.
E- Samples were processed as in (D). Data were combined from three independent experiments. Chi
square test between the group with * and the group with ** shows a p value of 0.0021.
F- Platinum replica electron micrographs of lamellipodia in Rat2 cells, with immuno-gold staining
for Coronin 1B (pseudo colored in yellow). Expanded views of dashed regions are presented along
the side of the large panel (a-d), with gold particles circled by green rings. Scale bar = 500 nm. An
expanded version of this table, including staining controls, is found in the supplemental data section.
G,H- Rat2 cells were treated with either latrunculin B 0.2 µM for 10 minutes (G) or cytochalasin D
0.2 µM for 30 minutes (H) and subjected to platinum replica electron microscopy, with immuno-gold
staining for Coronin 1B (indicated by yellow arrowheads). Scale bars = 50 nm.
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some absorption of labeled Coronin 1B onto the glass surface, labeled BSA showed
no specific labeling of branches (data not shown). Thus, we conclude that Coronin
1B specifically targets actin branches in vitro.
To confirm this result at higher resolution, we used immuno-gold labeling in con-
junction with negative staining electron microscopy using purified proteins. With
two different primary antibodies against Coronin 1B, we saw that gold particles pref-
erentially label actin branches (Figure 5.10-D “1-2”). Interestingly, when we used 6
nm gold particles to label Coronin 1B, we observed many gold particles at branches,
suggesting that Coronin 1B is in a multimeric form when it targets branches. As
expected, Arp2/3 complex and Cortactin are also localized to actin branches (Fig-
ure 5.10-D “3-4”). Interestingly, the antibodies we used for Cortactin recognize the
C-terminus of the protein and the gold particle labeling was always 20-30 nm away
from the actin branch (Figure 5.10-D “4”), which is consistent with previous observa-
tions that Cortactin binds to Arp2/3 complex via its N-terminus (Weed et al., 2000).
Using two different sized gold particles, we examined the co-localization of these
components at branches. Simultaneous labeling of Arp2/3 complex and Cortactin
producedmany examples of branches containing both proteins (Figure 5.10-D “5-6”,
5.10-E). When we examined branches stained with antibodies to Arp2/3 complex
and Coronin 1B, we observed single labeling frequency similar to our previous ex-
periments, but only one double labeled branch out of over 900 branches examined
(Figure 5.10-E, Table 5.1). To exclude the possibility that these two antibodies are
sterically incompatible, we confirmed these results with a second antibody that rec-
ognizes a different subunit of the Arp2/3 complex. In the absence of Arp2/3 com-
plex, Coronin 1B does not induce the formation of end-to-side branches (data not
shown), suggesting that Coronin 1B targets pre-existing Arp2/3-containing branches
152
Figure 5.11: Arp2/3 complex localization in vivo visualized by electron microscopy
A- Platinum replica electron micrographs of lamellipodia in Rat2 cells, with immuno-gold staining
for p41Arc. Scale bar = 500 nm.
B- Expanded views of 36 regions from samples described in (A). Scale bar = 50 nm.
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Table 5.1: Coronin 1B and Arp2/3 are mutually exclusive in actin branches
Reactions containing 20 nMArp2/3, 1 nMGST-VCA and 1.5 µMactin were mixed with 1:100 dilution
of primary antibodies, 1:25 dilution of colloidal gold secondary and 2 µM phalloidin, and incubated
at 4◦C overnight. 150 nM Coronin 1B or 60 nM Cortactin was used in the reactions. Samples were
prepared by negative staining, and visualized by transmission electron microscopy. Data were com-
bined from three independent experiments.
and replaces this complex. Together, these data demonstrate that Coronin 1B specif-
ically targets actin branches, and suggest that Coronin 1B and Arp2/3 complex are
mutually exclusive at actin branches in vitro.
To confirm that Coronin 1B localizes to branches in vivo, we used immuno-gold
staining in conjunction with platinum replica electronmicroscopy (Svitkina and Borisy,
1999). Consistent with previous reports, we observed Arp2/3 complex staining at
actin branches using antibodies against the p41Arc subunit (Figure 5.11). Signifi-
cantly, Coronin 1B also localizes to actin branches in vivo (Figure 5.10-F, 5.12). In
addition to labeling end-to-side branches, Coronin 1B also labels complex filament
junctions containing multiple actin filaments. To better visualize single actin branch
structures, we limited the density of actin network using either latrunculin B (Figure
5.10-G) or cytochalasin D (Figure 5.10-H). In these conditions, we observed staining
of Coronin 1B at single actin branches. Thus, consistent with our in vitro observa-
tions, Coronin 1B localizes to actin branches in vivo.
Figure 5.12: Coronin 1B in vivo localization visualized by electron microscopy
Similar to the data to presented in Figure 5.10-F, except a different cell. Platinum replica electron
micrographs of lamellipodia in Rat2 cells, with immuno-gold staining for Coronin 1B (pseudo colored
in yellow). Expanded views of dashed regions are presented on the side of the figures (a-g), with gold
particles circled by green rings. Scale bar = 500 nm.
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Figure 5.13: RNAi strategy to deplete Cortactin and p34Arc
A- Rat2 cells were infected with lentivirus expressing the Cortactin shRNA (CTTN) or the control
shRNA (ctrl). Lysates were blotted with anti-Cortactin (CTTN) to verify the efficiency of knockdown.
Actin and p34Arc protein were detected as loading controls.
B- HEK293 cells were transfected with plasmids expressing the p34Arc shRNA (KD-p34) or the con-
trol shRNA (NS). Lysates were blotted with anti-p34Arc to verify the efficiency of knockdown. Coro-
nin 1B protein (Coronin 1B) was detected as a loading control.
C- Mean cell speeds of Rat2 cells expressing the Cortactin shRNA (KD-CTTN), without or with the
expressing of the RNAi resistant Cortactin EGFP fusion protein (rescue). Over 50 cells were analyzed
in each group. Error bars represent 95% CI; ⋆⋆ = p<0.01.
D- Mean cell speeds of Rat2 cells expressing the control shRNA (NS), the p34Arc shRNA (KD-p34),
without or with the expressing of the RNAi resistant p34Arc EGFP fusion protein (p34Arc-EGFP). N
shows the number of cells analyzed in each condition. Error bars represent 95% CI; ⋆⋆⋆ = p<0.0001.
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5.2.7 Coronin 1B andArp2/3 complex correlate in lamellipodiawith
sequential spatio-temporal dynamics
To study the relational dynamics of Coronin 1B, Cortactin and the Arp2/3 com-
plex in lamellipodia, we used live-cell imaging of cells expressing functional fluores-
cent fusion proteins. We utilized a previously reported knockdown/rescue lentivi-
ral system to deplete the endogenous proteins and express physiological levels of
fluorescently tagged versions (Figure 5.13, 5.14, Vitriol et al. (2007)). We used ky-
mography to analyze the dynamics of each protein by two parameters: retrograde
flow rate, and distance travelled during the retrograde flow. As in previous studies,
we observed periodic retrograde flow events for actin and associated components
(Ponti et al., 2005; Giannone et al., 2004). Actin, Cortactin, Coronin 1B and Arp2/3
complex all have similar retrograde flow rates (Figure 5.15-A,C). However, they have
distinct distances travelled during the flow, with actin traveling the longest distance
and Cortactin traveling the shortest distance. The Arp2/3 complex, as reported by
the p34Arc subunit, travels a similar distance to Cortactin, while Coronin 1B trav-
els nearly twice as far towards the cell body (Figure 5.15-B). These data are con-
sistent with our previous observations that Coronin 1B has a wider lamellipodial
distribution when compared to either Arp2/3 complex or Cortactin in fixed sam-
ples (Figure 4.15-C). In addition, similar observations concerning distance travelled
have recently been reported for actin and the Arp2/3 complex in Drosophila S2 cells
(Iwasa and Mullins, 2007).
Based on the differential localization of Cortactin and Coronin 1B (Figure 5.1), the
biochemical antagonism between these proteins (Figure 5.4, 5.7) and the mutually
exclusive presence of Coronin 1B and Arp2/3 complex at branches (Figure 5.10),
we formulated the following hypothesis: Coronin 1B replaces Arp2/3 complex at actin
branches in lamellipodia, in a manner that is antagonistic with Cortactin.
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Figure 5.14: Expression and localization of fluorescently tagged Coronin 1B, p34Arc
and Cortactin
A- Clonal Rat2 cell lines stably expressing p34Arc-EGFP were generated by FACS. Lysates from dif-
ferent clones were prepared and immunoblotted with indicated antibodies. Arrowhead points to
p34Arc-EGFP, while arrow points to the endogenous p34Arc. Clone CC7 was used for all the experi-
ment presented in Figure 5.15 that used p34Arc-EGFP.
B- Rat2 cells stably expressing p34Arc-EGFP and Coronin 1B-mCherry were generated by lentiviral
infection and subjected to live cell imaging. A single image was taken to demonstrate the localization
of these fluorescent proteins.
C- Rat2 cells stably expressing Cortactin-EGFP and p34Arc-mCherry were generated by lentiviral in-
fection and subjected to live cell imaging. A single image was taken to demonstrate the localization
of these fluorescent proteins.
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To test this hypothesis, we performed correlation analysis between Coronin 1B,
Cortactin and Arp2/3 complex using dual-color live-cell imaging. To examine spa-
tial correlation between these components, we adapted a contour-based pixel inten-
sity extraction technique to calculate Pearson’s correlation coefficient based on dis-
tance from the cell edge (Figure 5.15-D). Consistent with our hypothesis, Coronin 1B
Figure 5.15: Coronin 1B, Cortactin and Arp2/3 complex have distinct dynamics
A- Retrograde flow rate and distance travelled based on the dynamics of EGFP tagged actin/actin-
binding proteins are presented as a scatter plot. More than 6 cells from each category were imaged.
B- Distance travelled component from (A) presented as a box and whisker plot.
C- Representative kymographs showing retrograde flow of EGFP tagged proteins. Horizontal lines
= 5 µm; Vertical lines = 1 minute. Yellow solid line shows an example of Distance travelled, and the
angle α was used to calculate the retrograde flow rate.
D- Normalized fluorescence intensity profiles of a Rat2 cell, expressing Coronin 1B-mCherry and
p34Arc-EGFP, were extracted based on the distance from the cell edge. Three line profiles were plot-
ted, which were 0, -0.4, -0.9 µm from the cell edge.
E- Line profiles were extracted as described in (D) for different pair-wise combinations of labeled
proteins. Each line profile with a given distance from the cell edge was used to calculate Pearson’s
correlation coefficient between the red and green channels. Results from multiple cells (more than
6 cells were analyzed in each category) were grouped together and plotted as a function of distance
from the cell edge. Data are presented as means ± SEM.
F- Kymographs were generated from a Rat2 cell expressing Cortactin-mCherry and p34Arc-EGFP. On
the left, fluorescent intensity profiles of these two channels were extracted from five lines as indicated
on the kymograph. The peak pixel intensity of both channels closest to the cell edge was traced and
presented on the right. Horizontal lines = 1 µm; vertical lines = 1 minute.
G- Kymographs were generated from a Rat2 cell expressing Coronin 1B-mCherry and p34Arc-EGFP.
On the left, fluorescent intensity profiles of these two channels were extracted from five different lines
as indicated on the kymograph. The peak pixel intensity of both channels closest to the cell edge was
traced and presented in the middle. Normalized fluorescence intensity profiles were extracted based
on the distance from the cell edge. Profiles with 0, -0.4, -0.9 µm from the cell edge were plotted as
examples on the right.
H- Line profiles based on the distance to the cell edge were extracted as described in (G) from Rat2
cells expressing different pair-wise combinations of fluorescent proteins. Each line profile with a
given distance from the cell edge was used to calculate Pearson’s correlation coefficient between
the channels. Results from multiple cells (more than 6 cells were analyzed in each category) were
grouped together and plotted as a function of distance from the cell edge. Data are presented as
means ± SEM.
I- Retrograde flow rate and distance travelled of EGFP-actin and p34Arc-mCherry are presented as
scatter plots. Cross symbols represent the p34Arc-mCherry flow events, while dot symbols represent
the EGFP-actin flow. In addition to the two fluorescent proteins, cells expressed different shRNAs as
indicated. More than 16 cells from each category were subjected to analysis. The numbers of flow
events analyzed are listed as n in the graph. Yellow boxes represent the mean of actin for both pa-
rameters ± 2×SD (95% of data points), while the gray boxes represent the mean of p34Arc for both
parameters± 2×SD. ANCOVA analysis was used to generate the F and P values for each condition.
J-M- Values of (I) presented as a box and whisker plots. Dunnett’s multiple comparison test was used
after one-way ANOVA to generate the p values (⋆⋆⋆, p<0.0001).
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and Cortactin have the lowest correlation across the lamellipodia, while Cortactin
and the Arp2/3 complex have the highest correlation (Figure 5.15-E). Coronin 1B
and Arp2/3 complex have an intermediate correlation.
We also examined the spatio-temporal correlation between these components us-
ing kymographs generated from the dual-color movies. As expected, Cortactin and
Arp2/3 complex have a high correlation in both space and time (Figure 5.15-F,H).
Interestingly, we observed that every Arp2/3 complex-positive region close to the
membrane gradually transits into a Coronin 1B andArp2/3 complex double positive
region, and ends in Coronin 1B alone positive region (Figure 5.15-G). These qual-
itative observations are confirmed by Pearson’s correlation analysis (Figure 5.15-
H). Thus, the dual-color analysis supports three conclusions. First, Cortactin and
Arp2/3 complex likely co-exist in the distal lamellipodia. Second, Cortactin and
Coronin 1B localize in a largely mutually exclusive manner in the lamellipodia, con-
sistent with the fact that Coronin 1B andCortactin biochemically associate with inde-
pendent pools of Arp2/3 complex (Figure 5.1-E). Finally, Coronin 1B targets regions
enriched with Arp2/3 complex, but persists longer than Arp2/3 complex as these
regions move towards the cell body by retrograde flow. Together, these data support
the idea that Coronin 1B can replace Arp2/3 complex in the actin network in vivo.
5.2.8 Depletion of Coronin 1B and Cortactin interfere with retro-
grade flow dynamics of actin and Arp2/3 complex
To address the functional roles of Coronin 1B and Cortactin during lamellipodial
protrusion, we visualized the actin and Arp2/3 complex dynamics in Coronin 1B
or Cortactin depleted cells. In general, depletion of either gene product reduced
the distance travelled and the retrograde flow rate of actin (Figure 5.15-I-K). These
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data indicate that both Coronin 1B and Cortactin are required for normal lamel-
lipodial actin dynamics. Conversely, only Cortactin depletion significantly affects
the dynamics of Arp2/3 complex using this technique (Figure 5.15-I,L,M). Upon
depletion of Cortactin, Arp2/3 complex travels a shorter distance than in control
cells, consistent with the in vitro branch stabilization activity of this protein. Surpris-
ingly, depletion of Cortactin increases the retrograde flow rate of Arp2/3, suggesting
that this protein participates in the retardation of Arp2/3-actin branch movement in
lamellpodia. This observation may be consistent with the inefficient formation of
adhesions previously observed in Cortactin-depleted tumor cells (Bryce et al., 2005).
Since these data were collected from cells co-expressing EGFP-actin and p34Arc-
mCherry, we were able to make several interesting observations about the coordi-
nate dynamics of actin and the Arp2/3 complex in lamellipodia. If all of the actin in
lamellipodia were in the form of Arp2/3-containing branches, then one would ex-
pect these proteins to have identical dynamic properties. Our observations in control
shRNA-expressing fibroblasts strongly argue against this idea. In these cells, actin
and Arp2/3 complex have distinct rates of retrograde flow and travel different dis-
tances. Interestingly, depletion of Coronin 1B leads to a convergence of the dynamic
properties of actin and the Arp2/3 complex, suggesting that Coronin 1B plays a
major role in the dynamic restructuring of Arp2/3-containing actin networks. Con-
versely, depletion of Cortactin leads to a divergence in the dynamic properties of
actin and Arp2/3 with increased rates of Arp2/3 retrograde flow, but decreased
rates of actin retrograde flow. These data suggest that Cortactin plays a role coordi-
nating the dynamics of Arp2/3 and actin, presumably by affecting branch stability
and/or adhesive coupling (Bryce et al., 2005). To quantify these effects, we used
the ANCOVA test of co-variance for multiple conditions. Whereas, control cells
and Cortactin-depleted cells have statistically significant divergence in the dynamic
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Figure 5.16: Targeting of active Coronin 1B to the plasma membrane alters actin ul-
trastructure
A- Schematic diagram of Coronin 1B-GAAX construct, which fuses EGFP and CAAX sequence to the
C-terminus of Coronin 1B. If Coronin 1B S2A mutant was used, it is labeled S2A-GAAX.
B- Rat2 cells infected with Coronin 1B-GAAX retrovirus were immunostained for Cortactin and F-
actin (AlexaFluor-568-phalloidin). Scale bar = 10 µm.
C- Lysates from HEK293 cells expressing Coronin 1B-EGFP or Coronin 1B-GAAX were immunopre-
cipitated with antibodies to GFP and immunoblotted with indicated antibodies. Cells were treated
with or without 100 nM PMA for 30 minutes before the lysis.
D,E- Platinum replica electron micrographs of lamellipodia in Rat2 cells (D) or Rat2 cells expressing
S2A-GAAX (E). Scale bars = 500 nm.
properties of Arp2/3 and actin (P≪0.0001), Coronin 1B-depleted cells show no sig-
nificant difference in the co-variance of these markers (Figure 5.15-I-M). Together,
these data indicate that a balance of Coronin 1B and Cortactin activities are required
for maximally efficient lamellipodial actin dynamics.
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5.2.9 Targeting active Coronin 1B to the plasmamembrane disrupts
the dendritic actin network
To further test the activity of Coronin 1B in vivo, we used a mis-localization strategy
to drive this protein to the plasma membrane where it is not normally found. We re-
engineered our Coronin 1B-GFP construct to include the CAAXmembrane targeting
sequence of H-Ras (Coro1B-GAAX; Figure 5.16-A). When this construct is expressed
in Rat2 cells, it localizes to the plasma membrane, but does not induce any obvious
effect on leading edge dynamics or dendritic actin architecture (Figure 5.16-B, data
not shown, Figure 5.18). In analyzing this puzzling result, we discovered that this
fusion protein is hyper-phosphorylated on Ser2, a phosphorylation site that nega-
tively regulates Coronin 1B activity (Figure 5.16-C; Chapter 2, 3). To explore this
effect, we treated cells with a pan-PKC inhibitor (Ro32-0432) that we had previously
shown to block Coronin 1B phosphorylation in response to PMA (Chapter 2). Unlike
the case of cytosolic Coronin 1B, this treatment did not affect the phosphorylation of
Coronin 1B-GAAX, suggesting that Coronin 1B cannot be dephosphorylated at the
plasma membrane (Figure 5.17-A). To exclude the possibility that a plasma mem-
brane resident kinase distinct from PKC is responsible for this phosphorylation, we
also treated cells with staurosporine, a general kinase inhibitor. Under these condi-
tions, Coronin 1B-GAAXwas still hyper-phosphorylated (Figure 5.17-B), suggesting
that Slingshot-1L, the known phosphatase for Coronin 1B, is not active at the mem-
brane.
To overcome this problem and test our original notion about mis-targeting Coro-
nin 1B to the plasma membrane, we membrane targeted the non-phosphorylateable
S2A mutant of Coronin 1B (S2A-GAAX). This construct was localized to the plasma
membrane as expected (data not shown), but was not phosphorylated on Ser2 (Fig-
ure 5.17-B). Expression of S2A-GAAX in cells drastically alters actin ultrastructure
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Figure 5.17: Membrane targeted Coronin 1B is hyper-phosphorylated because it can-
not be dephosphorylated by the normal mechanism
A- Rat2 cells stably expressing Coronin 1B-GAAX were treated with 1 µM Ro32-0432 for various
times up to overnight (O/N). Lysates from these cells were immunoprecipitated with antibodies to
GFP and immunoblotted with indicated antibodies. Arrowheads point to Coronin 1B-GAAX protein,
while arrow point to the endogenous Coronin 1B. Normally, Coronin 1B-GFP is rapidly dephospho-
rylated under the same conditions (Figure 3.10-A).
B- Rat2 cells stably expressing Coronin 1B-GAAX, either wild type (WT-GAAX) or S2Amutant (S2A-
GAAX), were treated with 100 nM Staurosporine (STS) for various time up-to 2 hours, and processed
as in (A). Note that endogenous Coronin 1B (arrow) co-immunoprecipates with the GAAX-tagged
forms and is hyper-phosphorylated as well.
in lamellipodia compared to cells expressing the wild type Coronin 1B-GAAX or
untransfected control cells (Figure 5.18, 5.16-D,E). The dendritic meshwork is dra-
matically reduced in these cells, but actin bundles were not affected. Thus, targeting
active Coronin 1B to the plasma membrane inhibits Arp2/3-based branching, con-
sistent with our biochemical assays.
5.2.10 Coronin 1B and Cortactin antagonize each other in vivo
Our data in vitro strongly suggest that Coronin 1B and Cortactin antagonize each
other. If this antagonism exists in vivo, we postulated that some of the defects ob-
served in single knockdowns should be rescued by double knockdown. Since both
Coronin 1B and Cortactin are concentrated at lamellipodia, we tested this hypothesis
using kymography analysis. As reported previously, depletion of either Coronin 1B
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Figure 5.18: Rat2 cells expressing membrane targeted Coronin 1B has normal lamel-
lipodial actin structure
Platinum replica electron micrographs of lamellipodia in Rat2 cells expressing Coronin 1B-GAAX.
Scale bars = 500 nm.
(Figure 5.22-B) or Cortactin (Bryce et al., 2005) reduces protrusion persistence. Inter-
estingly, depletion of either gene also reduced protrusion distance (Figure 5.22-A).
Strikingly, cells depleted of Coronin 1B and Cortactin have increased protrusion per-
sistence and distance relative to the single knockdowns (Figure 5.22-A). These data
provide strong in vivo evidence of the Coronin 1B-Cortactin antagonism. Interest-
ingly, another parameter of lamellipodial behavior, protrusion rate, did not show a
recovery in the double knockdown cells, but rather a synergistic reduction. We also
analyzed whole cell random motility using single cell tracking and found that dou-
ble knockdown did not rescue the defects observed in single knockdowns (Figure
5.19). Jasplakinolide is a cell permeable drug that strongly inhibits actin dynamics in
vivo. Unlike control cells, Coronin 1B or Cortactin depletion cells were less sensitive
to its treatment (Figure 5.21), suggesting that the motility defects observed in the
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Figure 5.19: Double depletion of Coronin 1B and Cortactin cannot rescue migration
defects observed in single knockdowns
Mean cell speeds of Rat2 cells expressing the control shRNA (NS), the Coronin 1B shRNA (KD-1B),
the Cortactin shRNA (KD-CTTN) or both. Newman-Keuls multiple comparison test was used after
one-way ANOVA to generate the p values; error bars represent 95% CI.
depleting cells are likely due to altered actin dynamics. Since Coronin 1B and Cor-
tactin have opposite effects on Arp2/3-containing actin branches, we were hoping
that depleting one gene and overexpressing the other might produce dramatic de-
fects. We excluded this possibility after the single cell tracking assays (Figure 5.20).
Together, these data suggest that Coronin 1B and Cortactin antagonize each other in
some processes, but that there are more complex functions of these proteins in whole
cell motility.
5.3 Discussion
In this work, we present evidence that Coronin 1B antagonizes Cortactin both in vitro
and in vivo. Coronin 1B potently inhibits the synergistic effect of Cortactin on Arp2/3
nucleation. Coronin 1B debranches nascent Arp2/3-containing actin branches, and
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Figure 5.20: Coronin 1B and Cortactin regulates cell motility in a complex manner
Mean cell speeds of Rat2 cells simultaneously expressing shRNA against either Coronin 1B (KD-1B)
or Cortactin (KD-CTTN), and different GFP fusions. Mean value is presented; error bars represent
95%CI. Dunnett’s multiple comparison test was used after one-way ANOVA to generate the p values
(⋆, p<0.05; ⋆⋆, P<0.01). The numbers of cells analyzed are listed as N.
competes with the branch stabilization activity of Cortactin. At the molecular level,
Coronin 1B promotes the dissociation of the Arp2/3 complex from the side of actin
filaments, whereas Cortactin enhances this association. Using electron microscopy,
we show that Coronin 1B specifically targets actin branches, and that Coronin 1B and
the Arp2/3 complex are mutually exclusive at branches suggesting that Coronin 1B
has the ability to replace Arp2/3 complex at branches. Consistent with this idea,
Coronin 1B targets pre-existing areas of Arp2/3 in lamellipodia, but persists longer
at these sites than Arp2/3 complex during retrograde flow. Together, these obser-
vations indicate that Coronin 1B has the unique function of remodeling Arp2/3-
containing actin branches and plays an important role in coordinating actin dynam-
ics within lamellipodia.
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5.3.1 A working model for Coronin 1B function
Based on our data, we propose the following working model to explain the events
that follow the initial Arp2/3 complex activation and branch formation steps (Fig-
ure 5.22-D). Activated Arp2/3 complex readily nucleates a daughter filament on
the side of mother filament and forms a stereotypical Y shaped branch structure.
Unlike other NPFs, Cortactin remains stably associated Arp2/3-containing actin
branches and protects those branches from spontaneous disassembly. Coronin 1B
targets Arp2/3-containing actin branches in an antagonistic manner with Cortactin.
This targeting requires both F-actin and Arp2/3 binding for maximum efficiency
and involves multimeric Coronin 1B complexes. Subsequently, Arp2/3 complex
dissociates from the branch, leaving an oligomer of Coronin 1B in its place. This
Arp2/3-free branch has an altered geometry with a larger angle than before. Previ-
ously, we showed that Coronin 1B promotes the leading edge targeting of Slingshot
1L (SSH1L), the activating phosphatase of Cofilin. Recruitment of SSH1L brings it
into close proximity to F-actin, an essential co-factor for its activation. SSH1L ac-
tivation leads to local dephosphorylation of Cofilin. Active Cofilin promotes the
release of inorganic phosphate from the subunits of the surrounding actin filaments.
Since Coronin 1B binds with ∼50-fold lower affinity to ADP F-actin, this will lead
to disassembly of the Coronin 1B-containing branches. In addition, locally activated
Cofilin may sever actin filaments and lead to filament turnover. This model pro-
vides a mechanistic explanation of Coronin 1B function and explains the turnover of
Arp2/3 branched actin networks.
It is worth comparing this model to previous ideas about the mechanism of Coro-
nin function. It has been proposed that soluble yeast Coronin (Crn1) binds to Arp2/3
complex and holds this complex in an inactive state (Rodal et al., 2005). Upon the
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Figure 5.21: Coronin 1B and Cortactin regulates cell motility by affecting actin dy-
namics
Mean cell speeds of Rat2 cells expressing shRNA against either Coronin 1B (KD-1B) or Cortactin
(KD-CTTN), simultaneously with jasplakinolide treatment. Increased amounts of jasplakinolidewere
used in each condition (0, 0.01, 0.1, 1, 10 nM). Mean value is presented; error bars represent 95% CI.
Newman-Keuls multiple comparison test was used after one-way ANOVA to generate the p values
(⋆⋆, p<0.0001). The numbers of cells analyzed are listed as N.
docking of this inactive Crn1-Arp2/3 complex on actin filaments, the Arp2/3 inhibi-
tion is relieved and nucleation can proceed (Humphries et al., 2002). One prediction
of this model is that a mutant version of Coronin that can bind to Arp2/3 complex,
but not F-actin should be a potent inhibitor of Arp2/3-mediated nucleation. We
found that the R30D mutant of Coronin 1B, which cannot bind to F-actin, but binds
normally to Arp2/3 complex in vitro (Chapter 4), does not inhibit Arp2/3 nucleation
(Figure 5.5). Furthermore, if Coronin were helping to dock Arp2/3 complex as part
of an activation mechanism, it would localize with Arp2/3 complex concurrently in
the extreme distal lamellipodium. Based on our data in mammalian cells and ob-
servations from others, Coronins are recruited secondarily to sites of Arp2/3 enrich-
ment/activation (Sirotkin et al., 2005; Etzrodt et al., 2006; Rosentreter et al., 2007). It
is possible these differencesmay arise due to divergentmechanisms of Coronin func-
tion between species. Future experiments will be required to resolve this issue.
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5.3.2 Cortactin stabilizes Arp2/3 complex at actin branches in vivo
In vitro data suggest that Cortactin stabilizes actin branches generated by Arp2/3
complex (Weaver et al., 2001). In Cortactin depleted tumor cells, a decreased barbed
end density relative to F-actin was observed (Bryce et al., 2005). This decrease could
arise due to insufficient nucleation or failure to stabilize Arp2/3-containing branches.
Our observations indicate that Arp2/3 retrograde flow is cut short in the absence of
Cortactin suggesting that Cortactin indeed stabilizes Arp2/3-containing actin branches
in vivo. This observation does not preclude an additional effect of Cortactin in en-
hancing Arp2/3 nucleation at the plasma membrane, but does provide the first in
vivo evidence for branch stabilization. Another phenotype observed in Cortactin-
depleted tumor cells is the failure to efficiently form nascent adhesions at the lamel-
lipodia (Bryce et al., 2005). Surprisingly, our data indicate that depletion of Cortactin
leads to increased rates of Arp2/3 retrograde flow. Together, these observations sug-
gest that Cortactin may play a role in anchoring Arp2/3-containing branches to sites
of adhesion. In future studies, it will be interesting to use dual-color live cell imag-
ing to study the role of Cortactin in coupling the dendritic actin network to sites of
adhesion.
Figure 5.22: Coronin 1B antagonizes Cortactin and coordinates actin dynamics in
lamellipodia
A- Protrusion parameters of Rat2 cells expressingCoronin 1B shRNA (KD-1B), Cortactin shRNA (KD-
CTTN), or both. Mean values are presented; error bars represent 95% CI. Newman-Keuls multiple
comparison test was used after one-way ANOVA to generate the p values. More than 7 cells from
each category were subjected to analysis. The numbers of protrusion events analyzed are listed as n
in the graph.
B- Model of Coronin 1B function at actin branches
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5.3.3 Antagonism between Coronin 1B and Cortactin
One of the most striking observations we made in this work is that Coronin 1B po-
tently antagonizes Cortactin and vice versa. In lamellipodia, these proteins are local-
ized in distinct patterns with Cortactin alwaysmore distally concentrated than Coro-
nin 1B. Biochemically, these proteins interact with different pools of Arp2/3 complex
and little to no interaction occurs between them. These data are validated by the low
correlation between Coronin 1B and Cortactin observed during dual-color live cell
imaging. In addition, the relative strengths of the co-immunoprecipation interac-
tions between Coronin 1B-Arp2/3 and Cortactin-Arp2/3 are well correlated with
the interactions observed by live-cell imaging.
In multiple biochemical assays in vitro using purified proteins and in functional
analysis in vivo, Coronin 1B and Cortactin compete with each other in all assays.
This competition does not simply reflect the antagonistic binding of these proteins
to F-actin, but involves both Arp2/3 and F-actin binding events. Future studies
will focus on defining the precise molecular interactions required for this compe-
tition. Interestingly, both Coronin 1B (Chapter 4) and Cortactin (Bryce et al., 2005)
bind with higher affinity to ATP/ADP-Pi containing actin filaments than ADP F-
actin suggesting that nucleotide state of the actin filaments provides specificity for
multiple actin binding proteins.
While the biochemical antagonism between Coronin 1B and Cortactin was com-
plete, our in vivo results suggest a more complex interaction between these proteins
exists in cells. The incomplete nature of the rescue observed upon double depletion
of these genes indicates that Coronin 1B and Cortactin likely have functions outside
the antagonistic relationship in lamellipodia. Another aspect of the interaction be-
tween these proteins is the spatio-temporal sequence of events that occurs during
actin network assembly. Actin branches generated by Arp2/3 complex, which are
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transiently stabilized by Cortactin, must exist first for Coronin 1B to exert its func-
tion. Due to the nature of the interactions involved, it seems unlikely that Arp2/3
complex and/or Cortactin could attack a Coronin 1B-containing actin branch and
reverse the process.
5.3.4 Coronin 1B remodels the Arp2/3-containing actin network
The observation that Coronin 1B can replace Arp2/3 complex in actin branches
raises several interesting structural issues. First, the Coronin 1B found at branches
is oligomeric in nature suggesting that different subunits within a Coronin oligomer
may engage the mother and daughter actin filaments. Second, Coronin 1B potently
disrupts the interaction between the Arp2/3 complex and the side of actin fila-
ments. This suggests that dissociation of Arp2/3 from the mother filament is likely
to happen first during the process of branch replacement, followed the capture of
the daughter filament in a second step. This may explain why Coronin 1B induced
frequent debranching of nascent daughter filaments in TIRF assays. These nascent
daughter filaments are unlikely to be anchored to the NEM-Myosin-coated surface
due to their short length. Third, the altered geometry of actin branches containing
Coronin 1B may help explain the complex nature of the actin network at the back
of the lamellipodia. Future studies will focus on describing the properties of these
altered networks using biophysical approaches.
The remodeling of the Arp2/3-containing branched actin network by Coronin 1B
may generate a second actin network with distinct properties. Our data from dual-
color live-cell imaging indicate that Arp2/3 complex and actin have non-identical
dynamic parameters. Lamellipodial actin flows a much greater distance towards the
cell body than Arp2/3 complex in fibroblasts. This is consistent with recent obser-
vations fromDrosophila S2 cells using speckle microscopy (Iwasa and Mullins, 2007).
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Figure 5.23: Coronin 1B, Cortactin and GST-VCA affect the association of Arp2/3
complex with actin filaments
Actin was mixed with different concentrations of Coronin 1B, Cortactin or GST-VCA (labeled as
G.A.V. in the figure). Reactions were processed overnight at 4◦C and subjected to high-speed cen-
trifugation. Samples were separated by SDS-PAGE, and Coomassie Blue stained or immunoblotted
with anti-p34Arc antibodies.
Intriguingly, Coronin 1B depletion leads to a perfect synchronization of Arp2/3 and
actin dynamics in the lamellipodium. Together with our biochemical data, this re-
sult strongly implies that Coronin 1B remodels Arp2/3-containing branches into a
new actin network free of Arp2/3 complex. Other studies have identified diverse
and seemingly independent actin networks within lamellipodia (Ponti et al., 2004).
Future studies will be required to delineate the role of Coronin 1B-mediated actin
remodeling in generating diversity in lamellipodial actin networks.
What advantage does this type of actin network remodeling provide to the cell?
First, this mechanism allows efficient recycling of the Arp2/3 complex for contin-
ued branched actin nucleation. Although the cytosolic concentration of Arp2/3 is
high (Pollard et al., 2000), it is possible autocatalytic branching could locally deplete
the Arp2/3 complex and stall actin network assembly. Coronin 1B allows continued
branch formation while maintaining existing branches. Second, Coronin 1B branch
replacement allows the flexibility to maintain branches or initiate branch disassem-
bly on demand. This mechanism gives precise temporal control over the structural
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integrity of the actin network depending on the needs of the cell. Third, Coronin 1B-
containing branches allow control of actin filament severing/depolymerization via
the local activation of Cofilin (see below). Although our studies have been focused
on lamellipodia, the mechanism of Coronin function revealed by these experiments
likely applies to all Arp2/3-based branched actin networks such as those found on
endosomes, in dendritic spines or phagocytic cups.
5.3.5 Turnover of the branched actin network through the combined
action of Coronin 1B, Slingshot 1L and Cofilin
Previous models of branched actin network turnover relied on a Cofilin depolymer-
ization/severing step, but regulation of Cofilin activity at the back of the lamellipo-
dia is incompletely understood. Coronin 1B spatially couples Arp2/3 branch remod-
eling to Cofilin-based actin turnover via the recruitment of Slingshot 1L (Chapter 3).
This provides a fine-tuned mechanism for precise regulation of actin dynamics.
In our model, Coronin 1B indirectly regulates Cofilin activity by affecting SSH1L
targeting. It is quite different from a recent proposed model, in which Coronin pro-
motes the F-actin binding of Cofilin and enhances its severing activity (Brieher et al.,
2006). This model was proposed based on the observation that Coronin enhances
Cofilin’s ability to disassemble Listeria actin tails from cell lysates. Using purified
proteins, we did not observed any enhanced Cofilin binding to actin filaments upon
the addition of Coronin 1B. On the contrarily, we found that Coronin 1B protects
actin filaments from Cofilin depolymerization in pyrene actin assays (Chapter 4).
It is worth to mention that Coronin 1B binds to ATP/ADP-Pi F-actin with ∼50-
fold higher affinity than ADP F-actin, while Cofilin preferentially binds to ADP
F-actin. Consistent with this nucleotide preference differences, we observed that
Cofilin competes Coronin 1B off the actin filaments, which is likely due to Cofilin’s
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ability to accelerate Pi releasing from the subunits of actin filaments. Since Listeria
actin tails assembled from cell lysates likely contain mixture of proteins, not limited
to currently identified Coronin and AIP, further studies are required to reconsoli-
date these data. Actually, the formation of Listeria actin tail is dependent on Arp2/3
nucleation, and majority of the tail contains branched actin structures (Sechi et al.,
1997). It is highly possible that upon the addition of Coronin proteins, these Arp2/3-
containing actin branches were remodeled into Coronin-containing actin branches,
which were extremely sensitive to Cofilin. Addition of µM concentrations of Cofilin
into the Listeria actin tails reconstituted system likely induced a global nucleotide
change of actin subunits, which resulted in the quick depolymerization of actin fila-
ments debranched by Coronin. One strong prediction is that addition of any factor
that slows down ADP F-actin depolymerization, such as phalloidin, jasplakinolide
or actin ends cappers, will prevent the rapid destabilization of these actin filaments.
Future studies are required to purse the complex relationship between Coronin and
Cofilin.
Cofilin has been thought to be the critical player in recycling both Arp2/3 com-
plex and actin at the back of lamellipodia (Svitkina and Borisy, 1999). Our model
also emphasizes the importance of Cofilin’s depolymerization/severing activity. When
we globally activated Cofilin by expressing its activation phosphatase - SSH1L, we
found that the entire lamellipodial dynamics was altered substantially. It is consis-
tent with the phenotypes observed in cells overexpressing constitutively activated
Cofilin S3Amutant (Chapter 3). Similarly, recent observations made inDrosophila S2
cells indicate that depletion of SSH causes lamellipodia expansion (Iwasa and Mullins,
2007), suggesting that active Cofilin is absolutely required for normal actin dynam-
ics. Using quantitative fluorescent specklemicroscopy, it has been shown that Cofilin
is down stream of Rac1-PAK1 signaling and plays an essential role in generating
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Figure 5.24: BSA does not co-sediment with actin filaments
1.5 µM actin was mixed with different amounts of BSA, and reactions were allowed to polymerize at
room temperature for 1 hour. Reactions were subjected to high-speed centrifugation to pellet actin
filaments. Samples were separated in SDS-PAGE and stained by Coomassie Blue.
highly dynamic actin speckles in vivo (Delorme et al., 2007).
A global activation of Cofilin may be required to supply the actin monomer pool,
our model suggests a localized activation of Cofilin for efficient actin branches disso-
ciation and/or actin filaments remodeling. A similar model was proposed recently
suggesting that during chemotaxis Cofilin is globally inactivated and locally acti-
vated (Mouneimne et al., 2006; Sidani et al., 2007). Their data indicated that upon
the EGF stimulation, it is localized Cofilin activation by releasing from membrane
PIP2 inhibition that generates barbed ends for Arp2/3 nucleation and defines the di-
rection for migration. In future studies, it will be interesting to study the correlation
between Coronin 1B-containing actin branches dissociation with localized Cofilin
activation.
5.3.6 Regulation of Coronin 1B branch remodeling activity
In this work, we present evidence that Coronin 1B actively remodels Arp2/3-containing
actin branches. This un-documented activity of Coronin 1B is extremely potent, im-
plying strict regulations are involved. Strikingly, the cell senses the danger and has
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extremely clever ways preventing the branch dissociation to happen at the distal re-
gion of lamellipodia, when nascent actin branches are generated. Primarily, there is
active PKC residing on the plasma membrane (Gallegos et al., 2006; Zhu et al., 2005)
to inactivate Coronin 1B by stimulating its Serine 2 phosphorylation. Secondarily,
it restricts the localization of SSH1L away from the distal region of lamellipodia.
In addition, Cortactin is enriched at that location readily to prevent Coronin 1B ex-
erts its function. When we artificially targeted non-phosphorylatable Coronin 1B to
the membrane, the dendritic actin network was altered significantly indicating the
importance to properly regulate Coronin 1B activity.
There are many biological events inside the cell involve actin based structures,
such as phagosome-lysosome fusion (Anes et al., 2003; Ferrari et al., 1999). Mycobac-
terium tuberculosis evades the innate macrophages defense by prolonged phagoso-
mal retention. Recent data indicate that this smart escape involves Coronin, in
which specific mycobacterial protein displayed on the surface of phagosomes and
recruits cellular Coronin to halt the phagosome-lysosome fusion (Deghmane et al.,
2007). Coronin inhibits the fusion likely by the debranching or Arp2/3 complex dis-
sociation mechanism. Future studies around this mechanism would provide novel
targeting strategies to preventMycobacterium tuberculosis infection diseases.
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Chapter 6
Future prospect
This chapter focuses on the outstanding questions related to Coronin 1B. It is a
series of previews of potential research directions. Since the topics included are very
subjective, I would like to start with a general exposition about my personal view of
biological research. Life follows the basic chemical and physical rules. Organisms
with life are extremely complex machines beyond the knowledge of current human
beings. No matter how “simple” the life format is, men still cannot replicate any.
Rather considering the life format as messy and only caring what works, I believe
any life format is a self-contained, self-organized, and self-learnt system having ex-
traordinary abilities to survive in the fickle environment. Pathways or signaling
transductions that look redundant or diseconomic, are the reflection of ignorance.
With accumulated knowledge over years, I believe that mankind should be able to
manipulate life in the future. To archive this ultimate goal, enormous work and sin-
cere collaboration are required during the exploring journey. I am willing to take a
modest attitude and be a part of this process. Start with learning what the nature
has archived during the evolution.
6.1 The interaction between type I Coronins and the
Arp2/3 complex
Wehave shown that Coronin 1B directly binds to the Arp2/3 complex (Figure 3.8-C).
Although, the interaction between Coronin 1B and the Arp2/3 complex is relative
weak, less than 1% of the Arp2/3 complex was co-immunoprecipitated. Other peo-
ple in the group have shown that Coronin 1C interacts the Arp2/3 complex 1. Recent
data from a group in Genentech have shown that Coronin 1A interacts the Arp2/3
complex in a manner that is sensitive to Ser2 phosphorylation. Together, these data
indicate that the interaction between type I Coronins and the Arp2/3 complex rep-
resent a general regulatory mechanism in mammal. To address the significance of
this interaction, the following questions need to be resolved. First, what are the in-
terfaces on both proteins that are responsible for the interaction? Second, is there
any regulatory mechanisms involved, other than the phosphorylation on Coronin?
Third, what is the role of debranching during the Arp2/3 complex cycle?
Although we discovered that the Ser2 phosphorylation on Coronin 1B signif-
icantly diminished its interaction with the Arp2/3 complex, we do not have any
evidence suggesting that Ser2 is the residue directly docking on the complex. Con-
trarily, since Coronin 1C does not have Ser2 but still binds to the Arp2/3 complex,
we believe that Ser2 phosphorylation affects the conformation of the “real” bind-
ing patch on Coronin 1B. To map the interfaces responding for the direct binding, a
carefully designed experimental scheme is required. The first approach worth trying
is site-directed mutagenesis based on sequence alignments. The region on Coronin
1 Personal communication with Dr. David Roadcap
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that is binding directly to the Arp2/3 complex must meet the following criteria:
conserved between type I Coronins, different between type I and type II Coronins,
surface exposed and in close proximity to Ser2. Using Coronin 1C as the template
for this targeted mutagenesis could eliminate the potential phosphorylation inter-
ference.
One fact we found about the interaction between Coronin 1B and the Arp2/3
complex is that it is a relatively weak interaction. Less than 1% purified Arp2/3
complex directly interactedwith recombinant Coronin 1B immobilized on beads and
<0.5% Arp2/3 complex in the lysate could co-immunoprecipitate with Coronin 1B.
To map the binding interfaces for this weak interaction, zero-length cross-linking of
purified components followed by mass spectrometry analysis could be used.
Interestingly, the nucleotide status of the Arp2/3 complex has significant im-
pact of its interaction with Coronin 1B. Studying the specificity of this interaction
not only extends current knowedge about the Arp2/3 complex nucleotide cycle, but
also shines light on how the spacial and temporal regulation of actin filaments de-
branching is archived. Further, better understanding about the interactions between
type I Coronins and the Arp2/3 complex, better chance to separate the branched
structure targeting step from the debranching step. As we discussed earlier (Section
5.3.6), certain types of pathogen are using inappropriate debranching as the defense
mechanism to bypass the immunological clearance. Clear understanding about the
molecular interactions behind disassembly of branched actin network will provide
us with opportunities to develop novel therapeutic protocols.
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6.2 The interactions between Coronins and SSH1L
We found that Coronin 1B interacts with SSH1L in vivo, and indirectly regulates
Cofilin activity in lamellipodia (Figure 3.10-H-J, (Figure 3.19-A-C)). The interaction
between Coronin 1B and SSH1L is stronger than the interaction between Coronin
1B and the Arp2/3 complex, probably due to the lower expression level of SSH1L.
Other people have shown that Coronin 2A interacts SSH1L as well 2, suggesting that
the interactions between Coronins and SSH1L reflect a general regulatory mecha-
nism affecting Cofilin activity. Considering the different localizations of Coronin
proteins, this mechanismmaywell explain the precise control of Cofilin activity over
the entire cell, not only in the lamellipodia, but also in focal adhesions, intracellular
trafficing vesicles, etc.
To examine whether this in vivo interaction requires additional factors, we puri-
fied both proteins and preformed the direct binding experiments (Figure 3.13). We
found that Coronin 1B is able to bind to SSH1L directly in vitro, indicating that there
is no requirement for any additional factor. It is worth mentioning that the purified
SSH1L in the assay is the phosphatase dead mutant of SSH1L, not the wild type
protein. Due to the potent effect upon the expression of active Cofilin phosphatase
– SSH1L, even in the presence of Cofilin S3D mutant, we failed to purify enough
recombinant protein for the direct binding experiments. Future studies are required
to confirm the direct binding results using wild type SSH1L protein. One potential
modification may help the protein production is using low dose of Jasplakinolide
during cell culture, which dramtically decrease the actin dynamics and should be
able to buffer the Cofilin over-activation effects.
To further understand the localization and activation mechanisms of SSH1L, we
2 Personal communication with Thomas Marshall
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need to examine the molecular interfaces participated in Coronins – SSH1L interac-
tion. Since both Coronin 1B and 2A interacts with SSH1L, it is likely that the region
responsible for binding on Coronins is conserved. We could start with the Coronin
1B/2A chimera constructs (Figure 4.2-D), and use site-direct mutagenesis to pin-
point residues on Coronins participated in the interaction. To map the regions on
SSH1L that is responsible for this interaction, traditional truncation mutants based
analysis could be used. The fact that Coronin 1B does not interact SSH3 (Figure 3.15),
could help to reduce the regions need to examine.
We found that Coronin 1B is hyper-phosphorylated on the membrane (Figure
5.16-C), and based on data from pharmacological treatments, we concluded that the
phosphatase for Coronin 1B, especially SSH1L, is inactive on the plasma membrane.
The reason by membrane targeted SSH1L is inactive is extremely interesting. Is it
because SSH1L cannot localize to that compartment? Is it because SSH1L lacks es-
sential factors for its activation on the membrane? Is it because some membrane spe-
cific lipids inhibit SSH1L activity? Or the membrane residual Cofilin, inhibited by
PIP2, sequesters SSH1L activity? One simple experiment could eliminate couple po-
tential mechanisms is to membrane target SSH1L together with membrane targeted
Coronin 1B. If membrane targeted SSH1L could prevent the hyper-phosphorylation,
it would suggest that the localization is the most important factor regulating SSH1L
activity. Otherwise, the activity of SSH1L is controlled by complex mechanisms. Re-
solving the molecular interactions between Coronins and SSH1L will help to under-
stand the complex regulation during Cofilin activation. It will also provide subjects
for computational biology to study the generation of functional diversity during the
evolution.
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6.3 Redundancy of Coronin genes in mammal
In ameba or yeast, there is only one Coronin gene. During evolution, this family ex-
panded, and there are at least six Coronin genes inmammal. Whymultiple Coronins
are required in higher organisms? Are there any redundancy between the genes?
Based on sequence alignments, mammalian Coronin genes could be divided into
three groups. Type II Coronins have very different intracellular localizations and
expression levels from type I Coronins, suggesting completely different functions in
vivo. POD, the Coronin gene having two copies of WD40 repeats, stands alone as the
third Coronin group. It has unique actin filaments and microtuble cross-linking ac-
tivity, and may affect mitochondria dynamics. The gene redundancy issue is mainly
within the group. Why Coronin 1A, 1B and 1C are all required within the same
animal?
We have used quantitive real-time PCR and shown that Coronin 1A is mainly
expressed in hematopoietic cells, while both Coronin 1B and Coronin 1C are ubiqui-
tously expressed with Coronin 1A has the highest mRNA level in vivo (Figure 2.1-B).
Tissue specific expressed Coronin 1A has been shown to been essential for T cell
chemotaxis and cellular homeostasis. Since mice lacking both Coronin 1A and 1B
have much severe defects in T lymphocyte trafficking than lacking either gene (per-
sonal communication 3), I believe that Coronin 1A and 1B have redundant functions.
The potential reason for hematopoietic cells to have two type I Coronins is that high
level of actin remodeling is involved in their life cycle, which requires “extra” actin
debranching factor.
Coronin 1C is different from Coronin 1A and 1B. They all bind to the Arp2/3
complex, but unlike Coronin 1A and 1B, Coronin 1C does not have the Ser2 residue
3 With Dr. Andrew C. Chan, Department of Immunology, Genentech
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Figure 6.1: Coronin 1C lacks Serine 2 phosphorylation
Different Coronin GFP fusion proteins were expressed in HEK293 cells. Cells were treated with PMA
to stimulate PKC phosphorylation. GFP fusions were immunoprecipitated by GFP antibodies, and
immunoblotted with phospho-specific antibodies to detect the Serine phosphorylation. S21C is a
Coronin 1C mutant, which has the first five amino acids replaced by Coronin 1B’s. S21CFESV, is
another Coronin 1C mutant. Addition to the mutation in S21C, S21CFESV also has F378V E379S
mutation.
and can not be phosphorylated by PKC (Figure 6.1). Interestingly, Coronin 1C was
classified into core serum responsible genes, and Coronin 1C was up-regulated in
multiple types of highly metastatic breast cancer. I think that Coronin 1C is the
constitutively active Coronin 1B, and positively promotes actin branches disassem-
bly and actin remodeling. This notion is supported by the experiment that moving
the N terminal five amino acids of Coronin 1B onto Coronin 1C created a Coronin
1C mutant which can be phosphorylated in vivo (Figure 6.1). Future studies are
required to full examine the biochemical activities of Coronin 1C, and to compare
with Coronin 1B. The potential reason for the ubiquitous existence of both Coronin
1B and 1C is that Coronin 1C is transcriptionally regulated, which can be expressed
upon the request. Since Coronin 1C cannot be inactivated by phosphorylation and
has potent effect in promoting actin remodeling, it may well explain the reason why
it is up-regulated in metastatic cancer cells.
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6.4 Regulated oligomerization of Coronin could influ-
ence its function
We have shown multiple lines of evidence that Coronin 1B is oligomerized in vivo,
and the oligomer form is the functional form (Figure 2.1-C,D, Figure 4.11, Figure 5.8-
A). Other groups have shown that Coronin 1A and 1C are oligomerized as well. In
the case of Coronin 1A, it trimerized through the coiled coil domain. Since Coronin
1B has the “RhxxhE” trimerization motif within its coiled coil domain, we believe
that Coronin 1B trimerizes, which needs to be verified by gel filtration in the future.
One excellent question is whether Coronin monomer has any unique function.
If it does, whether switching Coronin oligomerization status is a regulatory scheme
for its in vivo function. Current data do not suggest that monomer Coronin 1B has
unique function. However, if considering the increased biochemical avidity upon
oligomerization, it is possible that the trimerization could at least enhance Coronin
activity. For instance, Coronin is produced as monomer form and stored in cyto-
plasm. Under certain circumstance, monomer Coronin trimerizes and starts to ex-
ert its functions. Future studies are required to address the functional alteration of
Coronin during the process of oligomerization.
6.5 Functions of WD40 repeats containing proteins
Search in SMART database reveals that there are over 183 proteins in human pre-
dicted to have WD40 repeats, including actin binding proteins, microtuble motors,
DNA binding proteins, transcription initiation factors, nuclear pore complex pro-
teins, RNA splicing factors, guanine nucleotide exchange factors, protein phosphatase
regulatory subunits, phospholipase activating proteins, phosphoinositide-3-kinase
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Figure 6.2: Phylogenetic tree of WD40 repeats containing proteins
Tree was constructed by Phyml and plotted in Treeview. The region containing several Coronins is
presented. 183 human protein sequences were downloaded from SMART, and subjected to Phyml
for analysis, using TJJ 4GI bootstrapmethod.
regulatory subunits, mitogen-activated protein kinase organizers, etc. Coronins are
a small set of this giant family (Figure 6.2). Is there any general function of these
WD40 repeats containing proteins?
The most characteristic WD40 repeats containing proteins are the α subunits of
G-proteins, which are assembled into seven bladed β-propeller structures. Het-
erotrimeric G-proteins are intracellular binding partners of G-protein-coupled re-
ceptors. Upon the stimulation from the receptor, the α subunit of G-protein liber-
ates from the β and γ subunits, along with GDP release and GTP binding. These
separated subunits will further target different effectors and transmit the signal-
ing. There are 16 Gα genes in human genome encoding 23 known Gα proteins
(McCudden et al., 2005). These proteins have altered structures upon GTP binding
and signal downstream to adenylyl cyclases, phosphoinositide-specific phospholi-
pases and Rho-family guanine nucleotide exchange factors. Gα signaling is involved
in sensory transduction as well.
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TAFII transcription factors, which bind to class II promoters, are another group
of classic WD40 repeats containing proteins. For example, TATA-binding-protein-
associated factor TAFI I31 is required for p53-mediated transcriptional activation
(Lu and Levine, 1995). While TAFI I80 interacts multiple general transcription fac-
tors and mediates activation-dependent transcription (Hisatake et al., 1995). Lim-
ited number of transcription factors have to regulate hundreds and thousands of
genes. It will be very interesting to study how the structural features of these factors
contribute to the transcription recognition specificity.
Interestingly, the core molecular Apaf-1 in apoptosome also has WD40 repeats.
Apoptosome delicately handles the cytosolic signaling cascade to precisely regu-
late cell death. Upon the release of cytochrome c from the mitochondria, monomer
Apaf-1 oligomerized and forms apoptosome, which initiates the apoptosis path-
way. The oligomerization of Apaf-1 is mediated by the N terminus of the pro-
tein, while the C terminal WD40 repeats form the out leaves of the apoptosome
(Riedl and Salvesen, 2007). Unlike previous examples, in which WD40 repeats di-
rectly assemble propeller-like structures, WD40 repeats in Apaf-1 negatively regu-
lates the formation of apoptosome and inhibits the autoactivation of procasepase-9
(Hu et al., 1998).
Growing evidence suggest that a large family of WD40 repeats containing pro-
teins play important roles in mediating cullin E3 ubiquitin ligases substrate recogni-
tion. Ubiquitin-mediated protein modification and degradation are key regulatory
mechanisms in most cellular processes. The specificity of these ubiquitination is
archived by unique recognition between the E3 ubiquitin ligase and the substrate.
In one case, cullin E3 ligases target activated E2 ubiquitin-conjugating enzymes to
various protein substrate through the help from WD40 repeats containing proteins
(He et al., 2006). These cullin E3 ligase complex is emerging as the largest known
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protein complex family that control the ubiquitination of a variety of substrates.
Wnt proteins form a family of highly conserved secreted signalingmolecules that
regulate cell-cell interactions during embryogenesis. Arrow/LRPs are receptors for
active Wnt ligand and have YWTD motif, which is very similar as WD40 repeat
and assembled into propeller structure. Upon the ligand binding, Arrow interacts
with Frizzle, and regulates Axin’s ability to modulate β-catenin nuclear localization
(Tolwinski et al., 2003). YWTD domain assembled propeller localizes extracellularly
and directly mediates specific ligand recognition.
WD40 repeats containing proteins also play important roles in regulating the
specificity of epigenetic modification. EED, an essential player of polycomb group
proteinsmediated gene inactivation, has fiveWD40 repeats aswell. Polycomb group
proteins were first identified as regulators of homeotic genes expression. Recent data
suggest that these proteins repress gene expression by orchestrating DNA accessibil-
ity and regulating histone modification (Rajasekhar and Begemann, 2007). EED pro-
tein was found not only involved in histone deacetylation (van der Vlag and Otte,
1999), but also histone methylation (Montgomery et al., 2005). More interestingly,
the specificity of histone modification is archived by different components within
the polycomb group proteins complex (unpublished data 4). Again, it is the sce-
nario that one propeller structure surrounded by different factors recognizes unique
substrate.
All these experimental data strongly support the following speculation: WD40
repeats containing proteins play regulatory roles in multiple biological processes by assem-
bling unique enzyme-substrate complex, fine tuning signaling pathways and coordinating
multiple regulatory factors. These proteins are assembled into β-propeller like struc-
tures, and have multiple protein recognition sites around the surface. The N and
4 From Dr. Terry Magnuson, Department of Genetics, UNC at Chapel Hill
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C termini of the structure are relative flexible and possess the potential to be regu-
lated by either post-modification or protein interactions. Understanding the acute
regulation within this protein family will help various research in the post-genome
era.
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Appendix A
List of E.coli stock
Table A.1: E.coli stock listed by chronicle (Jan 13th 2004 – Oct 29th 2007)
Name Location Frozen
on
Strain Antibiotic
IMAGE 3583508 m1B Box3-10 1/13/2004 1B = Coronin 1B
m1B-siRNA-99-1-
pLL3.7
Box3-22 6/3/2004 SURE Amp
pQE80L-7WD, chaperon Box3-25 6/15/2004 BL21 Amp 7WD: i-SLR
pQE80L-h1B-1 Box3-28 1/19/2004 SURE Amp
m1B-siRNA-4-pLL3.7 Box3-31 6/3/2004 SURE Amp
pMLT-7WD Box3-34 6/15/2004 SURE Amp
pML2-m1B-1 Box3-37 1/19/2004 SURE Amp
pQE80L-h1B-1, chap-
eron
Box3-39 6/4/2004 BL21 Amp
pMLT-3.1-h1B Box3-43 6/15/2004 SURE Amp
pML2-h1B-DWD40-1 Box3-46 1/13/2004 SURE Amp
pMLT-3.1-h1B-CC-1 Box3-49 1/13/2004 SURE Amp
pML2-RFP-h1B-1 Box3-52 1/19/2004 SURE Amp
pQE80L-7WD Box3-55 7/2/2004 SURE Amp
pML2-1B2Ac1 Box3-58 7/2/2004 SURE Amp
pMAL-c2g-m1Btail Box3-61 7/13/2004 BL21(DE3)RPAmp
pML2-h1B-S2A-2 Box3-64 8/11/2004 DH5a Amp
pML2-h1B-S2D-2 Box3-67 8/11/2004 DH5a Amp
pQCXIX Box3-70 11/4/2004
pQE80L-h1B,mix Box3-76 8/31/2004 BL21 Amp chaperon
pLentiLox3.7 Box3-79 8/16/2004 SURE Amp
pMAL-c2g-1B-
Cextension
Box4-1 9/29/2004 BL21(DE3)RPAmp
pGEX-6p1-Nextension-
S2A
Box4-4 10/14/2004 BL21(DE3)RPAmp
pGEX-6p1-Nextension-
1B
Box4-7 10/3/2004 BL21(DE3)RPAmp
020441-siRNA-human-
1B
Box4-10 9/15/2004
pGEX-6p1-Nextension-
S2D
Box4-13 10/14/2004 BL21(DE3)RPAmp
pMAL-c2g Box4-16 10/2/2004 BL21(DE3)RPAmp
pMAL-c2g-h1B Box4-19 9/15/2004 BL21(DE3)RPAmp
pGEX-6p1 Box4-22 10/2/2004 BL21(DE3)RPAmp
pML2-DPRO-h1B Box4-25 9/15/2004 SURE Amp
pML2-1B2Ac2 Box4-28 10/18/2004 SURE Amp
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Table A.1: E.coli stock listed by chronicle (Jan 13th 2004 – Oct 29th 2007)
Name Location Frozen
on
Strain Antibiotic
pML2-h1B-PRO Box4-31 9/15/2004 SURE Amp
pML2-h1B-DCC Box4-34 9/15/2004 SURE Amp
pML2-C4-2Apro Box4-37 11/14/2004 DH5a Amp
pML2-C5-1B567 Box4-40 10/18/2004 SURE Amp
pML2-2A1Bc2 Box4-43 10/18/2004 SURE Amp
pML2-C3-1Bpro Box4-46 10/21/2004 SURE Amp
pML2-2A1Bc1 Box4-49 10/21/2004 SURE Amp
pMAL-c2g-STOP Box4-52 10/22/2004 SURE Amp not real stop
Red-pLL3.7-372siRNA Box4-55 10/22/2004 SURE Amp
pMAL-c2g-S2D-h1B Box4-58 10/25/2004 BL21(DE3)RPAmp
pMAL-c2g-S2A-h1B Box4-61 10/25/2004 BL21(DE3)RPAmp
pGEX-6p1-short1B Box4-64 10/28/2004 BL21(DE3)RPAmp
pMAL-V2-h1B Box4-67 11/19/2004 BL21(DE3)RPAmp
pMAL-V2-h1BCC Box4-70 11/19/2004 BL21(DE3)RPAmp
pML2-1B-CC Box4-73 11/19/2004 SURE Amp
pML2-1B-Nextension Box4-76 11/19/2004 SURE Amp
pML2-V2 Box4-79 11/19/2004 SURE Amp
GST-Vt-TtoA, Martin Box5-1 12/18/2004 BL21(DE3)RPAmp
GST-Vt-SSAA, Martin Box5-4 12/18/2004 BL21(DE3)RPAmp published
pMAL-V3 Box5-7 12/18/2004 SURE Amp
pMAL-V3-h1B Box5-10 12/20/2004 BL21(DE3)RPAmp
pMAL-V3-S2D-h1B Box5-13 12/23/2004 BL21(DE3)RPAmp
pMAL-V3-S2A-h1B Box5-16 12/23/2004 BL21(DE3)RPAmp
Box5-73 9/30/2004 DH5a
pML2-m1Btail(U+CC) Box5-19 1/17/2005 DH5a Amp
pML2-h1Btail(U+CC) Box5-22 1/17/2005 SURE Amp
pET21a Box5-25 1/17/2005 SURE Amp
pQC-WT1B Box5-28 1/30/2005 SURE Amp
pQC-S2A-h1B Box5-31 1/30/2005 SURE Amp
pQC-S2D-h1B Box5-34 1/30/2005 SURE Amp
pET21a-h1B Box5-37 1/30/2005 DH5a Amp
pMALV2-h1B-PRO Box5-43 1/30/2005 BL21(DE3)RPAmp
pET21a-h2A Box5-40 1/30/2005 DH5a Amp
pMAL-V2-h1B-DPRO Box5-46 1/30/2005 BL21(DE3)RPAmp
pET21a-h1B Box5-49 1/30/2005 BL21(DE3)RPAmp
pET21a-h2A Box5-52 1/30/2005 BL21(DE3)RPAmp
pML2-1BDPRO-S2A Box5-55 2/16/2005 SURE Amp
pMT/V5-HisA Box5-58 2/16/2005 SURE Amp
pMTV5-h1B Box5-61 2/16/2005 SURE Amp
pML2-1BDCC-S2D Box5-64 2/16/2005 SURE Amp
pML2-1BDCC-S2A Box5-67 2/16/2005 SURE Amp
pML2-1BDPRO-S2D Box5-70 2/16/2005 SURE Amp
p20Arc-EGFP-N3, Kris Box5-74 2/27/2005 Kan
p34Arc-EGFP-N3, Kris Box5-75 2/27/2005 Kan
Box5-77 3/1/2007 XL1-Blue Amp
pCoHyGro Box5-80 3/1/2007 XL1-Blue Amp
pBS-PURO Box6-1 3/7/2005 SURE Amp
pBS-Tap-N Box6-3 3/7/2005 SURE Amp
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Table A.1: E.coli stock listed by chronicle (Jan 13th 2004 – Oct 29th 2007)
Name Location Frozen
on
Strain Antibiotic
pML2-p34Arc-myc Box6-5 3/7/2005 SURE Amp
pMAL-V2-CEUC-h1B Box6-7 3/7/2005 BL21(DE3)RPAmp
pML2-F1V Box6-9 4/21/2005 SURE Amp
pML2-POD-full Box6-10 3/7/2005 SURE Amp
pLL3.7-Red Box6-12 3/7/2005 SURE Amp
GFP-PAK, xinming Box6-13 3/18/2005 SURE Kan
pMTV5-HisA-1BDCC Box6-15 4/3/2005 SURE Amp
IMAGE 4053628 Box6-17
pML2-1B-RRAA Box6-19 4/21/2005 SURE Amp
pML2-DCC1B-F2V Box6-21 4/21/2005 SURE Amp
pML2-DCC1B-F1V Box6-23 4/21/2005 SURE Amp
pML2-F2V Box6-25 4/21/2005 SURE Amp
pAc7 Box6-27 5/25/2005 SURE Amp from pAc5.1-
HisA, no SalI
MTV5-1B-RRAA Box6-28 5/8/2005 SURE Amp
MT-actin-GFP Box6-30 5/8/2005 SURE Amp
CA-Pak1, xinming Box6-32 5/25/2005
pAC5.1-HisA Box6-34 5/25/2005 SURE Amp
pAc7-1BGFP Box6-37 5/25/2005 SURE Amp
pAc7-1BDCCF2-GFP Box6-39 5/25/2005 SURE Amp
pAc7-1B2Ac1-GFP Box6-41 6/8/2005 SURE Amp
pAc7-2A1Bc2-GFP Box6-43 6/8/2005 SURE Amp
pAc7-2A1Bc1-GFP Box6-45 6/8/2005 SURE Amp
pAc7-1Bpro-F2-GFP Box6-46 6/8/2005 SURE Amp
pAc8 Box6-48 6/8/2005 SURE Amp from pAc5.1-
HisA, no KpnI
no SalI
pAc7-1B2Ac4-GFP Box6-50 6/8/2005 SURE Amp
pAc7-1B2Ac3-GFP Box6-52 6/8/2005 SURE Amp
pGEX-VCA, from Kris Box6-55 6/8/2005 VCA
of
N-
WASP
pAcS=pAc8-(mRFP)-
GFP
Box6-57 6/8/2005 SURE Amp
pAc7-1B2Ac5-GFP Box6-59 6/8/2005 SURE Amp
pAc7-1B2Ac2-GFP Box6-61 6/8/2005 SURE Amp
pMTV5-SSH3, human Box6-63 6/28/2005 SURE Amp
IMAGE 4053628, LC Box6-64 6/28/2005 Chl
pML2-p20Arc-myc Box6-66 6/28/2005 SURE Amp
pML2-hSSH3 Box6-68 6/28/2005 SURE Amp
pAcS-hSSH3 Box6-70 6/28/2005 SURE Amp
pML2-SSH3-DRM Box6-78 7/13/2005 SURE Amp
pML2-SSH1-myc Box6-74 7/13/2005 SURE Amp
pAc7-1B-REK3a-GFP Box7-1 7/13/2005 SURE Amp all pAc7 or
pAc8 has GFP
at the C termi-
nus
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Table A.1: E.coli stock listed by chronicle (Jan 13th 2004 – Oct 29th 2007)
Name Location Frozen
on
Strain Antibiotic
pML2-1B-K287Q Box7-3 7/13/2005 SURE Amp
pML2-SSH1L-V5DRM Box7-5 7/13/2005 SURE Amp SSH1 = SSH1L
pML2-V5mRFP Box7-7 7/13/2005 SURE Amp
pAc7-1B-V5DRM Box7-9 7/13/2005 SURE Amp
pML2-1B-REK3a Box7-10 7/13/2005 SURE Amp
pML2-SSH1CS-myc Box7-12 7/13/2005 SURE Amp
pML2-SSH1CS-V5DRM Box7-14 7/13/2005 SURE Amp
pML2-V5DRM Box7-16 7/13/2005 SURE Amp
pMTV5-1B-K287Q Box7-19 7/13/2005 SURE Amp
pML2-SSH3-CS Box7-21 7/13/2005 SURE Amp
pAc7-1B-K287Q Box7-23 7/13/2005 SURE Amp
pML2-p20Arc-DRM Box7-25 7/13/2005 SURE Amp
pML2-p20Arc-V5DRM Box7-27 7/13/2005 SURE Amp
pLL3.7-control-siRNA Box7-28 8/9/2005 SURE Amp
N2-1B Box7-30 8/15/2005 SURE Amp pML2-1B has
GFP at N termi-
nus
pMSCV-1B-GFP-CAAX Box7-34 8/15/2005 SURE Amp named GAAX
GAAX-1B Box7-32 8/15/2005 SURE Amp
pML2-1BS2D-V5-EYFP Box7-37 8/15/2005 SURE Amp
pML2-1BS2A-mycX3-
ECFP
Box7-39 8/15/2005 SURE Amp
pML2-mycX3-ECFP Box7-41 8/15/2005 SURE Amp
pML2-V5-EYFP Box7-43 8/15/2005 SURE Amp
pML2-p21Arc-myc Box7-45 8/15/2005 SURE Amp
pMTV5-1Bpro Box7-46 8/15/2005 SURE Amp
pMTV5-1BDPRO Box7-48 8/15/2005 SURE Amp
pAc7-SSH1-V5-
DsRedMono
Box7-50 8/15/2005 SURE Amp
pMTV5-1B-REK3a Box7-52 8/15/2005 SURE Amp
pLL4-372-hCoro1B Box7-55 8/15/2005 SURE Amp res = pLL4.0-
372-
pML2-SSH1CS-mRFP Box7-57 8/15/2005 SURE Amp
res1B-S2A Box7-59 8/15/2005 SURE Amp
res1B-S2D Box7-61 8/15/2005 SURE Amp
GAAX-1BDCC Box7-63 8/15/2005 SURE Amp
res1B-REK3a Box7-64 8/15/2005 SURE Amp
pLL4.0-372 (1B siRNA) Box7-66 8/15/2005 SURE Amp
GAAX-1B-S2D Box7-68 8/31/2005 SURE Amp
GAAX-1B-REK3a Box7-70 8/31/2005 SURE Amp
GAAX-1B-S2A Box7-73 8/31/2005 SURE Amp
GAAX-SSH3-CS Box7-75 8/31/2005 SURE Amp
GAAX-SSH1CS Box7-77 8/31/2005 SURE Amp
res1B-DCC Box7-79 8/31/2005 SURE Amp
pML2-1B-DNe Box8-1 8/31/2005 SURE Amp Ne = N terminal
extension
pIR2-V5-1BDPRO Box8-3 10/5/2005 SURE Amp
pIR2-CofilinS3D Box8-5 10/5/2005 SURE Amp
195
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Name Location Frozen
on
Strain Antibiotic
pIR2-cofilinS3A Box8-7 10/5/2005 SURE Amp
pIR2-1B-S2A Box8-9 10/5/2005 SURE Amp
pML2-mycX3-V5-EYFP Box8-10 10/5/2005 SURE Amp
pIR2-1B-S2D Box8-12 10/5/2005 SURE Amp
pIR2 Box8-14 10/5/2005 SURE Amp a construct with
IRES, not work
well
res1B-DCC, second time Box8-16 10/5/2005 SURE Amp
pMAL-c2g-rat-1Btail Box8-19 10/5/2005 SURE Amp
pLL5.0-372-1B, reL1B Box8-21 11/3/2005 SURE Amp reL = pLL5.0-
372-
pLL5.0-372, 1BshRNA Box8-23 11/3/2005 SURE Amp
pLL4.0-372-paxillin Box8-25 11/3/2005 SURE Amp Paxillin from
cai, with GFP at
C terminus
pMTV5-HisA-SSH1 Box8-27 11/3/2005 SURE Amp
pMSCV-VC-RHE-ECFP-
CAAX
Box8-36 12/9/2005 SURE Amp VC of N-WASP
pML2-RHE-V5EYFP Box8-28 12/9/2005 SURE Amp
pML2-SSH1myc-
W458A
Box8-30 12/9/2005 XL10-
GOLD
Amp
pLL5.0-GFPPXN Box8-34 12/9/2005 SURE Amp GFPPXN =
GFP-Paxillin
pLL6.0-372-1B Box8-37 12/9/2005 SURE Amp pLL6.0, Tet pro-
moter
pLL5.0-372-1C Box8-39 12/9/2005 SURE Amp
pMSCV-ECFP-CAAX Box8-41 12/9/2005 SURE Amp
pGL-rat-EF1a Box8-43 12/9/2005 DH5a a transcription
factor
pMSCV-RHE-
ECFPCAAX
Box8-46 12/9/2005 SURE Amp
pMSCV-VC-
ECFPCAAX
Box8-48 12/9/2005 SURE Amp
pQE80L-A Box8-50 12/9/2005 SURE Amp A of N-WASP
pML2-A-RHE-V5-EYFP Box8-52 12/9/2005 SURE Amp
pLL5.0-NS-GFPPXN Box8-54 12/9/2005 SURE Amp
pLL5.0-372-GFPPXN Box8-55 12/9/2005 SURE Amp
pLL4.0-372-1BDCCF1 Box8-57 12/9/2005 SURE Amp
pBABE-Tet-HA-RF1 Box8-59 12/9/2005 SURE Amp
pMSCV-SV-tTA Box8-61 12/9/2005 SURE Amp
pMTV5-1B-
K198AK216A
Box8-32 1/21/2006 SURE Amp
pLL5-372-1BK198A Box8-73 1/31/2006 SURE Amp
pAc7-1B-K198AK216A Box8-75 1/31/2006 SURE Amp
pLL5-372-1BK216A Box8-77 1/31/2006 SURE Amp
pLL5-372-1BF3R Box8-79 1/31/2006 SURE Amp
reL-S21C-F3R Box9-1 1/31/2006 SURE Amp
pML2-sF1 Box9-3 1/31/2006 SURE Amp
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Name Location Frozen
on
Strain Antibiotic
pMSCV-VC-F1E-
ECFPCAAX
Box9-5 1/31/2006 SURE Amp
pLL5-372-K198AK216A Box9-7 1/31/2006 XL10GOLD Amp
pAc7-1B-R30A Box9-9 3/1/2006 SURE Amp
reL-S21C-FE-SV Box9-10 1/31/2006 SURE Amp
pMTV5-1B-K198A Box9-12 1/31/2006 SURE Amp
pMTV5-1B-K216A Box9-14 1/31/2006 SURE Amp
pAc7-S21C-FESV Box9-16 3/1/2006 SURE Amp
pAc7-1B-K73A Box9-19 3/1/2006 SURE Amp
pAc7-1B-E215A Box9-21 3/1/2006 SURE Amp
pAc7-1B-R30AK73A Box9-23 3/1/2006 SURE Amp
pNB560-TAP2 Box9-25 3/1/2006 SURE Amp for yeast, tan-
dem affinity pu-
rification
pBJ1283, GST-Cortactin Box9-27 3/1/2006 BL21DE3 Amp
reL-S21C-FESV Box9-28 3/1/2006 SURE Amp
pNB560-TAP2-1B Box9-30 3/1/2006 SURE Amp
pNB560-TAP1 Box9-32 3/1/2006 SURE Amp
pRK5-CIN, from Gary Box9-34 3/1/2006 SURE Amp the other Cofilin
phosphatase
pLL4.0-372-1BDCC-Btri Box9-37 3/24/2006 DH5a Amp
pML2-SSH12SA-myc Box9-39 3/24/2006 DH5a Amp
pML2-Ne-Btri Box9-41 3/24/2006 SURE Amp
pLL5.0-372-1BR30D Box9-43 3/24/2006 SURE Amp
TAP1-CEN Box9-45 3/24/2006 SURE Amp
pLL5.0-A-RHE-V5 Box9-46 3/24/2006 SURE Amp
pML2-1BDCC-Btri Box9-48 3/24/2006 SURE Amp
pAc7-1B-K216E Box9-50 3/24/2006 SURE Amp
pAc7-1B-K73E Box9-52 3/24/2006 SURE Amp
pAc7-1B-R30D Box9-55 3/24/2006 SURE Amp
pMTV5-1B-R30D Box9-57 3/24/2006 SURE Amp
pML2-1BDCC-tri Box9-59 3/24/2006 SURE Amp not work
TAP2-1B-2mu Box9-61 3/24/2006 SURE Amp
TAP2-1B-CEN Box9-63 3/24/2006 SURE Amp
BB944, pTEV expression Box9-64 5/13/2006 BL21(DE3) Kan
BB945, pTEV Box9-66 5/13/2006 DH5a Amp
2mu-1BDCC Box9-68 5/15/2006 SURE Amp
pML2-1B-R30D Box9-70 5/15/2006 SURE Amp
pLL5-372-1B-K73E Box9-73 5/15/2006 SURE Amp
pLL5-372-1B-K216E Box9-75 5/15/2006 SURE Amp
pLL5-372-1B-E215A Box9-77 5/15/2006 SURE Amp
GAAX-1B-R30D Box9-79 5/15/2006 SURE Amp
2mu-1B-2 Box10-1 5/15/2006 SURE Amp
2mu-1B-R30D Box10-3 5/15/2006 SURE Amp
2mu-1B-S2D Box10-5 5/15/2006 SURE Amp
2mu-1B-S2A Box10-7 5/15/2006 SURE Amp
Yeast1791, 2mu1B-S2D Box10-9
Yeast1789, 2mu1B-DCC Box10-18
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on
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Yeast1792, 2mu1B-R30D Box10-27
Yeast1788, 2mu1B-2 Box10-36
Yeast1790, 2mu1B-S2A Box10-45
pRK603 Box10-10 6/2/2006 SURE Kan
pRK793, TEV Box10-12 6/2/2006 Amp BL21RPRIL
pML2-1B-E215KDCC Box10-14 6/20/2006 SURE Amp
pLL5-Aw500s-
RHEV5EYFP
Box10-16 6/20/2006 SURE Amp not in frame
pRK793 Box10-19 6/20/2006 BL21RPRIL
pLL5-SSH1L Box10-21 6/20/2006 DH5a Amp
pLL5-NS-SSH1L Box10-23 6/20/2006 DH5a Amp
pLL5-372-SSH1L Box10-25 6/20/2006 DH5a Amp
pRK603 + DCC-TVH Box10-28 6/20/2006 BL21(DE3)RPAmp
pRK603 + R30D-TVH Box10-30 6/20/2006 BL21(DE3)RPAmp
pRK603 + 1B-TVH Box10-32 6/20/2006 BL21(DE3)RPAmp
pRK603 + S2D-TVH Box10-34 6/20/2006 BL21(DE3)RPAmp
pMAL-VC-F1E-
ECFPCAAX
Box10-37 6/20/2006 SURE Amp
pMAL-A-RHE-V5EYFP Box10-39 6/20/2006 SURE Amp not in frame
pMAL-A-RHE-V5EYFP Box10-41 6/20/2006 BL21(DE3)RPAmp not in frame
pMAL-VC-F1E-
ECFPCAAX
Box10-43 6/20/2006 BL21(DE3)RPAmp
pML2-1B-K216EDCC Box10-46 6/20/2006 SURE Amp
pMAL-1BDCC-TVH Box10-48 6/20/2006 SURE Amp
pMAL-1BR30D-TVH Box10-50 6/20/2006 SURE Amp
pLL5-A2RHE-V5EYFP Box10-52 6/20/2006 SURE Amp
pML2-1BDCCE257K Box10-54 6/20/2006 DH5a Amp
1B-TVH Box10-55 6/20/2006 BL21(DE3)RPAmp
pMAL-1B-S2D-TVH Box10-57 6/20/2006 SURE Amp
pRK603 Box10-59 6/20/2006 Kan
pMAL-1BTVH Box10-61 6/20/2006 SURE Amp
pMAL-V2-SSH1L Box10-64 7/20/2006 SURE Amp
QE1B-E215A Box10-66 7/20/2006 BL21(DE3)RPAmp
QE1B-K216E Box10-68 7/20/2006 BL21(DE3)RPAmp
pML2-1BDCC-E219K Box10-70 7/20/2006 DH5a Amp
ARY-w500s Box10-72 7/20/2006 SURE Amp
res-E215K Box10-73 7/20/2006 SURE Amp
res-E219K Box10-75 7/20/2006 SURE Amp
res-E257K Box10-77 7/20/2006 SURE Amp
ARY Box10-79 7/20/2006 SURE Amp
pQE80L-1B-E215A Box11-1 7/20/2006 SURE Amp
pQE80L-1B-K216E Box11-3 7/20/2006 SURE Amp
pML2-1BDCC-L261E Box11-5 7/20/2006 DH5a Amp
pMAL-V2-SSH1L Box11-7 7/20/2006 BL21(DE3)RPAmp
CMV-1B-V5His8 Box11-9 9/16/2006 DH5a Kan
pBabe-xNcoI Box11-10 9/16/2006 SURE Amp
mycARY Box11-12 9/16/2006 SURE Amp
mycARY-w500s Box11-14 9/16/2006 SURE Amp
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pBabe-PURO Box11-16 9/16/2006 SURE Amp
pML2-N2GFP-mCherry Box11-19 9/16/2006 SURE Amp
pML2-N2GFP-RHEV5-
EYFP
Box11-21 9/16/2006 SURE Amp
pN2GFP-RHE-V5EYFP-
fix
Box11-23 9/16/2006 SURE Amp pN2GFP =
pML2-N2GFP
pLL5-GFP-RHE Box11-25 9/16/2006 SURE Amp
pET21a-IRES Box11-27 9/16/2006 SURE Amp
pLL5-IRES-A2new Box11-28 10/23/2006 SURE Amp A2, newer ver-
sion of A
His-Cofilin Box11-30 10/23/2006 Kan from Tom - Bur-
ridge Lab
pTT5SH8Q2 Box11-32 10/23/2006 SURE Amp
Q1B-R30D Box11-34 10/23/2006 SURE Amp Q =
pTT5SH8Q2
modified to
in frame with
pML2
Q1B-E219K Box11-37 10/23/2006 DH5a Amp
IMAGE 1886083 Box11-39 10/23/2006 SURE Amp Mouse WASP
Q2-GFP tracer Box11-41 10/23/2006 SURE Amp Q2 =
pTT5SH8Q2
A2new-final Box11-43 10/23/2006 SURE Amp pLL5-GFPRHE-
A2
IMAGE 1886083 Box11-45 10/23/2006 SURE Amp Amp 100
Q1B-E257K Box11-46 10/23/2006 DH5a Amp
Q2-1B, not in frame Box11-48 10/23/2006 SURE Amp
pBabe-xNcoI-VC2new Box11-50 10/23/2006 SURE Amp
Q1B-S2A Box11-52 10/23/2006 SURE Amp
Q-Coro1B Box11-54 10/23/2006 DH5a Amp
Q1B-S2D Box11-55 10/23/2006 SURE Amp
Q1B-DCC Box11-57 10/23/2006 SURE Amp
Q1B-K73E Box11-59 10/23/2006 DH5a Amp
Q1B-E215A Box11-61 10/23/2006 DH5a Amp
Q1B-E215K Box11-64 10/23/2006 DH5a Amp
Q1B-K216A Box11-66 10/23/2006 DH5a Amp
Q1B-K216E Box11-68 10/23/2006 DH5a Amp
pLL5-V-F-V Box11-70 11/23/2006 DH5a Amp
Q2-SSH1L Box11-72 11/23/2006 DH5a Amp
pET21a-VC2new Box11-73 11/23/2006 DH5a Amp
GAAX-mCTTN Box11-75 11/23/2006 SURE Amp
pLL5-372-mCTTN Box11-77 11/23/2006 SURE Amp
Q-Coro1A Box11-79 11/23/2006 SURE Amp
pLL5-shRCTTN-WT1B Box12-1 11/23/2006 SURE Amp
pBabe-xNcoI-VC2new-
final
Box12-3 11/23/2006 SURE Amp
pLL5-shRCTTN Box12-5 11/23/2006 SURE Amp RNAi only to rat
Cortactin
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Q5-Coro1B Box12-7 11/23/2006 DH5a Amp Q5 = StrepTagII
+ V5
pML2-mCTTN Box12-9 11/23/2006 SURE Amp
V-F-V + V5 Box12-10 11/23/2006 DH5a Amp
Q-mCTTN Box12-12 11/23/2006 SURE Amp
Q2-1BDCCF1 Box12-39 12/11/2006 SURE Amp
5CC Box12-41 12/11/2006 SURE Amp pLL5-
shRCTTN-
mCTTN-GFP
Q2-CofS3D-GFP Box12-16 1/26/2007 SURE Amp
pLL4-mCherry Box12-19 1/26/2007 SURE Amp
Q2-SSH1L-CS Box12-21 1/26/2007 SURE Amp
pLL5-shRCTTN-
GFPactin
Box12-23 2/28/2007 SURE Amp
Q1BDD, S2D+R30D Box12-25 2/28/2007 SURE Amp
pML2-mCTTN-
mCherry
Box12-27 2/28/2007 SURE Amp
Q2-CofHis8 Box12-28 2/28/2007 SURE Amp
pLL4-mCTTN-mCherry Box12-30 2/28/2007 SURE Amp
Q-p34Arc Box12-32 2/28/2007 SURE Amp all p34Arc
expressing is
resistent to
shRNA
pML2-p34Arc Box12-34 2/28/2007 SURE Amp
pLL3.7-red-shRCTTN Box12-37 2/28/2007 SURE Amp
pLL3.7-red-KD-p34 Box12-43 4/3/2007 SURE Amp
pLL5.0-green-KD-p34 Box12-45 4/3/2007 SURE Amp
pLL5-KDCTTN-
CTTNmCherry
Box12-46 5/8/2007 SURE Amp
pLL5-KDCTTN-
GFPactin
Box12-48 5/8/2007 SURE Amp
pMAL-c2g-mCTTN-
His8
Box12-50 4/3/2007 SURE Amp
pMAL-c2g-mCTTN-
His8
Box12-52 4/3/2007 BL21(DE3)RPAmp
pLL7-372-1BmCherry Box12-55 5/8/2007 SURE Amp
pLL7-p34mCherry, fix Box12-57 5/22/2007 SURE Amp
pLL7-mCTTNmCherry Box12-59 5/8/2007 DH5a Amp
pLL7 Box12-61 5/8/2007 DH5a Amp pLL7, modified
from pLL3.7,
CMV driven
MCS-mCherry
pLL5-KDp34-
p34mCherry
Box12-63 5/8/2007 SURE Amp
Q3-SSH1L Box12-64 5/8/2007 SURE Amp
pLL7-Coro1B-mCherry Box12-66 5/8/2007 SURE Amp
pLL7-Kdp34-p34, fix Box12-68 5/22/2007 SURE Amp
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Q3.1-mCTTN Box12-70 5/8/2007 SURE Amp modified Q3
to fit pML2
in-frame; better
purification
output
Q3 Box12-73 5/8/2007 SURE Amp Q3, pTT5SH8Q2
with an oligo
inserted, replac-
ing StrepTagII
with StrepTag
III
pML2-p34-mCherry Box12-75 5/8/2007 SURE Amp
pLL5-KDp34-p34EGFP Box12-77 5/10/2007 SURE Amp
pLL5-mRFPactin Box12-79 5/22/2007 SURE Amp
Q3-Arp2 Box13-1 8/24/2007 DH5a Amp no affinity tag
for purification
Q3-Arp3 Box13-3 8/24/2007 DH5a Amp no affinity tag
for purification
Q3-ArpC1A, frame shift Box13-5 8/24/2007 SURE Amp no affinity tag
for purification,
from Jim
Q3-ArpC4, from Jim Box13-7 8/24/2007 SURE Amp no affinity tag
for purification
Q3-ArpC5, from Jim Box13-9 8/24/2007 SURE Amp no affinity tag
for purification
Q3-ArpC3 Box13-10 8/24/2007 SURE Amp no affinity tag
for purification
Q3-ArpC1A, fix Box13-12 8/24/2007 SURE Amp no affinity tag
for purification
pML2-S2A-GFP-RHE Box13-14 8/24/2007 SURE Amp
Q3.1-p34Arc Box13-16 8/24/2007 SURE Amp
201
Appendix B
List of PCR primers
Table B.1: Primers for shRNA constructs
NAME SEQUENCE NOTE
m1B-1-99 5-/5Phos/TGTTG TGCGG CAGAG CAAAG TTCAA GAGAA
TTTGC TCTGC CGCAC AACTT TTTTC-3
knockdown
mouse/rat version
Coronin 1B
m1B-1-99rev 5-/5Phos/TCGAG AAAAA AGTTG TGCGG CAGAG CAAAT
TCTCT TGAAC TTTGC TCTGC CGCAC AACA-3
m1B-3-372 5-/5Phos/TGTCA TTGCC AGTGG ATCAA TTCAA GAGAC
TGATC CACTG GCAAT GACTT TTTTC-3
knockdown
mouse/rat version
Coronin 1B, good
m1B-3-372rev 5-/5Phos/TCGA GAAAA AAGTC ATTGC CAGTG GATCA
GTCTC TTGAA TTGAT CCACT GGCAA TGACA-3
m1C-195si 5-/5Phos/T GACGGGACGAATTGACAAG TTCAAGAGA
TTTGTCAATTCGTCCCGTC TTTTTT C-3
knockdown
mouse/rat version
Coronin 1C, good
m1C=195siREV 5-/5Phos/TCGAG AAAAAA GACGGGACGAATTGACAAA
TCTCTTGAA CTTGTCAATTCGTCCCGTC A-3
m1C-1327si 5-/5Phos/T GATTCTGAAAGAGATCAAC TTCAAGAGA
TTTGATCTCTTTCAGAATC TTTTTT C-3
knockdown
mouse/rat version
Coronin 1C
m1C-1327siREV 5-/5Phos/TCGAG AAAAAA GATTCTGAAAGAGATCAAA
TCTCTTGAA GTTGATCTCTTTCAGAATC A-3
For-KDp34hmr 5- /5Phos/T GGCATGTTGAAGCGAAATG TTCAAGAGA
AATTTCGCTTCAACATGCC TTTTTT C-3
knockdown hu-
man/mouse/rat
version p34Arc
Rev-KDp34hmr 5- /5Phos/TCGAG AAAAAA GGCATGTTGAAGCGAAATT
TCTCTTGAA CATTTCGCTTCAACATGCC A-3
F-rCTTN 5-T GAACGCATCCACCTTTGAG TTCAAGAGA
TTCAAAGGTGGATGCGTTC TTTTTT C-3
knockdown rat
version Cortactin
R-rCTTN 5-TCGAG AAAAAA GAACGCATCCACCTTTGAA TCTCTTGAA
CTCAAAGGTGGATGCGTTC A-3
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NAME SEQUENCE NOTE
h1B-5-S2A 5-CGCCACC ATG GCC TTC CGC AAA GTG GTC-3
h1B-3-S2A 5-GAC CAC TTT GCG GAA GGC CAT GGTGGCG-3
h1B-5-S2D 5-CGCCACC ATG GAC TTC CGC AAA GTG GTC-3
h1B-3-S2D 5-GAC CAC TTT GCG GAA GTC CAT GGTGGCG-3
1B5’-R1 5-GCG AAT TCG CCA CCA TGT CCT TCC GCA AAG TGG TCC GGC-3
1B3’-Sal 5-TGT GGT CGA CTC CGC ATC CCC GTT CTC CAT GCG GCC-3
1B seq ORF 220 5-CGCATTGACAAGGCCTACCCGAC-3
1B seq ORF 595 5-TCAGCATGCAAGGACAAGAGCG-3
1B seq ORF 885 5-AGCATCCGGTACTTTGAGATCAC-3
1B seq ORF 1305 (h) 5-ACCACCACTGCTGCTGATGCCAC-3
1B seq rev ORF 300 5-CACCATGA CCGTGCAGTC CTC-3
pQE80-7WD-3Hind3 5-GC AAGCTT CTA CCG CAG TGA GAT GAG GAT CGG-3
pMLT-7WD-3EcoR1 5-GC GAATTC CCG CAG TGA GAT GAG GAT CGG GTC-3
1B-1B2Ac1-3 5-AGA GCC AGG CCG CAG TGA GAT GAG GAT CGG-3
2A-1B2Ac1-5 5-TCA CTG CGG CCT GGC TCT GAG CTG CTG-3
pMAL-5EcoR1-
rm1Btail
5-CG GAATTC GAAGCCTATGTGCCCAG-3
pMAL-3Hind3-
rm1Btail
5-CG AAGCTT CTATGTATCCCCATTCTCC-3
h1B-5-S2A 5-CGCCACC ATG GCC TTC CGC AAA GTG GTC-3
h1B-3-S2A 5-GAC CAC TTT GCG GAA GGC CAT GGTGGCG-3
h1B-5-S2D 5-CGCCACC ATG GAC TTC CGC AAA GTG GTC-3
h1B-3-S2D 5-GAC CAC TTT GCG GAA GTC CAT GGTGGCG-3
3Sal1-delCC-h1B 5-TGTG GTCGAC TC CCC GGC TCT GGC CAG GCT G-3 delCC-h1B
5R1-PRO-h1B 5-CG GAATTC GCCACC ATG TGC TAT GAG GAC ATT CGC G-3 PRO-h1B
3Sal1-PRO-h1B 5-TGTG GTCGAC TC CAG TTT GTA GAA CCG GGC-3
3-1B-1B2Ac2 5-CAG TTT GTA GAA CCG GGC GAT C-3 after FYKL
5-2A-1B2Ac2 5-TTC TAC AAA CTG ATC ACA ACC AAA AGC C-3
3N-delPRO-h1B 5-ATG GCCGCCGCCGCC CTG GTC GTT CTT GAC CGG C-3 delPRO-h1B
5C-delPRO-h1B 5-CAG GGCGGCGGCGGC CAT GAG CGC AAG TGT GAG C-3
5-R1-MBP-c-exte 5-GC GAATTC ATG CAT GAG CGC AAG TGT GAG C-3 works with pQE80-
7WD-3Hind3
3-Xho1-GST-N-exte 5-AG CTCGAG CTA CTG GTC GTT CTT GAC CGG C-3 works with 5
hCoro1bFWD-BamH1
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3-2A-1B2Ac3 5-AATGTCCTCATAGCA GTT CTC CTT GCT GGC TGG-3 1B2Ac3, 1B propeller,
others are 2A, works with
5-2A-R1
5-1B-1B2Ac3 5-TGC TAT GAG GAC ATT CGC G-3 1B2Ac3, 1B propeller,
others are 2A, works with
3-2A-Sal1
C4-2Apro-3-1B 5-CTGGTCGTTCTTGAC CGG C-3 work with 1B-5-R1, 1B
template
C4-2Apro-5-2A 5-GTCAAGAACGACCAG TGC TAC GAC TCC GTG CC-3 work with 1B-3-Sal1,
2A1Bc2 template
C5-567-3-2A 5-GGCCCGCATGGGCCG GTG CCC TTT GTA GCT G-3 work with 2A-5-R1, 2A
template
C5-567-5-1B 5-CGGCCCATGCGGGCC ATC-3 work with 2A-3-Sal1,
1B2Ac2 template
2mRFP-5-Nhe1 5-GA GCTAGC GCCACC ATG GCC TCC TCC GAG GAC G-3
2mRFP-3-EcoR1 5-GA GAATTC TTA GGC GCC GGT GGA GTG G-3
stopMBP-5 5-G TAA GCC GCC TAG C A-3
stopMBP-3 5-AGCTT G CTA GGC GGC TTA CTGCA-3
RevEGFPseq 5-C AGC TCC TCG CCC TTG CTC ACC-3
Rev2Aseq400 5-GT GGG GTG CCA CTC CAC CAG-3
Rev2Aseq1100 5-TT CAT CCC GCT GAG CCA CTC-3
pMAL-V2-PreS 5-TCGGG GAT CTGGAAGTTCTGTTCCAGGGGCCC CTG GAATTC CCATGG
GGATCC GTCGAC G TGA A-3
pMAL-V2-PreS-Rev 5-AGCTT TCA C GTCGAC GGATCC CCATGG GAATTC CAG
GGGCCCCTGGAACAGAACTTCCAG ATC C-3
pML2-cc-5 5-GC GAATTC GCCACC ATG GAG GCT GGG AAG CTG GAGG-3 work with 3-SalI-1B
pML2-Ne-3 5-TGTG GTCGAC TC CTG GTC GTT CTT GAC CGGC-3 work with 5-R1-1B
MBP-PCR-5-Pst1 5-GA CTGCAG ATG AAA ACT GAA GAA GG-3
MBP-PCR-3-Hind3 5-GC AAGCTT TCA CGA GCT CGA ATT AGT CTG C-3
V3-McsHisPre 5-TA GAATTC TCTAGA GGATCC GTCGAC A CATCACCATCACCATCAC
CTGGAAGTTCTGTTCCAGGGGCCC CTGCA-3
V3-McsHisPreRev 5-G GGGCCCCTGGAACAGAACTTCCAG GTGATGGTGATGGTGATG T
GTCGAC GGATCC TCTAGA GAATTC-3
pET21a-1B-5-NdeI 5-GGAATTC CATATG TCC TTC CGC AAA GTG GTC C-3
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pET21a-2A-5-NdeI 5-GGAATTC CATATG TCA TGG CAC CCC CAG TAC C-3
pET21a-h1B-3Hind3 5-GC AAGCTT CGC ATC CCC GTT CTC CAT G-3
pET21a-h2A-3Hind3 5-GC AAGCTT GAG CTG CTC TGA GCC CAT C-3
1B5R1-S2A 5-GC GAATTC GCCACC ATG GCC TTC CG-3
1B5R1-S2D 5-GC GAATTC GCCACC ATG GAC TTC CG-3
3-HA-NcoI 5-GA CCATGG C TGC GTA GTC TGG TAC G-3 Good for FV1E FV2E
F2E RHE
5-F1E-BamHI 5-GA GGATCC G TCT AGA GGA GTG CAG G-3
5-F2E-BamHI 5-GA GGATCC G AGC CAG CGC TCT AGA GG-3
1B-RRAA-1 5-CCTG AAG ATC AGC GCGGCC AAC GTG TTG TCTG-3
1B-RRAA-2-Rev 5-CAGA CAA CAC GTT GGCCGC GCT GAT CTT CAGG-3
5-RHE-BamHI 5-GA GGATCC G ATG GCT TCT AGA ATC C-3
5-R1-mRFP 5-GA GAATTC GCCACC ATG GCC TCC TCC GAG GAC G-3
3-SalI-mRFP 5-GA GTCGAC TTA GGC GCC GGT GGA GTG G-3
5-R1-SSH3 5-GC GAATTC GCCACC ATG GCC CTG GTC ACA G-3
3-KpnI-SSH3 5-GA GGTACC AT GGC CTC GCC CTC CTC TC-3
5-SSH3CS-FWD 5-G GTC CAC AGC AAG ATG GG-3
3-SSH3CS-REV 5-C CAT CTT GCT GTG GAC CAG-3
SSH3CS-seq-Cata 5-A GCC TCC CGC ATC TTC-3
3-1BK287Q-REV 5-GAT GCT GGA GTC ACC CTG GCCGC-3 work with 1B-R1
5-1BK287Q-FWD 5-AG GGT GAC TCC AGC ATC CGG-3 work with 1B-SalI
5-REK3a-FWD 5-GCCGCTGCC GCT CAT GAG GGG GCC CGG-3 work with EGFPrevSeq
3-REK3a-REV 5-CTC ATG AGC GGCAGCGGC CTC TGC CAC CAG GGT GCC-3 work with R1-1B
5-V5-FWD-NcoI 5-CATGG AC GGT AAG CCT ATC CCT AAC CCT CTC CTC GGT CTC
GAT TCT ACG CT-3
3-V5-REV-NcoI 5-CATG AG CGT AGA ATC GAG ACC GAG GAG AGG GTT AGG GAT
AGG CTT ACC GT C-3
N-ECFP-MfeI 5-GCT CAATTG GCCACC ATG GTG AGC AAG GGC GAG G-3 useful for GFP CFP YFP
C-ECFP-EcoRI 5-GC GAATTC AGATCT CTT GTA CAG CTC GTC CAT G-3 useful for GFP CFP YFP
5-c-Myc-FWD-NcoI 5-CATGG AC GAG CAG AAG CTG ATC TCA GAG GAG GAC CTG CT-3 useful for GFP CFP YFP
3-c-Myc-REV-NcoI 5-CATG AG CAG GTC CTC CTC TGA GAT CAG CTT CTG CTC GT
C-3
DsRed2-3-HindIII 5-TCC AAGCTT AAG CGG CCG C-3 mRFP-5-NheI for the 5-
DsRed2
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IRES-5-NcoI 5-GA CCATGG CC TGA GCC CCT CTC CCT CCC CC-3
IRES-3-XbaI 5-GC TCTAGA TTA TCA TCG TGT TTT TCA AAG G-3
mSSH1-5-SalI 5-TGTG GTCGAC GCCACC ATG GCC TTG GTG ACC CTT CAG C-3
mSSH1-3-BamHI 5-AA GGATCC TC GCT TTT GTT TAC CCT CGA CGG GC-3
SSH1W458A-for 5-caagctg GCC cgtcagcagac-3
SSH1W458A-rev 5-gctgacg GGC cagcttgttgtg-3
5-RHE-BamHI 5-GA GGATCC G ATG GCT TCT AGA ATC CTC TGG-3 work with NcoI 3 primer
5-R1-VC-NWASP 5-GA GAATTC GCCACC ATG CCT TCT GAT GGG GAC CAT C-3
3-BamHI-VC-NWASP 5-GA GGATCC AG TGA AGA ATG AAT GGC TTT GCT C-3
5-BamHI-A-NWASP 5-GA GGATCC GAT GAA GAT GAA GAT GAA GAT G-3
3-KpnI-A-NWASP 5-TGT GGTACC AG GTC TTC CCA CTC ATC ATC ATC-3
SSH1W458A-fL 5-gcggcacaacaagctg GCC cgtcagcagacagacagcagcc-3
SSH1W458A-rL 5-ggc tgc tgt ctg tct gct gac g GGC ca gct tgt tgt gcc
gc-3
Along-for 5-GATCC gatgaagatgaagatgaagatgatgaagaagattttgaggatgatgatgagtgggaagac
AG GGTAC-3
Along-rev 5-C CT gtcttcccactcatcatcatcctcaaaatcttcttcatcatcttcatcttcatcttcatc
G-3
1C400rev 5-AA GCA CAT TGC GGG CCG-3 a sequencing primer at
about 430 bp of hm1C
F3R 5-GC GAATTC GCCACC ATG TCC cgg CGC AAA G-3 work with EGFPrev or
Sal1-1B by PCR
K216A-FWD 5-g gca gag cgg gag GCC gct cat gag ggg gc-3 work with EGFPrev or
Sal1-1B
K216A-REV 5-gc ccc ctc atg agc GGC ctc ccg ctc tgc c-3 work with EcoR1-1B
K198A-f 5-ca gca tgc aag gac GCC agc gtg cgc atc atc-3 work with EGFPrev or
Sal1-1B
K198A-r 5-gat gat gcg cac gct GGC gtc ctt gca tgc tg-3 work with EcoR1-1B
3-F1E-NcoI 5-GA CCATGG C ATA ACT AGT TTC CAG-3 work with 5-F1E-BamHI
1C-F378VE379S-fwd 5-g gag gca gaa gag tgg GTCTCA ggc aag aat gca gac c-3
1C-F378VE379S-rev 5-ggtctgcattcttgcc TGAGAC ccactcttctgcctcc-3
R30A-fwd 5-gc tat gag gac att GCC gtg tcc cgt gtt acc-3
R30A-rev 5-ggtaacacgggacacGGCaatgtcctcatagc-3
K73A-FWD 5-g ggc cgc att gac GCC gcc tac ccg acg g-3
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NAME SEQUENCE NOTE
K73A-REV 5-ccgtcgggtaggcGGCgtcaatgcggccc-3
E215A-f 5-g gtg gca gag cgg GCC aag gct cat gag g-3
E215A-r 5-cctcatgagccttGGCccgctctgccacc-3
5-trimer-BamHI 5-GA GGATCC G ggttatatt cctgaagcgc caagagatgg
gcaagcttac gttcgtaaag acggcgaatg ggtattgctt tctacctttt
ta-3
fibritin last seq for
trimerization, GYI
PEAPRDGQAY
VRKDGEWVLL STFL
3-trimer-NcoI 5-GA CCATGG C taaaaaggtagaaagcaataccc-3
R30Dforward 5-gc tat gag gac att GAC gtg tcc cgt gtt acc-3 EGFP reverse
R30Dreverse 5-ggtaacacgggacacGTCaatgtcctcatagc-3 1B-R1
K73E-F 5-g ggc cgc att gac GAG gcc tac ccg acg g-3 1B template, EGFPrev
K73E-R 5-ccgtcgggtaggcCTCgtcaatgcggccc-3 1B template, 1B-R1
K216Efor 5-g gca gag cgg gag GAG gct cat gag ggg gc-3 work with EGFPrev, 1B
template
K216Erev 5-gc ccc ctc atg agc CTC ctc ccg ctc tgc c-3 work with 1B-R1, 1B
template
C6-1B123-f 5-cac cct gac GTG ATC CTC TCC ATG-3 1Bpro template, work
with EGFPrev
C6-1B123-r 5-GAGGATCACgtcagggtgcaggc-3 1Bpro template, work
with 2A-R1
C7-1B12345F 5-ac tcg agc TCG GGC GTG CTG TTT C-3 1Bpro template, work
with EGFPrev
C7-1B12345R 5-CACGCCCGAgctcgagtccagttc-3 1Bpro template, work
with 2A-R1
S978A-f 5-g aag cgc tca cac GCC ctt gcc aag ctg-3 with SSH1L-rev
S978A-r 5-cagcttggcaagGGCgtgtgagcgcttc-3 with SSH1L-for
S937A-f 5-g acc cgg agt tcc GCC agc gat agc atc-3 with SSH1L-rev
S937A-r 5-gatgctatcgctGGCggaactccgggtc-3 with SSH1L-for
5-RI-Anew 5-GC GAATTC GCCACC ATG GAT GAA GAT GAA GAT GAA GAT G-3
3-BglII-V5 5-GTCAGATCTGACGTAGAATCGAGACCGAGGAG-3
control siRNA FOR-
WARD
5-T GATCGACTTACGACGTTAT TTCAAGAGA CTAACGTCGTAAGTCGATC
TTTTTTC-3
5-MfeI-SSH1L 5-GCT CAATTG GCCACC ATG GTC CTG GTG ACC C-3
3-BglII-SSH1L 5-GC AGATCT GG GCT TTT GCT CAT CCA CGA AGG-3
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E215Kfor 5-g gtg gca gag cgg AAG aag gct cat gag g-3
E215Krev 5-cctcatgagccttCTTccgctctgccacc-3
5-MfeI-MTVH-1B 5-GCT CAATTG gaa aat ctt tat ttt caa ggt ATG TCC TTC
CGC AAA GTG GTC CGG-3
3-HindIII-MTVH 5-GC AAGCTT cta atg gtg atg gtg atg gtg atg atg acc ggt
acg-3
5MfeI-1BS2D-TVH 5-GCT CAATTG gaa aat ctt tat ttt caa ggt ATG gac TTC
CGC AAA GTG GTC CGG-3
3-A-W500S-SacII 5-GC CCGCGG TACCGTCGACCCGGGGTACC ct GTC TTC gct CTC ATC
ATC ATC-3
work with 5-LTR-NotI,
directly into A2re
NotI/SacII
E219K-fwd 5-gag aag gct cat AAG ggg gcc cgg ccc atg-3
E219K-rev 5-catgggccgggccccCTTatgagccttctc-3
E257K-forwd 5-ca gaa aac ctc gag AAA ccc atg gcc ctg cag-3
E257K-rever 5-ctgcagggccatgggTTTctcgaggttttctg-3
L261E-FWD 5-gag gaa ccc atg gcc GAG cag gaa ctg gac tc-3
L261E-REV 5-gagtccagttcctgCTCggccatgggttcctc-3
5-mycARY-EcoRI 5-TC GAATTC gccacc atg GAG CAG AAG CTG ATC TCA GAG GAG
GAC CTG gat GAA GAT GAA GAT GAA GAT Gaa g-3
5-MfeI-FPs 5-gca CAATTG GCCACC ATG GTG AGC AAG GGC-3
3-HA-l-SacII-ApaI-s-
SbfI
5-CT cctgcagg TCA gggccc TCC ccgcgg TCC GCC GCT GCC TCC
tgcgtagtctggtacgtcg-3
FWD-GS-A2mWASP 5-GG gat gaa ggg gag gat cag acc ggc gag gat gaa gag
gat gat gaa tgg gat gac GGGCC-3
REV-A2 5-C gtcatcccattcatcatcctcttcatcctcgccggtctgatcctccccttcatc
CCGC-3
5-BglII-MyrPal-VC2-
mWASP
5-GGC AGATCT GCCACC ATG gga tgt ata aaa tca aaa GA
GGATCC gc CCATGG AG ggtgggggccggggtgcac-3
3-SalI-VC2 5-GCT gtcgac TCA atg gat gac tct act cct ctt c-3
5-BglII-MyrPal 5-GGC AGATCT GCCACC ATG gga tgt ata aaa tca aaa-3
3-SbfI-A2-W500S 5-CT cctgcagg TCA GGGCCC gtc atc GCT ttc atc-3
Fnew-A2mWASP 5-GG gat gaa ggg gag gat cag acc ggc gag gat gaa gag
gat gat gaa tgg gat gac TGA CCTGCA-3
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Rnew-A2mWASP 5-GG TCA gtcatcccattcatcatcctcttcatcctcgccggtctgatcctccccttcatc
CCGC-3
5-QSSH1L-NotI 5-GA gcggccgc GCCACC atg gtcctggtgaccctgc-3
5-QSSH1L-HindIII 5-GCaagcttCCgcttttgctcatccacgaagg-3
3-Q5-AgeI 5-GC accggttca CGTAGAATCGAGACCGAGGAGAGGGTT
AGGGATAGGCTTACCAGTTTTCTCGAA CTGCGGGTG g-3
use Q1B as the template,
put V5 after StrepII then
STOP
F-rCTTN 5-TGAACGCATCCACCTTTGAGTTCAAGAGATTCAAAGGTGGATGCGTTCTTTTTTC-3
R-rCTTN 5-TCGAGAAAAAAGAACGCATCCACCTTTGAATCTCTTGAACTCAAAGGTGGATGCGTTCA-3
mCTTN5-R1 (r h) 5-GC GAATTC GCCACC ATG TGG AAA GCC TCT GCA GGCC-3
hrmCTTN3-Sal 5-TGTG GTCGAC TC CTG CCG CAG CTC CAC ATA G-3
3Q-HA-HindIII 5-GC aagctt CC TGC GTA GTC TGG TAC G-3 Good for FV1E FV2E
F2E RHE
3-BglII-VC2 5-GCT agatct TCA atg gat gac tct act cc-3
3Q-His8-HindIII GGATCC ACC GGT CGC CAC C cat cat cac cat cac cat cac
cat gga gga cag TGA aagctt GC
3Q-His8-HindIII-2 5-GC aagctt TCA ctg tcc tcc atg gtg atg gtg atg gtg atg
atg GGTGGCGACCGGTGGA-3
use pML2 as the tem-
plate, 5-EcoRI primer,
His-8 replaces EGFP,
then STOP
Fresist-p34with3 5-ggAatgCtCaaAcgCaa ttgttttgcc-3
Rresist-p34with5 5-ttGcgTttGaGcatTcc agcttgatg-3
p34-5-R1 5-GC GAATTC GCCACC atgatcctgctggaggtgaac-3
p34-3-SalI 5-TGTG GTCGAC TC gcg gga tga aaa cgt ctt cc-3
seq5LTR 5-gcatccgaatcgtggac-3
seq5IRES 5-tacatgtgtttagtcgagg-3
pTTQ-SA=forseq 5-ctggccatacacttgagtgac-3
pTTQ-pA=revseq 5-gaggtcgaggtcgggggatc-3
1-For-GFPRHE-SalI 5-gca gtcgac C ggcggaggttcc GTGAGCA AGGGCGAGGA GC-3
2-Rev-GFPRHE-
BamHI
5-GA ggatcc TTA TGC GTA GTC TGG TAC GTCG-3
3-For-mpF1E5-PacI 5-GCG TTAATTAA gccacc ATG gga tgt ata aaa tc-3
4-Rev-mpF1E5-SbfI 5-TGA cctgcagg TCA ATA ACT AGT TTC CAG TTT TAG AAGC-3
5-seq-GFP-end 5-TCA CAT GGT CCT GCT GGA G-3
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6-seq-IRES-end 5-gctttacatgtgtttagtcgagg-3
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Appendix C
Published materials and methods
C.1 General materials and methods
Antibodies to Coronin 1B (4245.Exp) were affinity purified as described below. Com-
mercial antibodieswere obtained from Cell Signaling Technologies (pSerPKC, pLIMK1/2,
LIMK1), Upstate Biotechnology (p34Arc, 4F11/Cortactin), Cytoskeleton (Cofilin),
Chemicon (actin), Biosource (pPaxillinSer126, pErk1/2), Roche (7.1+13.1/GFP), Clon-
tech (JL-8/GFP), Sigma (9E10/myc), Santa Cruz (yN16/Arp2) and Jackson ImmunoRe-
search (Cy2, Rhodamine Red-X, Cy5, and Horseradish Peroxidase conjugated sec-
ondary antibodies). AlexaFluor dye conjugated phalloidins were from Molecular
Probes. Inhibitors Ro32-0432, Go¨6976 and okadaic acid were from Calbiochem. Pro-
tease and phosphatase inhibitors (phenylmethylsulfonyl fluoride, 1,10-phenanthroline,
aprotinin, leupeptin, sodium fluoride, and sodium orthovanadate) were from Sigma.
All other materials were from Fisher Scientific unless otherwise indicated. Rabbit
muscle G-actin and bovine Arp2/3 complex were generous gifts from Dr. Dorothy
Schafer (University of Virginia). Cells were obtained from ATCC (Figure C.1).
C.2 Coronin 1B antibody production and affinity pu-
rification
Rabbits were immunized with a GST fusion protein containing the human Coronin
1B C-terminal region (394-489 aa) by Covance. Serum was affinity purified against
an MBP fusion protein containing the equivalent region of mouse Coronin 1B to
ensure cross-reactivity. This MBP fusion protein was purified in a buffer contain-
ing 10 mM MOPS (pH 7.5) and 60 mM sodium citrate, which was used for direct
coupling to UltraLink biosupport media (Pierce) according to the manufacturer’s
protocol. The column was washed extensively with 10 mM Tris (pH 7.5), 100 mM
glycine (pH 2.5) and 100 mM triethylamine (pH 11.5) with neutralizing washes be-
tween. Crude serum was diluted 10 fold in 10 mM Tris (pH 7.5) and passed through
the column three times. The column was washed with 10 mM Tris (pH 7.5) and
then with 500 mM NaCl, 10 mM Tris (pH 7.5). Antibodies were eluted sequentially
with 100 mM glycine (pH 2.5), followed by 100 mM triethylamine (pH 11.5). The
antibody-containing factions were neutralized, combined and dialyzed against PBS.
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Figure C.1: Purified proteins used in in vitro assays
Purified proteins, the Arp2/3 complex, GST-VCA, actin, Coronin 1B and Cortactin, were separated
on SDS-PAGE, and Coomassie Blue stained for visulization. Please noticed that all the proteins have
been stored in 4◦C for one month before running this gel.
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C.3 Cell culture and viral transduction
HEK293 and Swiss 3T3 cells were cultured in DMEM-H supplemented with 10%
FBS (HyClone), 100 U/ml penicillin, 100 µg/ml streptomycin and 292 µg/ml glu-
tamine. Rat2 and NIH3T3 cells were cultured in the same media supplemented with
5% FBS or 10% calf serum (HyClone), respectively. Transient transfections were per-
formed using FuGENE 6 (Roche) for HEK293 cells, PolyFect (Qiagen) for Rat2 cells
and Lipofectamine 2000 (Invitrogen) for NIH3T3 cells. Retroviral packaging, infec-
tions, and fluorescence-activated cell sorting were as described (Bear et al., 2000).
Lentivirus production and infection were as described (Rubinson et al., 2003).
C.4 Molecular cloning
PCR and subcloning were performed using standard methods. Detailed methods
and primer sequences are available upon request. Plasmids expressing wild type
Coronin 1B, WT1B-EGFP, was constructed by amplifying the coding sequence of
human Coronin 1B and cloning it into a pMSCV-based retroviral vector (23). S2A-
EGFP and S2D-EGFP were generated from WT1B-EGFP by site-direct mutagenesis
using mutation-encoding primers. Coronin 1B-Myc was generated by subcloning
the Coronin 1B coding sequence into a pMSCV vector containing a C-terminal Myc
tag. Chimeras between Coronin 1B/2A and mutations on Coronin 1B were gen-
erated by over-lapping PCR method and verified by sequencing. Drosophila S2
cell expression constructs were generated by sub-cloning Coronin 1B-EGFP frag-
ments into the pAc5.1/V5-HisA vector (Invitrogen). For mammalian cell protein
expression, the Coronin 1B coding sequence was inserted into the multi-cloning
sites of the pTT5SH8Q2 vector that contains the StrepTagII and 8xHis affinity tags
(Durocher et al., 2002; Shi et al., 2005). The Cortactin coding sequence was inserted
into a modified pTT5SH8Q2 vector that contains the StrepTagIII and 8×His affin-
ity tags. SSH1L-GFP was constructed by amplifying the coding sequence of human
Slingshot-1L (IMAGE clone 6376684) and inserting it into a pMSCV-based retroviral
vector. The CS version of SSH1L-GFP was generated by overlapping PCR muta-
genesis and confirmed by sequencing. SSH1L-Myc was generated by subcloning
the SSH1L coding sequence into a pMSCV vector containing a C-terminal Myc tag.
Wild type or Serine 3 mutant Cofilin constructs were cloned in the pMSCV-based
retroviral vector by PCR. Cofilin S3A and S3D mutants were generated by encod-
ing the mutation in the PCR primers. The short hairpin RNA (shRNA) construct
used to knockdown Coronin 1B (KD-1B) was generated according to the instructions
found at http://www.unc.edu/∼cail/biotool/2shRNA.html. The control shRNA
(NS; GATCGACTTACGACGTTAT) has no exact match in the human, mouse or rat
genome. The shRNA vector pLL-5.0 is a modification of the original pLentiLox
3.7 vector (Rubinson et al., 2003), in which the CMV promoter driving GFP ex-
pression was replaced with the 5’ LTR promoter from pMSCV and a short multi-
cloning site to facilitate lower expression levels of GFP fusion proteins for rescue or
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imaging. A schematic example of a construct in pLL-5.0 is shown in Figure 3.19-
A. The 19nt sequence against Cortactin is GAACGCATCCACCTTTGAA. The 19nt
sequence against p34Arc is GGCATGTTGAAGCGAAATT. In modified pLL-7.0 vec-
tor, the CMV promoter drives the expression of mCherry fusion proteins. To replace
the endogenous p34Arc, the KD-p34 shRNA sequence was inserted in the lentivirus
vectors first, and the p34Arc coding sequence, which was amplified from Hela cells
cDNA and obtained the silence mutation to resist to RNAi, was inserted after either
the LTR promoter or the CMV promoter. Constructs replacing endogenous Coro-
nin 1B and Cortactin were produced in a similar way. All the coding regions of the
constructs were verified by DNA sequencing.
C.5 TaqMan qRT-PCR
Total RNA was isolated from murine tissues using a Qiagen RNeasy Isolation kit
according to manufacturer’s protocol. Reverse transcription into cDNA was done
in 20 µl volume using oligo-DT (12-18) Primer, 10mM dNTP Mix, and Improm-II
Reverse Transcriptase (Promega) according to manufacturer’s instructions. PCR re-
actions were carried out in a 20 µl volume consisting of 10 µl of Universal Mas-
ter Mix - No AmpErase UNG (Applied Biosystems), 0.25 µg of fluorogenic probe
(Mm00486998 m1[1A],Mm00488552 g1[1B],Mm00488558 m1[1C],Mm00619135 m1[2A],
Mm00558512 m1[2B], Mm00504152 m1[POD], Applied Biosystems), and 8 µl of di-
luted cDNA (80ng of total RNA/reaction). The PCR reactions were carried out un-
der standard conditions in a 20 µl volume in duplicate for each sample in the ABI
Prism 7700 Sequence Detection System (Applied Biosystems). The number of PCR
cycles needed to reach the fluorescence threshold was determined in duplicate for
each cDNA, averaged, and then normalized against a reference gene, 18S (4333760-
0311007 Applied Biosystems), to yield the cycle number at which fluorescence was
reached (Ct). For the absolute copy number of Coronin 1A, 1B, 1C, 2A, 2B, and POD,
4-fold dilutions of the respective mouse full-length cDNAs were used to generate a
standard curve (22). All tissue samples tested were within the linear range (19-38
cycles) of the assay.
C.6 Drosophila S2 cell actin cable formation assay
Drosophila S2 cells were cultured as previously described with slight modifications
(Rogers et al., 2003). Briefly, S2 cells were maintained in Schneider’s Drosophila
medium (Gibco) supplementedwith 10%heat-inactivated FBS (HyClone), 100 units/ml
penicillin, 100 µg/ml streptomycin and 292 µg/ml glutamine (Gibco). S2 cells were
transfected using CellFectin reagent (Invitrogen) according to the manufacturer’s
protocol. For high resolution imaging, S2 cells were plated on concanavalin A-
coated coverslips and stained according to standard protocols.
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Silencing of endogenous Drosophila p20Arc was performed as previously de-
scribed (Rogers et al., 2003). Briefly, RNAi-depletion was performed on S2 cells
for 7 days according to previous published methods (Clemens et al., 2000) using
PCR products flanked at their 5’ and 3’ ends by T7 sequences (p20Arc primers:
5-CAGACAACAACCCGACACC-3 and 5-CAGTTTCATTTCGCTGATCTCC-3). On
day 5, p20Arc depleted cells were transfected with the Coronin 1B expression con-
struct.
C.7 Recombinant Coronin 1B protein production
Coronin 1B recombinant protein was expressed and purified either from theDrosophila
S2 expression system (Invitrogen) or a mammalian expression system. Purified pro-
tein was quantified from absorbance at 280 nm and the predicted extinction coeffi-
cient of 65890 M−1cm−1.
To produce the protein from insect cells, Coronin 1B coding sequence was sub-
cloned into the EcoRI and EcoRV sites in the pMT/V5-HisA vector (Invitrogen). This
construct was co-transfected with pBS-Puro (Benting et al., 2000) into S2 cells by
Cellfectin (Invitrogen). Cells were selected and expanded according to the manu-
facturer’s protocol to generate a stable cell line. To purify Coronin 1B protein from
S2 cells, a 100 ml culture containing 1×107 cells/ml was grown in a spinner flask,
and induced with 1 mM CuSO4 for 24 hours. Cells were harvested and washed
with phosphate-buffered saline (PBS) prior to purification. The cell pellet was re-
suspended in 14 ml His-Base Buffer (20 mM Tris-HCl pH 8.0, 0.5% Triton X-100,
0.5 M NaCl, 5% Glycerol, 5 mM 2-mercaptoethanol, 1 mM PMSF, 10 µg/ml 1,10-
phenanthroline, 10 µg/ml aprotinin and 10 µg/ml leupeptin), followed by a brief
sonication on ice for 10 seconds and rotation at 4◦C for 30 minutes. Lysates were
cleared by centrifugation (SS-34 rotor, 14,000×rpm, 15 minutes) and the supernatant
was added to His-Base buffer washed Ni-NTA Beads (Qiagen) supplemented with
20 mM imidazole. After binding at 4◦C for 1 hour, the beads were washed with
His-Base Buffer containing 20 mM imidazole. Protein was eluted with 220 mM imi-
dazole and dialyzed against MKEI-50 Buffer (10 mM imidazole pH 7.0, 1 mM EGTA,
2 mMMgCl2, 50 mM KCl, 0.2 mM ATP and 0.1 mM DTT).
For mammalian expression, the Coronin 1B coding sequence was inserted into
the multi-cloning sites of the pTT5SH8Q2 vector that contains the 8×His and Strep-
TagII affinity tags (Durocher et al., 2002; Shi et al., 2005). HEK293 cells growing in
Dulbecco’s modified Eagle’s medium (high glucose) with 5% calf serum were trans-
fected with the construct using linear polyethylenimine (M.W. 25,000) as described
previously (Durocher et al., 2002). Three days after the transfection, cells were lysed
in NewHope Buffer (350 mMNaCl , 5% Glycerol , 5 mM imidazole , 50 mM Tris-HCl
pH 8.0, 0.5% Triton X-100, 1 mM PMSF, 10 µg/ml 1,10-phenanthroline, 10 µg/ml
aprotinin and 10 µg/ml leupeptin). Cell lysate was cleared by centrifugation and
His-tagged protein was purified by Talon Beads (Clontech Laboratories). Protein
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was eluted with NewHope Buffer containing 250 mM imidazole. Elution fractions
containing Coronin 1B were pooled and further purified by StrepTactin Beads (Qia-
gen). The beads were washed with NewHope Buffer and MKEI-50 Buffer. Protein
was eluted with MKEI-50 Buffer with 2.5 mMD-desthiobiotin, and dialyzed against
MKEI-50 Buffer.
To produce phosphorylated Coronin 1B, 50 nM phorbol 12-myristate 13-acetate
(PMA) was used to stimulate HEK293 cells for 30 minutes prior to harvesting. Ac-
tivated sodium orthovanadate (4 mM) was added to all buffers used during the pu-
rification of phospho-Coronin 1B. The phosphorylation status of this protein was
further verified by both pSerPKC blotting and immunoprecipitation, as well as mass
spectrometry analysis (Figure 3.12).
Cortactin was purified using the protocol described above. The protein was
quantified from absorbance at 280 nm and the predicted extinction coefficient of
84355 M−1cm−1.
C.8 Actin co-sedimentation
High-speed actin co-sedimentation was performed as previously described with
modifications (Bryce et al., 2005). Briefly, F-actin was prepared from actin monomers
by polymerization in the presence of 50 mMKCl, 2 mMMgCl2, 5 mM Tris-Cl pH 8.0
and 1 mMATP for 30 minutes at room temperature. Coronin 1B was incubated with
F-actin at room temperature for 1 hour (with 4% glycerol), and sedimented using an
Airfuge (Beckman) at 23 psi (∼100,000×g) for 30 minutes. Pellet and supernatant
samples were prepared for SDS-PAGE using standard procedures. To calculate the
binding affinity of Coronin 1B to F-actin, we used an established supernatant de-
pletion method (Bryce et al., 2005). Coronin 1B bound to F-actin ([1Bp]) was de-
termined indirectly by immunoblotting the supernatant and quantified by densito-
metry ([1Bt]= 0.1 µM. All blots were within the linear range of detection (data not
shown). F-actin concentrations [Fa] were calculated from total G-actin concentration
and the known critical concentrations for ATP G-actin (0.1 µM) and ADP G-actin (5
µM). ADP G-actin was prepared as previously described and used within 4 hours
(Pollard, 1986). In order to appropriately compare ADP to ATP F-actin, the ATP G-
actin used for affinity measurements (Figure 4.5-C,D) was regenerated from ADP G-
actin by diluting the stock of ADP G-actin from 20 µM to 5 µMwith 0.1 mMMgCl2,
0.1 mMEGTA pH 8.0 and 1mMATP. To calculate Coronin 1B’s F-actin binding affin-
ity, the following formula was used to fit the experimental data. Statistical analysis
and graphing were performed with Prism (GraphPad Inc.). Low-speed actin co-
sedimentation was performed as previously described (Goode et al., 1999). Briefly, 1
µMCoronin 1B wasmixed with 1 µMATP F-actin and incubated for 2 hours at room
temperature. The reactions were subjected to centrifugation at low speed (13,000×g)
for 5 minutes and pellet and supernatant samples were analyzed as decribed above.
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C.9 Pyrene actin polymerization assay
Spectrin F-actin seeds (SAS), actin, pyrene labeled actin, GST-VCA andArp2/3 com-
plex were prepared as described (Bryan and Coluccio, 1985; DiNubile et al., 1995;
Egile et al., 1999; Higgs et al., 1999; Spudich and Watt, 1971). Seeded actin polymer-
ization reactions were performed as described (Barzik et al., 2005) with 1 µM actin
(5% pyrene labeled) and 0.2 nM SAS. VCA-induced Arp2/3 nucleation reactions
were performed as follows: Coronin 1B and Arp2/3 (20 nM) were mixed in MKEI-
50 Buffer and incubated at room temperature for 5 minutes; reactions were initiated
by the simultaneous addition of 1.5 µM actin (5% pyrene labeled, primed with 1
mM EGTA and 0.1 mM MgCl2 for 90 seconds) and GST-VCA (1 nM or 10 nM). The
delay between mixing reactants and recording fluorescence was 20 seconds. Fluo-
rescence of pyrene-actin (excitation at 365 nm, emission at 386 nm) was monitored
for 2000 seconds at 25◦C. Fluorescence was converted to the molar concentration
of F-actin from the fluorescence of completely polymerized (24 hours post reaction)
and unpolymerized actin, assuming a critical concentration of 0.1 µM. Initial actin
assembly rates were determined from linear fits of data collected during first 200-400
seconds. Maximal actin assembly rates were determined from linear fits of the rate
as 0.5-1 µM actin polymer formed during the reactions. To examine the synergistic
effect of Cortactin, 0.5 µM Cortactin was mixed with Arp2/3 complex with or with-
out Coronin 1B in MKEI-50 Buffer for 5 minutes before the addition of G-actin and
VCA.
C.10 Pyrene actin depolymerization assay
Pyrene actin depolymerization assay was performed as previously described (Mose-
ley et al., 2006). Briefly, 5 µl of 5 µM ATP G-actin (30% pyrene labeled) was poly-
merized at room temperature for 1 hour in F-Buffer (10 mM Tris-HCl pH 7.5, 0.2
mM DTT, 0.2 mM CaCl2, 50 mM KCl, 2 mM MgCl2, and 0.7 mM ATP), with or
without 5 µM phalloidin (final concentration). To initiate depolymerization, 245 µl
MKEI-50 Buffer was added to the 5 µl pre-assembled actin filaments (final concen-
tration 0.1 µM actin in reaction) with or without Coronin 1B and/or Cofilin. His-
Cofilin was purified by standard methods. Care was taken to avoid filament shear-
ing. Pyrene fluorescence was monitored at 25◦C (Figure 4.8-A 1-second interval,
Figure 4.8-B 5-second interval; excitation 365 nm, emission 386 nm). Fluorescence
was converted to the molar concentration of F-actin from the initial fluorescence of
phalloidin-stabilized actin (assuming all F-actin) and the final fluorescence of 2 µM
Cofilin treated sample (assuming all G-actin).
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C.11 Actin TIRF assay
TIRF based actin branching assay was performed as published (Kuhn and Pollard,
2005). Briefly, thoroughly cleaned glass coverslips and parafilm strips were used to
prepare imaging chambers. NEM-inactivated myosin was diluted to 0.2 µM in HS-
TBS (50 mM Tris-Cl, pH 7.6, 600 mM NaCl; HS-TBS) and 10 µl were loaded into a
freshly prepared chamber. After 1 minute at room temperature, the chambers were
washed with 10 µl 1% (w/v) BSA in HS-TBS followed by 10 µl 1% BSA in LS-TBS
(50 mM Tris-HCl, pH 7.6, 50 mMNaCl) and 10 µl MEKI-50 Buffer. Freshly prepared
TIRF imaging buffer (100 mM KCl, 2 mM MgCl2, 2 mM EGTA, 20 mM imidazole
pH 7.0, 30 mM glucose, 1% 4000 cP methylcellulose, 200 mM DTT, 0.4 mM ATP,
40 µg/ml catalase, 200 µg/ml glucose oxidase) was used to mix the reactions. In a
standard condition, 0.5 µM actin (30% Oregon green labeled) was nucleated in the
presence of 13.3 nM Arp2/3 and 13.3 nM VCA. The reactions were captured at 10-
second intervals by objective based TIRFM, with automatic focusing components
enabled (ZDC, Olympus). AlexaFluor 568 C5-Maleimide dye labeled Coronin 1B
used in some TIRF assay was prepared following manufacturers protocol (Invitro-
gen).
C.12 Second-wave actin debranching assay
Debranching assay is a modified actin TIRF assay using unlabled G-actin and ob-
serving the result by labeling the actin filaments with Rhodamine phalloidin. First,
Reactions were initiated by mixing 0.5 µM G-actin with 13.3 nM Arp2/3 complex
and 13.3 nM GST-VCA in TIRF imaging buffer, and progressed for 10 minutes to
form actin branches inside the imaging chamber. Different proteins mixtures in TIRF
imaging buffer with 0.8 µM capping proteins were flushed into the reaction cham-
bers for 2 minutes, which also completely removed the residual VCA and G-actin.
Control experiments indicated that flushing without G-actin prevents the further
actin filament elongation. Finally, Rhodamine-phalloidin (1.5 µM) in TIRF imaging
buffer were flushed into the chamber to stop the reactions and stain the actin fila-
ments.
C.13 Arp2/3 dissociation assay
F-actin was polymerized from actin monomers either by spontaneous nucleation
or induced by SAS for 30 minutes at room temperature, with 50 mM KCl, 2 mM
MgCl2, 5 mM Tris-Cl pH 8.0 and 1 mM ATP. Either 50 nM or 25 nM Arp2/3 com-
plex was mixed with pre-formed actin filaments with or without Coronin 1B (Cor-
tactin, Cofilin or bovine serum albumin (BSA)) for 30 minutes at room temperature
or overnight at 4◦C, in the presence of 4% glycerol. Reactions were sedimented using
an Airfuge (Beckman) at 23 psi (∼100,000×g) for 30 minutes. Pellet and supernatant
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samples were prepared for SDS-PAGE using standard procedures. Arp2/3 complex
associated with actin filaments, which was in pellets, was quantified by densitom-
etry from immunoblotting. Statistical analysis and graphing were performed with
Prism (GraphPad Inc.).
C.14 Partial proteolysis and circular dichroism analysis
For partial proteolysis reactions, 6 µg either wild type or the R30D mutant protein
was mixed with 20 ng protease K and incubated at 55◦C. Reactions were stopped
at fixed time points by mixing with 2× SDS sample buffer and immediately boil-
ing. Samples were separated by PAGE and visualized by silver staining. To per-
form circular dichroism analysis, protein samples were dialyzed in 5 mM pH 7.4
Na2HPO4/NaH2PO4 buffer overnight at 4
◦C. Circular dichroism spectra was ob-
tained from Pistar-180 Circular Dichroism / Fluorescence spectrometer (Applied
Photophysics), scanning from 260 nm to 185 nm with steps of 0.2 nm.
C.15 Immunoprecipitation
Cells were washed twice with PBS and lysed with a KCl Buffer (20 mM HEPES pH
7.0, 100mMKCl, 0.5%NP-40, 1mMEDTA, 1mMPMSF, 10 µg/ml 1,10-phenanthroline,
10 µg/ml aprotinin, 10 µg/ml leupeptin, 10 mM sodium fluoride and 2 mM sodium
orthovanadate). Lysates were cleared at 13,000×g for 5 minutes and incubated with
1 µg of primary antibody for 1 hour at 4◦C, followed by the addition of 20 µl 50%
slurry ImmunoPure immobilized protein A beads (Pierce) or Protein G Sepharose
4 Fast Flow beads (GE Healthcare) and further incubation at 4◦C for an additional
hour. To immunoprecipitate GFP fusion, the antibody from Roche (7.1+13.1/GFP)
should be used, not the Clontech one (JL-8/GFP). Beads were pre-blocked with 1
mg/ml BSA and washed extensively with the KCl Buffer prior of usage. The im-
munocomplexes were collected, washed with the KCl buffer three times, separated
by SDS-PAGE and transferred to a PVDF membrane (Bio-Rad) for western blotting.
C.16 In vitro phosphorylation
2 µg of recombinant protein was incubated with 0.5 µg of PKCα (Panvera or Sigma)
in 100 µl Kinase Assay Buffer (7.2 mM HEPES pH 7.4, 3.6 mM MgCl2, 0.18 mM
EGTA, 0.1% Triton X-100, 0.63 mM CaCl2, 0.1 µM ATP, 0.5 µM PMA, 120 µM phos-
phatidylserine) containing 10 µCi [γ-32P]ATP for 30 minutes at 30◦C (24). Reactions
were terminated by adding an equal volume of 2× sample buffer. The samples were
subjected to SDS-PAGE and transferred to a nitrocellulose membrane for autoradio-
graphy and peptide mapping.
219
C.17 In vivo phosphorylation
Cells were serum-starved for 12 hours before metabolic labeling, and then incubated
with [32P]orthophosphoric acid (Amersham Biosciences) in phosphate-free mini-
mum essential medium (Sigma). After 8 hours, cells were treated with or without
100 nM PMA for 30 minutes and lysed with RIPA Buffer (50 mM Tris-HCl pH 7.3,
150 mMNaCl, 1% IPEGAL, 0.5% deoxycholate, 1 mM EDTA, 1 mM PMSF, 10 µg/ml
1,10-phenanthroline, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 mM α-naphthyl
acid phosphate, 10 mM sodium fluoride and 2 mM sodium orthovanadate). The
13,000×g cleared lysates were immunoprecipitated as described above. The im-
munocomplexes were separated by SDS-PAGE and transferred to a nitrocellulose
membrane for autoradiography and peptide mapping.
C.18 Peptide mapping
Peptide mapping was performed as described previously (25,26). Briefly, appro-
priate protein bands were cut from the nitrocellulose membrane and digested with
TPCK treated trypsin (95%, 284 U/mg; Worthington) in 0.05 M NH4HCO3 pH 7.8
at 37◦C for 24 hours. The peptides were washed and dried using a speed vacuum
centrifuge, and spotted onto cellulose HPTLC plate (Merck KGaA, Germany) for
2D mapping using pH 8.9 buffer (ammonium carbonate 10 g/l) for electrophoresis
in the first dimension and phospho-chromatography buffer (n-Butanol : pyridine :
glacial acetic acid : deionized water = 75:50:15:60) for chromatography in the second
dimension. After that the HPTLC plates were dried completely for autoradiography.
C.19 In vivo Coronin 1B dephosphorylation assay
The in vitro Slingshot phosphatase assay is a modification of a previously published
protocol (Nagata-Ohashi et al., 2004; Niwa et al., 2002). Briefly, SSH1L-myc was im-
munoprecipitated from transiently transfected HEK293 cells using myc antibodies
(9E10). Purified SSH1L-myc on beads was washed extensively with SSH Buffer (50
mMHEPES pH 7.4, 150 mMNaCl, 2 mM EGTA, 2 mMMgCl2, 1% NP-40, 1% Triton
X-100, 10% glycerol, 1 mM PMSF, 10 µg/ml 1,10-phenanthroline, 10 µg/ml apro-
tinin, 10 µg/ml leupeptin and 10 mM sodium fluoride) before use. Purified Coronin
1B was phosphorylated in vitro using purified PKCα as described above. Coronin 1B
was phosphorylated in vivo by 100 nM PMA stimulation for 30 minutes prior to ly-
sis. Cells were lysed in 1 ml SSH Buffer containing 1 µM Ro32-0432. Cleared lysate
was divided into five aliquots and varying amounts of SSH1L-Myc on beads was
added to each aliquot. Dephosphorylation reactions were performed at 30◦C for 30
minutes. The reaction was stopped by adding 700 µl chilled RIPA containing 4 mM
activated sodium orthovanadate. The SSH1L-Myc beads were spun out of the lysate
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andCoronin 1Bwas immunoprecipitated from the supernatant. Following immuno-
precipitation, the unbound fraction was concentrated by chloroform/methanol pre-
cipitation. The concentrated unbound fractions, the SSH1L-Myc beads and Coronin
1B immunoprecipitates were analyzed by immunoblotting as indicated in Figure
3.10-D.
C.20 Light microscopy and image analysis
For immunofluorescent staining, the cells were fixed, stained and mounted as de-
scribed previously (23). Cells were stained in various combinations with AlexaFluor
568 phalloidin for F-actin (1:400 dilution), p34Arc (1:400 dilution), Cortactin (1:500
dilution), or affinity-purified Coronin 1B antibody (1:200 dilution), etc. Images were
captured using a Nipkow-type spinning disk confocal scan head (Yokogawa CSU-
10) attached to an inverted microscope (model IX-81, Olympus) equipped with a
60× 1.45 NA objective, a CCD camera (model C4742-80-12AG, Hamamatsu), and
controlled by Andor iQ software (previously AQM Advance 6, Kinetic Imaging
Ltd.). The extended depth of focus plugin for ImageJ was used to combine multi-
ple images from a z-stack (8 slices, 150-200 nm interval) into a single in-focus image.
Images were combined and annotated in Photoshop for presentation. To stimulate
uniform lamellipodial protrusion, Rat2 cells were sodium azide treated (PBS sup-
plemented with 0.1 g/l CaCl2, 0.1 g/l MgCl2, and 20 mM NaN3) for 30 minutes and
recovery with fresh culture media for 5 minutes before fixation. To plot the distri-
bution of a protein around the cell edge, a contour based ImageJ macro was used
(Figure 3.1-B, detailed methods as described below). To compare the ratio between
two channels cross multiple cells, lower 50% of the capture range of the camera was
used and the imaging capture was performed with exact same hardware configu-
ration. Fluorescence recovery after photobleaching (FRAP) movies were captured
using a FluoView FV1000 scanning confocal microscope (Olympus) equipped with
a 405 nm laser and a 60× objective (N.A. 1.4). Photobleaching was performed using
tornado mode for 100 milliseconds on a circlular area (28-pixel diameter). Fluores-
cence intensities from the bleached area were measured using ImageJ, and analyzed
and graphed in Prism. The fluorescence intensities before irradiation and 20 seconds
after photobleaching were used to calculate the FRAP immobile fractions.
C.21 Lamellipodial co-localization analysis
To perform the lamellipodial co-localization analysis, confocal stacks were combined
by wavelet-based extended depth of focus projection (Forster et al., 2004) and ana-
lyzed using a custom ImageJ macro. Briefly, an ImageJ plugin was used to combine
multiple images from a multichannel z-stack (4 slices for each channel with 200 nm
interval) into a single in-focus RGB file, and further processed using a custom macro.
All three immunofluorescence images were collapsed into a single image that was
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then converted to a binary mask by thresholding (Figure 3.1-F). Dilation or erosion
operations were iteratively performed to create a series of contour lines both inside
and outside the perimeter of the cell using a custom ImageJ macro (Figure 3.1-D,E).
Pixel intensities for each labeled antibody or GFP along the contour lines were ex-
tracted from each channel and the average intensity is plotted as a function of dis-
tance from the edge of the cell (Figure 3.1-G). Since each point on the graph rep-
resents the average intensity of approximately 2000 pixels, variation of signal due
to fixation, staining or imaging artifacts is minimized. For cells that did not show
continuous protrusion around the entire periphery of the cell, as determined by the
anti-Cortactin labeling (Figure 3.1), a hand drawn polygon mask was used to ex-
clude those regions lacking peripheral Cortactin staining. Extracted pixel intensities
were exported to Excel for analysis and Prism (GraphPad Inc.) for graphing.
Pixel intensity information from -3 to 0 µm was utilized to generate an index of
relative leading edge enrichment. This index was calculated using the formula [(L -
C) / L] where L is lamellipodial peak intensity and C is cell body minimum intensity
and presented as percentile score.
C.22 Active/total Cofilin ratio imaging
To assess active/total Cofilin ratios, cells were stainedwith antibodies against Cofilin
(MAB22; 1:100) and phospho-Cofilin (4321; 1:170). Rat2 cells were infected with
lentivirus expressing shRNA against the target protein for 3 days. Cells were plated
onto glass coverslip coated with 10 µg/ml fibronectin for 4 hours. Cells were fixed
with 4% paraformaldehyde in Kreb’s S Buffer (145 mM NaCl, 5 mM KCl, 1.2 mM
CaCl2, 1.3 mMMgCl2, 1.2 mMNaH2PO4, 10 mM glucose, 20 mMHEPES pH 7.4 and
0.4 M sucrose), permeabilized with 0.1% Triton X-100 in phosphate-buffered saline.
After blocking the coverslip with 5% BSA and 5% normal goat serum (Jackson Im-
munoResearch, West Grove, PA, United States) in phosphate-buffered saline for 15
minutes, cells were stained with primary antibodies overnight at ◦C. After briefly
washed with phosphate-buffered saline for 10 minutes, cells were further processed
following standard protocol.
The images were captured in epifluorescent mode. Differential Interference Con-
trast (DIC) images were taken to demonstrate the shape of the cells. The ImageJ plu-
gin, Ratio Plus was used to calculate the image ratio between pCofilin and Cofilin
staining. The ratio was converted into active/total Cofilin ratio by [(Total Cofilin-
phosphoCofilin) / Total Cofilin], normalized and presented using a rainbow look-
up table. To quantify the ratio in whole cell level, images were taken under 2×2
binning setting, and the fluorescent intensity was in the linear range of the CCD
camera. Cells were outlined based on the GFP signal, and the average intensity of
both pCofilin and Cofilin was recorded and exported to Excel (Microsoft) for further
analysis.
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C.23 Analysis of free actin filament barbed ends in vivo
Free actin filament barbed ends were detected in fibroblasts as described previously
with slight modifications (Bryce et al., 2005). Rat2 cells were infected with lentivirus
expressing shRNA specific for Coronin 1B or control shRNA (co-expressing GFP-
actin as a marker of infection). Cells were plated onto glass coverslips coated with
10 µg/ml fibronectin for 4 hours. Cells were washed quickly with pre-warmed PBS,
and then permeabilized and labeledwith 0.4 µMAlexaFluor 568 in Permeabilization
Buffer (20mMHEPES, 138mMKCl, 4 mMMgCl2, 3 mMEGTA, 0.2mg/mL saponin,
1% BSA, 1 mM ATP, 3 µM phalloidin) for 30 seconds. After the labeling, the cells
were fixed with 4% paraformaldehyde in Kreb’s S Buffer (145 mMNaCl, 5 mM KCl,
1.2 mM CaCl2, 1.3 mM MgCl2, 1.2 mM NaH2PO4, 10 mM glucose, 20 mM HEPES
pH 7.4 and 0.4 M sucrose) for 10 minutes and counterstained with AlexaFluor 647
phalloidin. AlexaFluor-568-actin labeling was quantified from the pixel intensity
profile around the cell periphery using the method described for Figure 3.1. The
upper 50% of pixel intensities were used to determine the width of the zone of free
barbed ends (Figure 3.4). The ratio of the barbed end intensity to phalloidin intensity
along the edge was normalized and plotted as a function of distance from the cell
margin (Figure 3.4).
C.24 Negative stained samples to TEM
To visualize actin bundling effect, an equal volume of either 20 nM or 2 µM Coronin
1B was mixed with F-actin (2 µM Mg-ATP G-actin, pre-assembled for 30 minutes)
and incubated for 1 hour at room temperature. Aliquots of these samples were ad-
sorbed directly onto glow-charged thin carbon foils on 400-mesh copper grids with-
out fixation and stained with 2% (w/v) uranyl acetate. The grids were examined in a
Philips CM12microscope at 80 kV. The images were taken at magnification 10,000 or
45,000 on Kodak SO-163 film, scanned using an Imacon FlexTight 848 scanner (Has-
selblad AB) at resolution 2500 dpi and adjusted for publication using Photoshop
(Adobe).
To visualize actin branches, overnight equilibrated actin branches, formed by
20 nM Arp2/3, 1 nM GST-VCA, 1.5 µM actin and 2 µM phalloidin, were mixed
with an equal volumn either 560 nM Coronin 1B or 630 nM Cortactin for 5 minutes.
Aliquots of these samples were adsorbed directly onto glow-charged thin carbon
foils on 400-mesh copper grids without fixation and stained with 2% (w/v) uranyl
acetate. The grids were examined by TEM. Slightly modified version was used to
visualize Arp2/3 complex bound to actin filaments, which is explained in the figure
legends (Figure 5.7-B,C,D).
To check the protein components at actin branches, branching reactions were in-
cubated overnight with different antibodies. Briefly, actin branches were generated
by mixing 20 nM Arp2/3, 1 nM GST-VCA with 1.5 µM actin, with or without 150
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nM Coronin 1B or 60 nM Cortactin. Additional 1:100 dilution of primary antibod-
ies, 1:25 dilution of colloidal gold secondary antibodies and 2 µM phalloidin were
mixed with the reactions overnight and allowed to reach equilibrium at 4◦C. Sam-
ples were adsorbed directly onto glow-charged thin carbon foils on 400-mesh copper
grids without fixation and stained with 2% (w/v) uranyl acetate.
To examine the localization of Cortactin or Coronin 1B in vivo, Rat2 cells were
plated on collodion-filmed grides for 6 hours (Small and Sechi, 1998). Cells were
fixed and immuno-gold stained following a previous published protocol (Maunsbach,
1998). After the immuno-gold staining step, cells were negative stained with 2%
(w/v) uranyl acetate. The samples were examined under TEM.
C.25 Platinum replica electron microscopy
Rat2 cells were infected with retrovirus expressing membrane targeted Coronin 1B
and FACS sorted for GFP positive population with equal expressing of the fusion
protein. Cells were plated onto coverslips coated with 10 µg/ml fibronectin for 4
hours. Platinum replica samples were prepared as described previously, a detailed
protocol is included in Section D.1. Images were collected at 6300× using a Philips
CM12 microscope at 60 kV using Kodak SO-163 negative film.
To examine the localization of Coronin 1B or Arp2/3 complex in platinum replica,
a modified extraction buffer (10 mM MES pH 6.1, 3 mM KCl, 3 mM MgCl2, 2 mM
EGTA, 0.16 M sucrose, 0.1% Triton X-100 and 0.5 µM phalloidin) was used to pre-
serve the Coronin 1B localization. After the extraction, cells were processed as pre-
viously described. Coronin 1B antibody (4245.Exp) and the antibody against p41Arc
subunit of the Arp2/3 complex were used during immuno-gold staining.
C.26 PMA-induced ruffling assay
To quantify ruffling, Rat2 cells were serum-starved overnight, stimulated with 100
nM PMA, fixed at various times as indicated, and stained with AlexaFluor 568 phal-
loidin to visualize membrane ruffles. At least 200 cells were counted for each time-
point.
C.27 Single cell tracking
Migration of Rat2 fibroblasts was analyzed by single cell tracking. Cells were in-
fected with lentivirus co-expressing Coronin1B or control shRNAwith GFP or Coro-
nin 1B-GFP, or any other fluorescent constructs. GFP negative cells were analyzed
as an internal control. To increase data throughput, 10-20 different fields (containing
approximately 10 to 20 cells per field) were simultaneously recorded using an auto-
mated X-Y stage (Prior). To avoid bias in the analysis, every cell in each movie that
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met the tracking criteria (did not divide, was completely within the field of view
for the entire experiment, and did not touch another cell for more than two frames)
was tracked using Tracking Analysis software (Andor iQ, previous Kinetic Imaging)
with the point-click mode. Cell speed was calculated using the Tracking Analysis
software and directional persistence was calculated using custom Matlab macros (a
kind gift of B. Harms, MIT). Data were analyzed using Prism (GraphPad Inc.) for
statistical analysis.
C.28 Kymography analysis
Images were captured using a 40× 0.6 NA objective in phase contrast mode with 1-
second interval. Each movie contains 300 frames, and more than 5 movies were cap-
tured for each experimental condition. A plugin of ImageJ, Kymograph, was used
to generate time space plots. Briefly, a minimal intensity project was preformed for
each movie. The regions with more active protrusion events show stronger phase
dark in the output. Lines of interested were placed vertically to the protrusions,
pointed from center to periphery of the cell. In small protrusions, the line of inter-
est was placed in the center of the protrusion, while in big protrusions, less than 3
lines were placed with at least 30◦ between. Based on generated kymographs, lines
for rate measurement were placed following waves (from hollow to peak). Length
and angles of these lines were measured in ImageJ. A custom made perl script was
utilized to calculate all the protrusion parameter, including rate, persistence and dis-
tance. Data were exported to Prism for statistical analysis.
C.29 Actin retrograde flow measurement
Rat2 cells were infected with lentivirus expressing different fluorescent makers. Im-
ages were captured using spinning disk confocal microscopy (1-second interval, 1×1
binning for single channel signal; 2-second interval, 2×2 binning for dual-color sig-
nal). Kymographs were generated from these movies and analyzed to calculate the
retrograde flow rate and the distance travelled. To calculate the Pearson’s correlation
coefficient, pixel intensities in the region of interest were extracted by built-in func-
tion of ImageJ. Normalized values were imported into Excel (Microsoft) for analysis.
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Appendix D
Experimental protocols and recipes
D.1 2-D phospho-peptide mapping
Please use screw-cap tubes all the time.
1. Fraction 32P-labeled protein (from in vitro phosphorylation experiment or im-
munoprecipitated endogenous 32P labeled protein) by SDS-PAGE (load enough
protein marker next to samples).
2. Transfer the protein to membranes. In literature, they prefer nitrocellulose
membrane, but Immobilon-P, nylon, PVDFmembranes can also be used (choose
PVDF for phosphoamino acid assay). Rinse the membrane with water after the
transfer to remove glycine and SDS.
3. Autoradiography and excise the membrane piece of interest. Optional: multiple
cuts for different proteins.
4. Soak the piece of membrane immediately in 0.5% PVP-360 (to block the mem-
brane; polyvinylpyrrolidone, Mr 360000, Sigma) in 100 mM acetic acid for 30
min at 37◦C to increase the efficiency of peptide elution.
5. Aspirate the liquid, wash membrane with water for 5 times (1 ml/each). Then
wash with freshly made 0.05 M NH4HCO3 twice.
6. Incubate with 10 µg/15 µl tosylphenylalanine chloromethyl ketone (TPCK)-
treated trypsin for 2 hours in 150-200 µl (just cover the membrane) freshly
made 0.05 M NH4HCO3 at 37
◦C. Then for another 2 hours with an additional
10 µg/15 µl of fresh enzyme. Count the radioactivity in the membrane and the
supernatant. If there is still more than 50% radioactivity left in the membrane,
re-do the digestion. Transfer all the liquid, which should contain 90% of the
radioactivity, into a screw-cap tube.
7. Dry it on a Speed-Vac (3-4 hours; never dry completely, because peptides may
be stick to the bottom of the tube). Add 1.5 ml water and dry it. Repeat several
times to remove almost all the NH4HCO3. You can use a bit heat.
8. Optional, this step can be omitted if none of the peptides of interest contains methio-
nine or cysteine) Oxidize the dried peptides in 50 µl ice-clod performic acid (vortex
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thoroughly) at 0C for 60 min (be careful not to warm the sample, as performic acid
can cleave certain peptide bonds). Add 400 µl deionized water, freeze by dry ice, and
lyophilize the frozen sample.
9. Wash with 1.5 ml water then dry completely. Prepare the sample for mapping
using ∼5 µl pH 1.9 or pH 8.9 buffer (load ∼2.5 µl sample to one plate).
10. Load the sample onto the cellulose thin layer plate using pulled capillary tube.
Keep the wet area as small as possible. Allow air-dry or dry with cool air from
hair dryer.
11. Wet plate by buffer soaked filter paper. Set up the apparatus. Run first di-
mension with pH 1.9 or pH 8.9 buffer at 1000 V 30 min. Air-dry the plate in
hood.
12. Use phospho buffer to do the second dimension chromatography.
13. Air-dry the plate in hood. Expose the plate to film (Kodak).
14. Find the spot of interest on the film and mark the position on the plate. Scrape
the cellulose from the marked area. Elute the peptides using 100 µl of pH 1.9
buffer, followed by one wash with deionized water. Use Cerenkov counting to
check the elution efficiency.
15. Dry the sample. Add 100-200 µl 6N HCl at 110◦C for 1 hour. Lyophilize in
Speed-Vac with acid trap.
16. Resuspend hydrolysate in 5 µl pH 1.9 buffer with phosphoamino acid stan-
dards.
17. Load the sample onto the plate. Wet plate with running buffer. Set up appa-
ratus. Run first dimension in pH 1.9 buffer at 1500 V for 20 min. Air-dry the
plate in hood. Run second dimension in pH 3.5 buffer at 1300 V for 19 min.
Air-dry the plate in hood.
18. Spray the plate with 0.2% ninhydrin (in hood). Bake the plate in 65◦C for at
least 15 min to develop the stain. Expose the plate to film (Kodak).
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D.2 Combined TIRF assays
Coverslips preparation
Glass coverslips #1.5 of 24x40 mm is cleaned as in Kuhn and Pollard (2005).
1. Coverslips in glass container are sonicated for 45 min in 2% (v/v) Versa-Clean
detergent (Fisher Scientific) in hot tap water, rinsed 10 times in hot water, and
sonicated an additional 30 min.
2. Coverslips are rinsed 10 times with distilled water, incubated for 3 hr in 1 M
KOH at 42◦C, rinsed three times in double distilled (dd) water, and incubated
overnight in 1 M HCl at 42◦C.
3. Coverslips are cooled to room temperature, rinsed five times in dd water, son-
icated for 30 min in dd water, rinsed twice in 1 mM EDTA, and sonicated for
30 min in EDTA to reduce calcium contamination.
4. Coverslips are rinsed twice in 70% ethanol, sonicated for 30 min, rinsed twice
in absolute ethanol, sonicated for 30 min, and rinsed in absolute ethanol.
5. Clean coverslips are stored in absolute ethanol in screw-top plastic jars and are
used within two weeks.
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Flow cell preparation
Flow cells are prepared as in Kuhn and Pollard (2005).
1. A coverslip is removed from ethanol, flamed dry and cooled on a smooth glass
surface.
2. Strips of parafilm are stretched to approximately three times their length and
placed across the long axis of the coverslip, leaving a 4-mm gap. Please follow
the texture of the parafilm.
3. A glass slide is flamed and placed perpendicular across the parafilm strips.
4. The parafilm strips are compressed by firm hand pressure on the top of the
slide to seal the sides of the chamber.
5. The chamber is flamed again briefly and cooled to stick the protruding parafilm
strips to the open coverslip surface.
6. Solutions are loaded directly into the chamber via capillary action. Placing 2-
fold (∼10 µl) chamber volumes of solution at one end and pulling it through
with a piece of filter paper on the other side changed the solution in the cham-
ber. 10 µl of NEM-myosin in HS-TBS (50 mM Tris-HCl pH 7.6, 600 mM NaCl)
is loaded into a freshly prepared chamber. After 1 minutes, the flow cell is
washed with 1% BSA in HS-TBS, 1% BSA in LS-TBS (50 mM Tris-HCl pH 7.6,
50 mM NaCl) and MKEI-50 Buffer.
Braching/debranching assay
Branching/debranching assay is a modified version from Kuhn and Pollard (2005)
and Ichetovkin et al. (2002).
1. Prepare the TIRF imaging buffer: 100 mM KCl, 2 mM MgCl2, 2 mM EGTA,
20 mM imidazole pH 7.0, 30 mM glucose, 1% 4000 cP methylcellulose; freshly
added 200 mM DTT, 0.4 mM ATP, 40 µg/ml catalase, 200 µg/ml glucose oxi-
dase). The basic solution without the goodies should store in -20◦C, not 4◦C.
2. Oregon green 488 iodoacetamide (OG) labeledG-actin is dialyzedwith G buffer
and ultracentrifugated to ensure the monomeric form of actin. Other protein
components are prepared freshly to ensure the best biochemical activities.
3. First-wave branching: After washing the flow cell with MKEI-50 Buffer, 0.5
µM OG-actin, 13.3 nM Arp2/3 and 13.3 nM GST-VCA (pre-cleared by ultra-
centrifugation) are mixed quickly in the TIRF imaging buffer (final reaction
volumn ∼30 µl) and loaded into the flow cell via capillary. Reaction is allowed
to perform at the room temperature for 10-15minutes. Start imaging by TIRFM
if needed.
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4. Second-wave debranching: Wash the flow cell with any protein mixture in
TIRF imaging buffer in the presence of 0.8 µM capping proteins and image
the field to visualize debranching events. For fixed capture between different
samples, stop the reaction at appropriate time point (2 minutes etc) by loading
10 µl rhodamine phalloidin in the TIRF imaging buffer (1:3 v/v, 1.55 µM). Seal
the flow cell by grease to minimize the evaporation.
Branching reactions can be performed in the presence of Coronin 1B or Cortactin.
Debranching reactions can be performed by using AlexaFluor 568 labeled proteins.
Coronin 1B is “sticky” to BSA coated glass containers. I tried to use pLL-g-PEG
to coat the flow cell (Tosatti et al., 2003), and successfully prevented Coronin 1B’s
random surface absorption. But PEG nucleates actin filaments by itself.
D.3 293Q mammalian protein purification system
To make the Q expression construct, the insert needs to be in frame with pML2 vec-
tor. Cut the insert using EcoRI and SalI and put into the Q vector. Alternatively, check
the multi-cloning sites in the original pTT5SH8Q2 vector (developed by Dr. Yves
Durocher, Canada; using 293Q system needs to sign a material transfer agreement
with yves.durocher@nrc.ca), and use PCR strategy to insert the DNA. Remember no
STOP code at the end of the coding sequence. Midi-prep the Q construct. PEG midi-
prep produces the DNA with less purity than the DNA from Qiagen kits, so please
double the amount of DNA/PEI used.
Transfect cells with PEI (linear polyethylenimine, MW 25000). This PEI reagent
can be bought from PolySciences Inc [9002-98-6] or Fisher Scientific. Dissolve PEI in
water to a concentration of 1 µg/µl, and filter sterilized. Store them at -80◦C. Keep
the working stock at 4◦C.
Prepare a 15 cm2 dish with 80% confluence cells growing in 20 ml DMEM with
10% FBS. Conditioned culture media is fine. Usually, passaging two 10 cm2 dish cells
into one 15 cm2 dish gives a good dish ready for transfection the day after. OVER
CONFLUENCE IS BAD FOR THE TRANSFECTION. Transfect 293E cells with 20 µg
DNA and 50 µg PEI. A tracer construct, Q2-GFP, can be used, which expresses cyto-
plasmic GFP to help examining the transfection efficiency. Only 0.3 µg tracer DNA
is needed for each dish. Transfect 293FT cells with 20 µg DNA and 100 µg PEI. Use
2 ml DMEM without any additive, mix with DNA and PEI, and immediately pipe
completely. Drop the DNA-PEI complex onto the cells after exact 15-minute incu-
bation. After 12 hours, check the transfection efficiency with fluorescent microscope
and at least 50% of the cells should be green.
Prepare the NewHope Buffer and store at 4◦C. Remember absolutely no EDTA
EGTA or DTT in this buffer. 1 L NewHope Buffer: 350 mM NaCl (20.45 g), 5%
Glycerol (50 ml), 5 mM imidazole (5 ml of 1 M pH 7.0 stock), 50 mM Tris-HCl pH 8.0
(50 ml of 1 M stock) and 0.05% Triton X-100 (2.5 ml of 20% stock).
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Lyse each 15 cm2 dish with 10 ml NewHope Buffer and 0.5% Triton X-100 (20%
is 40×, 125 µl for each 5 ml lysis buffer). Add protease inhibitors. If using 50 nM
PMA 10 minutes treatment to produce phosphorylated protein, please remember
add phosphatase inhibitors in the lysis buffer. Scrape the dish, and rotate the lysate
at 4◦C for 10 minutes (all the steps after here must keep cold). Clear the lysate by
centrifugation. 13K rpm 10 minutes is sufficient. Add appropriate amount of Talon
beads (Clontech) or Ni-NTA beads (Qiagen). 1 ml of the 50% slurry beads is enough
for the lysate from one 15 cm2 dish with high transfection rate. Perform His-protein
binding for one hour. Wash the beads with NewHope Buffer three times. Elute the
protein with appropriate amount of NewHope Buffer with 250 mM imidazole, for
instance 750 µl × 4 times. Compare the input and unbound by SDS-PAGE to make
sure the binding is complete.
Add appropriate amount of StrepTactin beads (Qiagen; NOT from Novagen,
which is not good for batch purification due to smaller sized bead matrix) into the
elution. Perform the binding overnight at 4◦C. Wash the beads with NewHope
Buffer three times. Wash the beads with non-biotin buffer. Elute the protein with
2.5 mM D-dethiobiotin (Sigma). MKEI-50 Buffer is compatible with the beads and
Coronin protein. Purified Coronin protein is active in 4◦C for about 20 days. Unlike
Cortactin, freeze and thaw cannot be applied to Coronin.
D.4 Live cell staining by CellTracker
Labeling cells with the CellTrackerTM dye follows the manual from the manufac-
tures (Molecular Probes, Invitrogen). In brief, dissolve the dye powder using DMSO
to make a 2.5 mM stock and keep it in -20◦C. AWAY FROM THE LIGHT. Use the
serum free medium to make the probe containing 2.5 µM CellTracker. When the ad-
herent cells have reached the desired confluence, remove the medium from the dish
and add the prewarmed probe. Incubate the cells for 30 minutes under the growth
condition. Replace the probe solution with fresh, prewarmed medium and incu-
bated the cultures for another 30 minutes at 37◦C. Wash the cells with phosphate-
buffered saline, and they are ready for further experiments.
D.5 Microscopymedia for live cell imagingwithout CO2
supply
It is based on Sigma product D1152. After dissolve the powerdered medium in 90%
of final required volume of water, 0.37 g sodium bicarbonate or 4.93 ml of sodium
bicarbonate solution (7.5% w/v), which is 10% of the original amount, is added for
each liter of final volume of medium. Precisely adjust the pH to 7.4, and finalize to
the desired volume.
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D.6 Transferrin uptake assay
Transferrin uptake assay is a way to monitor the endocytosis. Using fluorescently
labeled transferrin, this assay can be adapted for live cell imaging or FACS based
quantification.
1. Plate appropriate amount of cells on tissue culture dishes 24 hours before ex-
periments.
2. Wash cells with prewarmed PBS. Put 30 µg/ml transferrin in 1% FBS in DMEM
medium onto the cells. Stock solution of the transferrin (AlexaFluor 633 la-
beled or AlexaFluor 568 labeled) is prepared in 1 ml H2O with 0.05% sodium
azide, and the final concentration is 5 mg/ml. Keep in dark.
3. Incubate the transferrin containing mediumwith cells at 37◦C for 3 minutes. A
pilot experiment to figure out the time course of uptake is highly recommended.
4. Fix the cells and process to immunostaining.
D.7 ATP depletion/recovery assay
The assay was performed as described (Bear et al., 2002). Cells were cultured under
the standard conditions for at least 16 hours before the assay, and >50% confluence
is required for good recovery of Rat2 cells. To initiate ATP depletion, culture media
was replaced with PBS supplemented with 0.1 g/l CaCl2, 0.1 g/l MgCl2 and 20 mM
NaN3. Cells were incubated for 30-60 minutes. The NaN3-containing buffer was
then replaced with fresh medium to allow ATP recovery.
D.8 Coronin 1B protein expression and purification from
S2 cells
Coronin 1B recombinant protein was expressed and purified from Drosophila S2 ex-
pression system (Invitrogen). Coronin 1B coding sequence was subcloned into EcoRI
and EcoRV in the pMT/V5-HisA vector. This construct was co-transfected with pBS-
Puro vector (20:1 ratio of pMT/V5-HisA : pBS-Puro) (Benting et al., 2000) into S2
cells by Cellfectin (Invitrogen). Cells were selected and expanded in Schneider’s
Drosophila Media (Gibco) containing 10% heat inactivated fetal bovine serum (Hy-
Clone), 100 units/ml penicillin, 100 µg/ml streptomycin, 292 µg/ml glutamine and
10 µg/ml puromycin for 1 month to generate stable cell line.
To purify Coronin 1B from S2 cells, a 100 ml culture with about 1×107 cells/ml
was prepared, and induced with 1 mM CuSO4 for 24 hours. Cells were harvested
and washed extensively with phosphate-buffered saline before processing to the pu-
rification. To purify His×6 tagged Coronin 1B, use 14 ml His-Base Buffer (20 mM
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Tris-HCl pH 8.0, 0.5 %Triton X-100, 0.5MNaCl, 5%Glycerol, 5mM2-mercaptoethanol,
1mMphenylmethylsulfonyl fluoride, 10 µg/ml 1,10-phenanthroline, 10 µg/ml apro-
tinin and 10 µg/ml leupeptin) to resuspend the cell pellet from a 100ml culture. Son-
icate quickly on ice for seconds and rotate at 4◦C for about 30 minutes. Spin hard to
clear the lysate (SS-34 rotor, 14000 rpm, 15 minutes). Mix pre-washed 60 µl Ni-NTA
beads (Qiagen) with cleared lysate, add imidazole to make the final concentration 20
mM, and rotate in 4◦C for about 1 hour. Wash the beads extensively with His-Base
Buffer containing 20 mM imidazole. Elute the protein with 220 mM imidazole and
dialyze it with MKEI-50 Buffer (10 mM imidazole pH 7.0, 1 mM EGTA, 2 mMMgCl2
and 50 mM KCl).
D.9 Produce Coronin 1B protein in E.coli by TVH sys-
tem
This protocol utilizes autoinduction and intercellular cleavage pMAL-TVHNewHope
system.
1. To make the construct, the insert needs to be in the pMTV5-HisA construct,
because the following primer design needs the V5 tag sequence. Then use two
primers to PCR the insert. Below is the example to amplify Coronin 1B.
# 5-MfeI-MTVH-1B, ENLFQG-1B
5-GCT CAATTG gaa aat ctt tat ttt caa ggt ATG TCC TTC CGC AAA GTG GTC CGG-3
# 3-HindIII-MTVH, V5-His6-HH
5-GC AAGCTT cta atg gtg atg gtg atg gtg atg atg acc ggt acg-3
2. Cut the insert with MfeI (New England Biolabs #4 buffer), and HindIII (#2
buffer). Cut the pMAL-c2g vector with EcoRI and HindIII (#EcoRI buffer).
3. Co-transform BL21(DE3) CodonPlus RP E.coli cells with the pMAL-TVH con-
struct and pRK603 (expressing TEV protease), and select on Kan and Amp
containing LB plates.
4. Prepare auto-induction media. For a 500ml culture: Tryptone 5 g, Yeast extract
2.5 g, 50×5052 10 ml, 50×M 10 ml, 1 M MgSO4 1 ml, 1000×ion 0.1 ml, NaOH
pH to 7.2 (about 4 pellets) and add antibiotic.
50×5052 (200 ml): Glycerol 50 ml, Glucose 5 g, α-Lactose 20 g; finalize to 200
ml, you need around 60◦C to dissolve all the components.
50×M (500 ml): Na2HPO4-12H2O 223.84 g, KH2PO4 85.06 g, NH4Cl 66.86 g,
Na2SO4 17.76 g.
1000×ion (100ml): FeCl3-6H2O 1.3516 g, CaCl2 0.22198 g, MnSO4-H2O 0.16902
g, ZnSO4-7H2O 0.28756 g, CuSO4-5H2O 0.049936 g, NiSO4-6H2O 0.05257 g,
(NH4)6Mo7O24-4H2O 0.03531 g, Na2B4O7-10H2O 0.0190685 g, trace CoCl2 and
Na2SeO3.
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5. Grow a 500 ml culture at 20◦C for 36 hours. Harvest at 5000 rpm 10 minutes.
6. Prepare the purification base buffer. 1000 ml NewHope Buffer: (No EDTA
EGTA DTT) 350 mM NaCl, 20.45 g; 5% Glycerol, 50 ml; 5 mM imidazole, 5 ml
of 1 M pH 7.0 stock; 50 mM Tris-HCl pH 8.0, 50 ml of 1 M stock; 0.05% Triton
X-100, 2.5 ml of 20% stock.
7. Resuspend cell pellet from 250 ml culture in 10 ml NewHope Buffer with pro-
tease inhibitors, 100× stock or 1 mini-pellet of Roche EDTA free cocktail.
8. Add appropriate mount of lysozyme (1 mg), DNase A (DN-25, 10 µl of 1000×)
and RNase A (10 µl of 1000×). On ice for at least 20 minutes. Add extra Triton
X-100 to 1% (10 ml, 0.475 ml of 20%). Rotate at 4◦C for 30 minutes.
9. Spin at 14000 rpm (SS-34 rotor) for 20 minutes.
10. Mix the supernatant with buffer pre-washed 1.6 ml Ni-NTA beads (Qiagen).
Binding in the cold room with rotating for 1 hour. Or pack an column, and
pass the supernatant through the column for 3 times at 4◦C.
11. Make a column with the beads. Collect the unbound fraction for SDS-PAGE
analysis.
12. Wash the Ni-NTA column with at least 50 ml NewHope Buffer.
13. Wash the column with 5 ml NewHope Buffer + 10 mMMgSO4 (0.05 ml of 1 M
stock) + 2 mM ATP (100 µl of 100 mM stock).
14. Wash the column with 40 ml NewHope Buffer + 1MNaCl (10 ml of 5 M stock).
15. Elute the protein with the NewHope Buffer containing 200 mM imidazole.
16. OPTIONAL: Pass the elution through an Amylose resin (New England Biolabs) col-
umn (pre-washed with the buffer) to get ride of the un-cleaved form.
17. Collect the flow through, dialysis and store at appropriate condition. For cross-
linking, avoid Tris, use HEPES. For protein tends to aggregate, keep 5% glycerol.
D.10 In vitro Slingshot phosphatase assay
It is a modification of previously published protocol (Nagata-Ohashi et al., 2004;
Niwa et al., 2002).
The phosphatase SSH1L was immunoprecipitated from HEK293 cells transient
transfected with SSH1L-Myc. SSH Buffer, containing 50 mM HEPES pH 7.4, 150
mM NaCl, 2 mM EGTA, 2 mM MgCl2, 1% NP-40, 1% Triton X-100, 10% glycerol, 1
mM phenylmethylsulfonyl fluoride, 10 µg/ml 1,10-phenanthroline, 10 µg/ml apro-
tinin, 10 µg/ml leupeptin and 10 mM sodium fluoride, was used to lyse the cells.
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Monoclonal antibody 9E10 and Protein G Sepharose 4 Fast Flow (GE Healthcare)
were used to perform the immunoprecipitation. Purified SSH1L-Myc was washed
extensively with SSH Buffer before usage.
Phosphorylated Coronin 1B was generated in vivo by stimulating a confluent 10
cm2 dish of HEK293 cells with 100 nM PMA for 30minutes. Cells were quickly lysed
in 1 ml SSH Buffer containing 1 µM Ro32-0432 (Calbiochem). Cleared cell lysate
was divided into 5 parts and various mount of SSH1L-Myc on Protein G Sepharose
(1/4, 1/8, 1/16 and 1/32 of the total SSH1L-Myc immunoprecipitate prepared from
a confluent 10 cm2 dish) was added into each 200 µl lysate. Dephosphorylation
reaction was performed at 30◦C for 30 minutes. 700 µl of chilled RIPA Buffer with 4
mM activated sodium orthovanadate was added into the mixture at the end of the
reaction.
The Protein G Sepharose was spinned out of the lysate and made into SDS-PAGE
samples for further analysis. Coronin 1B was immunoprecipitated using 4245.Exp
antibody and ImmunoPure Protein A Agarose (Pierce). The lysate after immunopre-
cipitation was subjected to chloroform/methanol precipitation. Precipitated sam-
ples, Protein G Sepharose samples and Coronin 1B immunoprecipitases were ana-
lyzed by immunoblotting using various antibodies.
D.11 Arp2/3 ATP hydrolysis assay
The ATP hydrolysis assay described here is a slight modified one of published ver-
sion (Dayel and Mullins, 2004). The Arp2/3 complex was purified from bovine calf
brain as described before (Higgs et al., 1999). We dialyzed freshly thawed aliquots
of Arp2/3 complex to 0.2 µM in 20 mM Tris-HCl pH 8.0, 50 mM KCl, 0.5 mM DTT,
2 mM MgCl2 and 1 mM EGTA. We added 6 µM γ-
32P-labeled 8-AzidoATP (Affin-
ity Labeling Technologies) into the Arp2/3 complex and incubated it on ice for 2
minutes to allow nucleotide exchange. We crosslinked it for 10 seconds using a UV
hand lamp (312 nm; Fisher Scientific). Reactions were stopped by adding 1 mM
ATP and 1 mM DTT to quench the reaction and buffer exchanged into 1×MKEI-
50 Buffer (1 mM MgCl2, 50 mM KCl, 10 mM Imidazole pH 7.0 and 1 mM EGTA)
plus 100 µM ATP, 1 mM DTT using a NAP5 column (17-0853-01, GE Healthcare,
formerly Amersham Biosciences). Reactions were performed in 1×MKEI-50 Buffer
with 20 nM Arp2/3 complex and 1.5 µM actin. Reactions were started by adding
750 nM bacteria produced recombinant GST-VCA. We took time points by mixing
100 µl of the reaction with premixed 100 µl of methanol and 25 µl of chloroform. We
washed the protein precipitates with 125 µl methanol and solubilized with 1×SDS
sample buffer. The subunits of Arp2/3 complex were seperated by SDS-PAGE and
32P level was quantified using a phosphoimager (Storm 840, Molecular Dynamics).
AFTER CROSSLINKING, THE ACTIVITY OF ARP2/3 COMPLEX NEEDS TO BE EX-
AMINED BY PYRENE ACTIN ASSAYS.
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D.12 Chloroform/methanol precipitation
This procedure is used to concentrate protein lysate for immunoblotting. For 500
µl protein lysate, a mix of 400 µl methanol and 100 µl chloroform is usually used.
After a quick vortex, the mixture is centrifuged at 13000 rpm for 2 minutes. After
spinning, a white pellet is generated. After taking out the supernatant, extra 500 µl
methanol is used to wash the pellet. After centrifugation, remove as much liquid
as possible without disturbing precipitate. Wait for couple minutes, and dissolves
dried sample with 1×SDS sample buffer. Heating at 95◦C for 5 minutes.
D.13 Polyclonal antibody affinity purification
The protocol is specific for Coronin 1B polyclonal antibody affinity purification, and
the purified antibody was named as 4245.Exp (Cai et al., 2005). Rabbits were immu-
nizedwith a GST fusion protein containing the human Coronin 1B C-terminal region
(394-489 amino acids) by Covance. Serum was affinity purified against maltose-
binding fusion protein, containing the equivalent region of mouse Coronin 1B to
ensure cross-reactivity. This maltose-binding fusion protein was purified in a buffer
containing 10 mM MOPS, pH 7.5, and 60 mM sodium citrate, which was used for
direct coupling to UltraLink biosupport media (Pierce) according to the manufac-
turer’s protocol. The column was washed extensively with 10 mM Tris pH 7.5, 100
mM glycine pH 2.5, and 100 mM triethylamine pH 11.5, with neutralizing washes
between. Crude serum was diluted 10-fold in 10 mM Tris, pH 7.5, and passed
through the column three times. After loading the antigen, the column was washed
with 10mMTris pH 7.5, and thenwith 500mMNaCl, 10 mMTris pH 7.5. Antibodies
were eluted sequentially with 100 mM glycine pH 2.5, followed by 100 mM triethy-
lamine pH 11.5. The antibody-containing fractions were neutralized, combined, and
dialyzed against phosphate-buffered saline. Below is a step-by-step protocol:
1. Prepare MBP-m1Btail purification buffers. Base Buffer: 0.01 M MOPS pH 7.5,
0.06 M sodium citrate. Elute Buffer: 0.1 MMOPS pH 7.5, 0.6 M sodium citrate,
10 mMmaltose.
2. Start a 50 ml culture with Ampicillin to 1× (50 µl of 1000× stock). Culture at
37◦C overnight.
3. Add 50 ml starter culture to 1 liter LB Media. Add Ampicillin.
4. Shake (250 rpm) at 37◦C to make OD600 0.6.
5. Cool culture on ice to room temperature. Add IPTG to 0.1 mM.
6. Shake at room temperature for ∼6 hours.
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7. Spin down cells (500 ml bottles, GS-3 rotor, 4700 rpm, 15 min). Pour off media.
Keep pellets in -20◦C or directly proceed the next step.
8. Warm cell pellet on ice. Resuspend it in Base Buffer (1 liter culture to 50 ml).
Sonicate for 6 minutes on ice(15-sec on, 15-sec off, 10 ml each sonication).
9. Freeze sample in a dry ice ethanol bath. Thaw in cold water. Rotate at cold
room for 15 minutes.
10. Spin the lysate at 27000×g (JA17 rotor, 14000 rpm, 15 min).
11. Dilute the supernatant 1:3 with Base Buffer. Apply it to Base Buffer equili-
brated amylose resin column (New England Biolabs, 1 ml 50% slurry for 330
ml culture).
12. Wash the column with 15 ml Base Buffer. Elute the column with 2×3 ml Elute
Buffer.
13. Regenerate the amylose resin column with 3 ml water; 3 ml 0.1% SDS; 3 ml
water and Base Buffer.
14. Coupling the antigen to a bead support (UltraLink from Pierce etc.). In most
circumstances, efficient coupling should exceed 90%. Extensive coupling may
lead to the loss of the antibody binding sites.
15. Transfer the beads with the bound antigen to a column. Wash with 10 bed-
volumes of 10 mM Tris (pH 7.5). Then wash with 10 bed-volume of 100 mM
glycine (pH 2.5), followed by 10 mM Tris (pH 8.8) until the pH of last drop
to be 8.8. Then 10 bed-volumes of 100 mM triethylamine (pH 11.5, prepared
fresh). Wash with 10 mM Tris (pH 7.5) until the pH reaches 7.5.
16. Clean the serum by centrifugation. Dilute the whole serum 10-fold by 10 mM
Tris (pH 7.5). Pass the serum through the column for three times.
17. Wash the column with 20 bed-volumes of 10 mM Tris (pH 7.5), and then with
20 bed-volumes of 500 mM NaCl, 10 mM Tris (pH 7.5).
18. Elute with 10 bed-volumes of 100 mM glycine (pH 2.5). Collect each bed-
volume elute in a tube containing 1/10 bed volume of 1 M Tris (pH 8.0).
19. Wash the column with 10 mM Tris (pH 8.8) until the pH rises to 8.8.
20. Elute with 10 bed-volumes of 100 mM triethylamine (pH 11.5, prepared fresh).
Collect each bed-volume elution in a different tube containing 0.1 bed-volume
of 1 M Tris (pH 8.0).
21. Wash the column with 10 mM Tris (pH 7.5) until the pH is 7.5. The column
may be re-used by storing it in buffers with 0.01% merthiolate.
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22. Blot 1 µl of the elutions onto the membrane. Use the appropriate secondary
antibody for detection.
23. Combine the antibody fractions and dialyze against PBS (add 0.02% sodium
azide for store). If necessary, concentrate it by ammonium sulfate precipitation
or protein A column.
D.14 Freeze E.coli cells
Overnight LB Media culture mixed with 30% in glycerol (from 80% glycerol stock).
Over grown cells may lose their plasmid.
D.15 Freeze mammalian cells
One 10 cm2 dish of 80-90% confluent Rat2 cells can be frozen into 3 vials. Trypsin
cells and spin down in a 15 ml tube (1000 rpm, 3 minutes). Discard the supernatant
and resuspend in 50% final volume of fresh culture medium. If the cells are sen-
sitive to the frozen density, please count the cell number precisely (# of five blocks
of 4×4 = #×5×104/ml). Add 50% final volume of Freezing Medium (60% DMEM
with 1×PSG, 20% FBS, 20% cell culture grade DMSO). Gently mix the cells with the
medium, and aliquot into 0.5-1 ml per vial. Label vials with cell type, construct, date
and experimenter. Freeze the cells slowly in Styrofoam Box. After at least 24 hours,
transfer the cells into liquid nitrogen or -180◦C freezer.
D.16 Using PolyFect transient transfect Rat2 fibroblasts
Plate cells at a density about 50-60% confluence. Serum starve the cells before the
transfection. For a 6 cm2 dish transfection, put 150 µl serum free medium in a mi-
crofuge tube. Add 4 µg plasmid into the mixture. Add 45 µl of PolyFect (Qiagen)
into the medium (pipe up and down throughly ). Incubate at room temperature for
15 minutes. Wash cells with 4 ml PBS and feed them with 3 ml of fresh media. Add
1 ml serum containing media into the tube and drop the transfection mixture onto
the cells. Exchange with fresh media after 12-16 hours. It takes 16-48 hours for the
plasmid to start expressing.
D.17 General media and solutions
• TBMedia for E.coli: BactoTM Tryptone 12 g, BactoTM Yeast Extract 24 g, Glyc-
erol 4 ml; dissolve into 900ml H2O, volume to 1000mlwith distilled water, and
sterilize by autoclaving.
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• LB Media for E.coli: BactoTM Tryptone 10 g, BactoTM Yeast Extract 5 g, NaCl
10 g; dissolve into 900 ml H2O, volume to 1000 ml with distilled water, and
sterilize by autoclaving.
• 1×Transfer Buffer: Tris 3.03 g, Glycine 14.4 g, 20% SDS stock solution 5 ml;
dissolve and volume to 800 ml, and add Methanol 200 ml.
• 10×Transfer Buffer: Tris 90.9 g, Glycine 432 g, SDS 30 g; dissolve and volume
to 3 liter. To make 1×, take 100 ml 10×, and add 700 ml H2O and 200 ml
Methanol.
• RIPA Buffer (200 ml): 150 mMNaCl (6 ml of 5 M stock), 1%NP-40 (2 ml), 0.5%
Deoxycholate (1 g), 0.1% SDS (0.2 g) and 50 mM Tris-HCl pH 8.0 (10 ml of 1 M
stock)
• 2×SDS sample buffer: Glycerol 20 ml, SDS 4 g, 0.5 M Tris-HCl pH 6.8 stock
solution 25 ml, Bromo Phenol Blue 1 mg; dissolve and volume to 95 ml, and
add 5% β-Mercaptoethanol before usage.
• 5×SDS sample buffer: Glycerol 5 ml, SDS 1 g, β-Mercaptoethanol 2.56 ml, 0.5
M Tris-HCl pH 6.8 stock solution 2.13 ml, Bromo Phenol Blue 0.1 mg; keep in
aliquots of 1 ml at -20◦C.
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